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ABSTRACT 
 
 
Chronic diseases are very complex conditions in which two or more disease 
processes may coexist. Managing patients with chronic conditions represents a 
major challenge to public health, since eighty per cent of GP consultations are 
related to these groups. Furthermore, five per cent of them represent roughly forty 
two per cent of the total acute day bed occupancy. 
 
Nowadays, the tendency is to bring patients from high levels of care to primary 
care and home settings. In this scenario, telehealth is one of the methods that can 
be used to improve and provide access to remote patient monitoring at home. 
This is important for patients with chronic diseases as it can help to recognise any 
signs of deterioration, provide health education and support management of their 
condition.  
 
Potentially, telehealth can reduce deaths, emergency visits, A&E visits, elective 
admissions, bed stays and costs. This can be done by designing and 
implementing telehealth interventions that help reduce unnecessary referrals to 
specialised services and monitor patients remotely at home. However, there is not 
a unique framework for designing telehealth interventions. In order to design a 
robust, accurate and reliable telehealth intervention, a number of important factors 
have to be taken into account. 
 
A review of three systematic reviews, and an in-depth investigation of a case 
study based on an EU funded project, were used to gather the evidence for 
telehealth interventions. These were used to identify the main components of the 
framework proposed. The investigation focused primarily on home monitoring for 
patients with diabetes, asthma, hypertension and COPD. We concluded that 
factors such as usability, safe intervention, patients’ individual requirements, 
training, safe interventions, ease of use, data integration, development of 
procedures and allocation of appropriate staff are important components that 
need to be considered in order to satisfy a robust framework. 
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Chapter 1. Introduction 
 
 
1.1 Background 
Last decade, around six hundred million people represented the total ageing 
population in the world, and it has been predicted to rise to around two billion by 
2050 (WHO, 2003). As three leading causes of diseases in adults aged 60 years 
and over are: (1) ischemic heart disease, (2) cerebrovascular disease, and (3) 
chronic obstructive pulmonary disease, the ageing population is more likely to 
suffer chronic and degenerative illnesses (WHO, 2003).  
 
In the case of the UK, seventeen and a half million people live with a chronic 
disease, such as diabetes, asthma, or arthritis (DH, 2005a). Roughly 80% of GP 
consultations are related to chronic diseases, and around 5% of inpatients with 
chronic conditions (very high intensive users) constitute 42% of all acute bed-day 
occupancy (DH, 2004). Numbers in the rest of the world are not much better. 
Global estimations predict that by 2020, approximately 75% of all worldwide 
deaths will be as a consequence of chronic diseases (WHO/FAO, 2003). 
 
In 2002, Derek Wanless (Wanless, 2002) explored future health trends and 
resources in terms of staff, equipment, and other technologies needed by the 
NHS to satisfy the health care demand by 2022. For this, a model was developed 
under three scenarios: “slow uptake”, “solid progress”, and “fully engaged”. The 
model predicted that, in the best of the cases (fully engaged), total health 
spending might increase from 7.7 to 10.6 percent of Gross Domestic Product 
(GDP); in the worst case scenario this would be up to 12.5 percent of GDP.  
 
One can conclude from his report that, on the one hand, morbidity plays an 
important role in health care expenditure in England (likely to be similar in other 
countries). On the other hand, there is a need of increasing or optimising 
resources on the supply side to avoid any eventual collapse of the healthcare 
system. 
 
It has been argued that access and consumption of technologies in everyday life 
may not only represent improvements to the quality of life, but also progress 
towards equity in contemporary societies. To avoid social segregation, a minimum 
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set of affordable products and services must be universally accessible and 
regulated by the state and local governments.  
 
Emerging or enhanced Information and Communication Technologies (ICT) are 
acknowledged to have the potential of being adopted by a significant number of 
healthcare systems across the world and be critical for service modernisation. In 
recent years, the global tendency has been to consider ICT a key service for 
future delivery of care. This is related: 
  First, to the latent worry and assumption that upcoming demand for health care 
is likely to be increased as a direct effect of the growing of the elderly 
population. In particular, the non disease-free groups and other particular health 
consumers living with long term conditions in whom disease management is 
often both complex and resource consuming.  
  Second, to the fact that health workforce is currently limited; predictions state 
that this may remain in the same way.  
  Finally, to the need for increasing health expenditure and optimising resources 
on the supply side. As stated above, by 2020, it has been predicted that the total 
health spending in the UK would increase up to 12.5 % of GDP in the worst 
case scenario.  
 
Uncertainty of being able to meet and satisfy future demands has made 
institutions like the Department of Health (DH) to look at a range of alternatives for 
finding methods that not only satisfy but also help to provide and improve access 
to health and social care anywhere. Some of these choices fall within the domain 
of telehealth and telecare. By 2010, it was expected that home based monitoring 
systems would play an important role in the management of patients with chronic 
diseases (DH, 2002). Recently, the Department of Health (DH, 2012) has 
announced that at least 3 million people living with long term conditions and social 
care needs could benefit from the use of telehealth and telecare services over the 
next five years. This announcement was based on the early findings published by 
Whole System Demostrator (WSD) programme (DH, 2011), the largest RCT of 
telehealth and telecare in the UK. The WSD indicated that telehealth can reduce 
deaths by 45%, emergency visits by 20%, A&E visits by 15%, elective admissions 
and bed stays by 14% and tariff cost by 8% (DH, 2011). These findings confirmed 
the expectations of many enthusiastic people, but are strongly questioned due to 
the lack of full results (McCartney, 2012).  
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1.2 Research problem and motivations 
Efforts have been made in telehealth research. This has generated roughly 6000 
publications between 1964 and 2003, and ranks the UK after the USA in the 
second position of published papers on this field (Moser et al., 2004; Demiris and 
Tao, 2005). However, in spite of the considerable amount of research done, the 
survival of telehealth and telecare projects in the long term is very low. 
Furthermore, evidence of benefits is still scarce.   
 
As observed by Hailey et al. (Hailey et al., 2002; Hailey et al., 2004), good quality 
studies are limited and insufficient. This is also confirmed by a similar study which 
concluded that there is little evidence about cost effectiveness (Whitten et al., 
2002). In the organisational part, Aas (2002) has remarked on the lack of analysis 
of organisational changes as a consequence of telemedicine implementation. 
Such changes are important to be studied because they may have side effects in 
healthcare organisations. For example, the implementation of telemedicine and 
telecare could interfere with other activities of health providers, increment 
workload, and promote resistance to adoption.  
 
In an effort to demonstrate the effects of telecare on frail elderly patients, a 
research group (Bayer et al., 2007) implemented a System Dynamics (SD) model. 
Their simulations showed that the impact of telecare would be minimal in the short 
term and, in the best of the cases, it could take up to 20 years to achieve a 
significant reduction in the demand for institutional care provided to the frail 
patient supported by telecare.   
 
For successful design and implementation of telehealth and telecare services, 
many feasibility, observational, clinical and evaluation studies have been carried 
out in the past. Traditionally, these projects are implemented to capture 
organisational changes, direct benefits and economic implications caused by the 
adoption of such systems into the healthcare practice. However, because of the 
complexity involved, clinical effectiveness and evidence based practice are rarely 
or superficially investigated.  
 
Besides, healthcare systems are usually messy and complex in nature. They 
involve different professions, divisions, and specialisations working together with 
the purpose of providing health services to patients and public in general. Issues 
in these organisations may be difficult to understand and interpret without a clear 
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notion of what is important to address. Others may be hard to decipher because 
of the complexity that they involve. Establishing a good framework for service 
design can help to make clear the relationships between the different components 
of a system and reduce its complexity. There is still room for research to be done 
and to get the evidence that proves what works best. 
 
1.3 Hypothesis 
Ill-defined projects, technology-driven approaches, and lack of complex system 
understanding seem to be the factors that lead non-satisfactory telehealth 
implementations. Additionally, it is unknown the effects of patients’ demographics 
on telehealth performance. Therefore, an investigations focusing on patient 
performance and effectiveness should help to develop a practical framework for 
the correct analysis, design, development, implementation and evaluation of 
telehealth services. 
 
1.4 Aim and Objectives 
Considering the situation described above, the aim of this research is to develop a 
framework applicable to a broad spectrum of telehealth interventions for patients 
with long term conditions.  
 
The specific objectives for the present work are: 
 to provide a comprehensive review of  literature on telehealth. 
 to identify the most effective telehealth interventions in the cases of 
diabetes, asthma, chronic obstructive pulmonary disease and 
hypertension. 
 to investigate any relationship between demographics, socio-economic 
status and patient’s performance on telehealth. 
 to evaluate the clinical effectiveness of a telehealth intervention 
 to summarise findings and make recommendations.  
 
1.5 Content 
The remainder of this thesis consists of the following chapters: 
 
Chapter 2, introduces the subject using a number of definitions, such as 
telemedicine, telehealth, telecare and eHealth. It also justifies the need for 
telehealth systems in healthcare. 
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Chapter 3, reports the findings and presents the summaries of the telehealth 
studies extracted from three systematic reviews by gathering the best available 
evidence on telehealth interventions, specifically in home monitoring for patients 
who have diabetes, asthma, hypertension, and COPD. The review was focused 
mainly on studies that were comparable to a case study “The REALITY project”. 
In this chapter some important limitations were found in the evidence reviewed.   
 
Chapter 4, is the introduction of our case study “The REALITY project”, an EU 
funded project in which UK, Estonia and Portugal were involved. In here clinical 
and demographic circumstances found among patients are summarised. It was 
concluded that in order to facilitate a more user centred approach, demographic 
characteristics must be considered in the design and implementation of the 
treatment intervention. 
  
In Chapter 5, the association between patients’ demographics and their 
performance during the project are investigated. For this, a series of cross-
tabulations and statistical tests for association were carried out, and it was found 
that the demographics of patients influences uptake of telehealth. 
 
Results generated by the clinical outcomes collected from our case study are 
analysed in chapter 6, and a brief discussion about clinical effectiveness is given.  
 
Study and main findings are summarised in chapter 7, limitations outlined and a 
series of recommendations made according to the research findings. 
 
Finally in chapter 8, research contributions, review of the aim and objectives; and 
future research necessary to help overcome the current limitations of this 
research are summarised.  
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Chapter 2. Literature review 
 
 
2.1 Introduction 
Telehealth has been around for decades or even centuries. Its history can be 
traced back to the transmission of disease information, such as bubonic plague 
through heliograph or bonfires in Europe, and the use of telegraph for ordering 
medical supplies during the USA civil war (Zundel, 1996). However, it was not 
until the end of the Cold War and the conclusion of the ‘space race’ between the 
United States and the ex-Soviet Union that formal telemedicine programs begun 
in earnest, mainly in the USA (Rinde and Balteskard, 2002). 
 
The National Aeronautics and Space Administration (NASA), one of the pioneers 
of the telemedicine research (Nicogossian et al., 2004), has made important 
contributions to this field since the first attempts to put a man in space, when 
remote monitoring of the astronaut’s health status was required. Currently, 
several technologies for telemedicine are commercially available and the rapid 
advance of telecommunications creates the opportunity to transmit not just bio-
signals, but also documents, images, audio, and video via regular phone lines.  
 
This chapter starts with an overview of defintions. Then, the chapter moves to 
examine why we need telehealth and ends with a discussion on aspects for 
adoption. 
 
2.2 Definitions 
Agreements on terminology are required and probably will create intensive 
debates among researchers, professional bodies, and funding organisations. 
However, that should not distract their (or our) attention from other more important 
issues attached to telehealth and telecare. After all, new terms in the “tele” and “e” 
healthcare field may emerge as more innovative and sophisticated technologies 
appear in the future. Besides, a lack of universal definitions may be reflecting the 
inherent complexity and dynamic changes involved in these relatively new 
disciplines. 
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2.2.1 Telemedicine 
Etymologically speaking, telemedicine means medicine at a distance. It comes 
from the Greek -τελε - tele (far away, far off, at a distance) and the Latin medicina  
(medicine). The term was applied for the first time in the 1970s (Moore, 1999), 
and linked to the provision of medical services using ICT for remote delivery of 
care. This delivery, by definition, has often implied the intervention of a doctor on 
either side of the healthcare facility.  
 
Commonly, telemedicine services are associated with the name of the medical 
speciality in matter. For example: 
 Teleradiology, digital transmission of radiographs and other images to 
radiologists for interpretation and supervision.  
 Telepathology, digital transmission of pathological details of samples to 
correspondent specialists for diagnostic. 
 Teledermatology, examination of skin abnormalities by transmission of 
digital pictures to dermatologists.  
 
Thus, semantically speaking, adding the prefix “tele” to a specific medical 
speciality can be generally referred to as telemedicine. 
 
It is believed that telemedicine could become crucial as an alternative way of 
practicing medicine, for example, where limitations in face to face 
communications persist between patients living remotely, while medical 
specialists live, generally, in urban areas. However, currently, there is not a 
universal definition accepted by all its promoters.  
 
For instance, the American Telemedicine Association (ATA) refers to telemedicine 
as “the use of medical information exchanged from one site to another via 
electronic communications to improve patients' health status”. Similarly, 
Nagendran et al. (2000) describe it as “medical practice at a distance, where the 
transmission of information and data related to the diagnostic and treatment of, as 
well as education about, medical conditions occur via electronic communication 
networks”. Darkins and Cary (2000) make evident the lack of consensus, and 
approach the issue suggesting the adoption of definitions already available in the 
literature. They argue that defining telemedicine is a matter of individual 
preference, and recommend the use of the word “telehealth” instead, as a more 
appropriate term. 
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The existence of several definitions can cause confusion and make telemedicine 
difficult to interpret (or to interpret in many different ways), including policy makers 
perceiving the implementation of EPR as telemedicine.  Consequently, a concise 
and effective description is needed to resolve any ambiguity.  
  
In this sense, Richard Wootton (Wootton, 2001) argues that telemedicine is “any 
medical activity involving an element of distance”. His conception is simple, 
concise, and comprehensive. He implicitly includes the use of technology, since 
non face to face communication processes currently involves any form of ICT, but 
at the same time, he leaves technology lying, perhaps intentionally, on a 
secondary plane. That opens the opportunity of perceiving telemedicine in a more 
clinical or patient-centred context.  
 
2.2.2 Telehealth 
A broader expression, which covers a whole range of healthcare professionals, 
has been introduced in the literature over the past few decades.  Bashshur (2000) 
argues that this term, telehealth, started to circulate in the late 1970s. 
 
Literally, the term means delivery of health at distance. Such delivery can be set 
for clinical, administrative, educational, and other purposes. Therefore, the range 
of healthcare professionals who participate in telehealth, or telehealthcare, 
includes not just doctors, but also nurses, psychologists, paramedics, medical 
social workers, and so on.  
 
Several telehealth definitions abound. To avoid citing all of them, we follow the 
approach by Darkins and Cary (2000), which proposes to embrace one of the 
descriptions already available in the literature. For this purpose, the latest 
definition published by Finch and colleagues is adopted below.  
 
“Telehealthcare refers to a wider and more diffuse set of systems often employing 
nurses, that develops and delivers advice and treatment management, where 
participants are geographically separated.” (Finch et al., 2006) 
 
Their definition covers two important aspects. First, they describe telehealth as a 
set of systems. This is an advantage, because thinking in terms of systems may 
be necessary for success implementation of telehealth. Second, they reveal one 
of the most common healthcare professionals truly involved in telehealth. It is 
 24 
important to identify the role that nurses may be playing in telehealth because 
evidence shows that health workforce, particularly doctors, may refuse to accept 
its implementation (Tanriverdi and Iacono, 1998; Lapointe et al., 2002). 
 
2.2.3 Telecare 
Telecare implies the delivery of either health or social care (or both) usually at 
home. Internationally, it is also known as telehomecare, home telehealth, or home 
based ehealth (Koch, 2005). Although several definitions of telecare abound, in 
the UK, telecare refers to the idea of enabling people to remain independent in 
their own homes by the use of sensors, alarms and monitoring devices to support 
the individual or their carers. 
 
Telecare can be classified into three major categories (Barlow et al., 2004): safety 
and security monitoring (bath overflowing, gas left on, door unlocked), personal 
monitoring (physiological signs and activities of daily living), and information and 
communication (health advice through the phone, internet, or digital interactive 
TV).  
 
Since the philosophy of telecare is to support independent living, especially for 
those who are vulnerable, the home environment becomes the usual care 
scenario. It is distinguished by the need of active commitment of patients (or 
people to be supported) in the adoption of telecare technology, and in handling 
self-management for their own care. 
 
One could think of telecare as telehealth systems that are applied outside of 
healthcare facilities. Nevertheless, the purpose of telecare is not just to help 
patients, but also other people who are not necessarily ill, but suffer from any 
physical or mental impairment. In those cases, it is required that health and social 
carers work together as a multidisciplinary team.  
 
2.2.4 eHealth 
It is most likely that the word electronic health or eHealth had been introduced into 
the “e-world” vocabulary (e-commerce, e-business, e-economics, e-consultancy, 
etc.) by industrial leaders and marketing people in the late 1990s (Eysenbach, 
2001). Currently, the term has been adopted by scientific communities, 
governments, medical suppliers, and others.  
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eHealth involves more than just the attempt to explore electronic commerce into 
the healthcare field. Practically, it includes any lifestyle information and health 
application based on the internet. It also includes telemedicine and telecare 
(Wyatt and Liu, 2002).  
 
At the present time, there is no single definition of eHealth and, most likely, there 
will not be one soon. A systematic review of eHealth published definitions (Oh et 
al., 2005), reported 51 different meanings of the term. Most of them included the 
words: health and technology as common denominators, and a combination of the 
words: commerce, activities, stakeholders, outcomes, places, and perspectives. 
Despite the lack of agreement, this term is widespread in industry and academia, 
and in clinical, finance, legal, educational, and health related journals (Pagliari et 
al., 2005).  
 
Although difficult to define, in the simplistic way, one could think of eHealth in 
terms of digital information, the use of internet, and the health care context. 
However a more complete definition is given below: 
 
“eHealth is an emerging field in the intersection of medical informatics, public 
health and business, referring to health services and information delivered or 
enhanced through the internet and related technologies. In a broader sense, the 
term characterizes not only a technical development, but also a state-of-mind. A 
way of thinking, an attitude, and a commitment for networked, global thinking, to 
improve health care locally, regionally, and worldwide by using information and 
communication technology.” (Eysenbach, 2001)     
 
This definition has been proven to be the one most often cited on the internet (Oh 
et al., 2005), and is thus the definition adopted in this research. 
 
In summary, first, we have emphasised the importance of terminology and have 
suggested the adoption of standard definitions for the terms telemedicine, 
telehealth, telecare, and eHealth. It is not easy to give a unique definition for each 
of them; however, it is clear that these terms have been commonly used for 
describing a non traditional approach to the remote delivery of care. 
 
Second, although, the use of some of those expressions are considered “more 
politically correct” (Wootton, 2001), after eHealth (google.co.uk 31/5/2012; 
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eHealth: about 23,300,000 results), telemedicine (google.co.uk 31/5/201; 
telemedicine: about 5,550,000) seems to be one of the preferred terms to express 
this concept. This can be demonstrated by Googling “telemedicine”, which returns 
the largest number of results in comparison to the other terms discussed in this 
chapter.  
 
Third, in any case, the correct use of one term over the others does not 
necessarily influence or affect the other issues (e.g., technological, organisational, 
legal, cultural, and ethical) related to these fields.  
 
Finally, it can be concluded that telemedicine, telehealth, and telecare are subsets 
of eHealth.  
 
2.3. Why do we need telehealth? 
Traditionally, telehealth has been seen as a way of enhancing healthcare 
systems. Ideally, it is expected that it will help to enable, not just equal access to 
healthcare for underserved populations, but also to enable people to remain living 
independently and to support them in their own homes. Concurrently, by 
introducing these unconventional health services, it is expected that healthcare 
systems will become more efficient through better use of the existing workforce 
and other resources. Decreasing waiting lists and costs (or at least, reduction in 
some health expenditure) are expected as a result of relocating patients from 
secondary and tertiary care to primary care and home settings.   
 
In recent years, telemedicine, and more specifically telehealth, have been 
considered key services for the future delivery of health care. This is most likely 
related to concerns about potential increases in health demand as a consequence 
of: 
 growing of an ageing population,  
 management of complex diseases, and chronic conditions, that are often 
resource consuming, and 
 workforce limitations to meet such demands.  
 
However, the integration of new healthcare services based on ICT systems have 
been shown not to be an easy task.  
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2.3.1 Life expectancy 
Life expectancy is the period of time (in years) that a given person is expected to 
live. This can be referred “at birth” or at any time of interest. Life expectancy has 
been increasing relatively rapidly, particularly over the last fifty years worldwide. In 
medieval England, for example, life expectancy used to be between 32 to 35 
years (Raleigh, 1999), whereas currently it is estimated to be around 80 years1.  
 
The achievements of general increase in life expectancy worldwide can be 
attributed to global modernisation, access and better quality of resources such as 
water and food (Besley and Kudamatsu, 2006), improvement in education (Meara 
et al., 2008), and advances and production of new medical technologies  (Kleinke, 
2001) such as development of antibiotics, vaccinations, nutritional products, and 
electronic devices for diagnostic and medical treatment. Such achievements have 
had a direct impact on life expectancy at birth and have contributed to the 
increase in the population aged 60 years and over. However, this trend is not 
necessarily present in all over the world. Low life expectancy levels are still 
present in some developing countries, and has dramatically decreased as a 
consequence of dreadful diseases such as AIDS and malaria (Azémar and 
Desbordes, 2009).  
 
2.3.2 Health demand and future issues in health and social care 
Ros and Drzymala (2002) argued that factors that affect or may change health 
demand are: 
 Size and age composition of population, 
 Changes in disease incidence and emerging new diseases, 
 Geographic distribution, 
 Education, 
 Literacy levels, 
 Individual income and wealth, 
 New technologies, treatments, and tests, 
 Increases in life expectancy, and 
 More informed population 
 
Ros and Drzymala have observed that increases in life expectancy will contribute 
to the demand for doctors in the future, and therefore, changes in the human 
                                                 
1
 http://www.statistics.gov.uk/hub/population/deaths/life-expectancies/ [Accessed 3 March 2012] 
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longevity may compromise health systems in the world. This is because an 
ageing population tends to require more health services as they are more likely to 
suffer from chronic and degenerative conditions, as previously mentioned in 
chapter 1. Chronic diseases are “diseases of long duration and generally slow 
progression” (WHO, 2012). This therefore represents a major challenge to public 
health.  
 
Estimations of people living with a long term condition such as diabetes, asthma, 
and arthritis are high (17.5 millions in the UK).  Furthermore, 80% of total GP 
consultations are related to these chronic disease groups, and 5% of them 
represent roughly 42% of the total acute bed day occupancy (DH, 2004; DH, 
2005b).  
 
In the UK (Wittenberg et al., 2004), it is expected that the number of people over 
65 years will rise from 9.3 to 16 million, and number of people over 85 years 
increase from 1.1 to 4 million by 2051. By 2020, population with long term 
conditions is expected to increase to 2.1 million (from 18.5 to 20.6 million). 
 
In the social care arena, places in residential care homes, nursing homes and 
hospitals will need to rise by 150%. The number of home care hours will need to 
increase by around 137%, and, to satisfy such demand, the social care workforce 
will need to be more than double by 2051 (Wittenberg et al., 2004).  
 
2.3.3 Benefits and factors of success 
Telehealth systems should satisfy patients’ needs. At the same time, it is 
expected that the use of such systems will help to enhance existing service 
delivery while relieving some of the pressure on services. Preliminary studies 
have shown multiple benefits in the utilisation of telemedicine. Such benefits can 
be grouped in six main categories (Hjelm, 2005): (1) improved access to 
information, (2) provision of care not previously deliverable, (3) improved access 
to services and increasing care delivery, (4) improved professional education, (5) 
quality control of screening programmes and (6) reduced health care cost.   
 
A systematic review has shown effectiveness when telehealth was used in areas 
such as diabetes, mental health, risk pregnancy monitoring, heart failure, and 
cardiac diseases (Bensink et al., 2006a). However, positive outcomes are not 
enough to guarantee adoption if telehealth cannot demonstrate other elements of 
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success. Therefore, it is sensible to establish which factors of success or failure 
should be accepted as valid before performing any evaluation of telehealth. Yet, 
doing this can be very complex and several key points need to be taken into 
account.  
 
For instance, Wootton and Herbert (2001) maintain that the appropriate indicators 
for measuring telemedicine factors are cost and quality of care. Table 2.1 
illustrates the factors they commonly associate with success. 
 
Table 2.1. Factors for success in telemedicine (Wootton and Hebert, 2001). 
Factor Quality metric Cost metric 
Routine operation 
 
  
Successful outcomes 
 
  
Mainly clinical activity 
 
  
Sustainable operation 
 
  
Cost-effectiveness 
 
  
Adequate financing 
 
  
High activity levels 
 
  
Acceptance by clinicians 
 
  
Improved access to 
health-care 
 
  
Avoidance of travel   
 
Once success is defined, the next step is to understand how to achieve it. 
Researchers, in several research areas, have concluded that success may 
depend on the stakeholders and their views. For example, Checkland and 
Scholes (1990) pointed out the importance of Weltanschauung, a German word 
that means “the view of the world and human life”, when dealing with soft 
problems. Vos (2003) remarks on the need of identifying stakeholders since they 
can influence organisational behaviours. She cited a classification of stakeholders 
based on three main elements: power, urgency, and legitimacy (fig. 2.1), and 
proposed the use of critical systems heuristics, a modelling methodology, for the 
identification of stakeholders. Heriksen et al. (2005) used the stakeholder theory 
for telemedicine evaluation, and argued that without the inclusion of stakeholders 
in project planning, implementation of new eHealth services would not succeed.  
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Power
8. Non-stakeholders 
Urgency
1
2
3
45
6
7
Legitimacy
1. Dominant stakeholder
2. Discretionary stakeholder
3. Demanding stakeholder
4. Dominant stakeholder
5. Dangerous stakeholder
6. Dependent stakeholder
7. Definitive stakeholder
Figure 2.1. Classes of stakeholders (as cited by Vos (2003). 
 
Success may also depend on the decision of the scale at which a system or 
subsystem is going to be evaluated (e.g. individual, managerial, or organisational 
level). Flood and Carson (1993) refer to this scale as “level of resolution” and the 
decision of the scale as “system in focus”. For instance, Herber et al. (2002) 
proposed an evaluation framework in both levels of resolution: individual and 
organisational level (see fig. 2.2).  
 
Is the technology 
acceptable?
Is the individual ready 
to use it?
Is training required?
Does the technology 
work?
Is it safe?
Is it conveniently 
located?
Satisfaction with 
care process?
Quality of interaction?
Effective match of
carer to client?
Satisfaction with 
care process?
Quality of interaction?
Effective match of
carer to client?
Quality of life?
Clinical measures?
Job satisfaction?
Cost-effectiveness?
Reduced travel?
Increased access?
      
Organisation
Individual
Structure Process Outcome
 
Figure 2.2. Framework for telehealth applications (Hebert et al., 2002). 
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As can be seen, telehealth success is multifactorial. Therefore an appropriate 
evaluation framework is likely to be the most valuable way to assess success. 
 
2.4 Adoption considerations 
Omitting financial and technology considerations, the major aspects to be 
considered for adoption of telehealth can be summarised as: 
 People 
 Organisational context 
 Evaluation 
  
2.4.1 People 
Previous studies have shown that people’s attitudes, expectations, perspectives, 
needs, and roles are determinant in the adoption of ICT (Rigby and Robins, 1997; 
Hu et al., 2000; Lahdenpera and Kyngas, 2000; Lehoux et al., 2002; Gagnon et 
al., 2003; Hibbert et al., 2003; Levy et al., 2003; Stronge et al., 2007). It is also 
important to bear in mind how people are going to be interacting with technology 
in order to avoid obtrusiveness (Hensel et al., 2006).  Therefore, it is imperative to 
identify and consider all of the key players in telehealth to guarantee the success 
of the service. 
 
In a telehealth system, stakeholders can range from patients to doctors, nurses, 
healthcare assistants, patients’ relatives, technology providers, and other 
healthcare professionals. They usually have different needs, expectations, and 
priorities. Understanding, determining, and satisfying them, should ensure, if not 
success, at least effective communication in the care practice. Three major 
groups are under discussion below. 
 
2.4.1.1 Doctors and other healthcare professionals 
As a whole, telehealth, and also telecare, can be “attractive” choices for delivery 
of health care and ways of workforce preservation in rural areas (Isles, 2001). 
However, it has been suggested that the health workforce, particularly doctors, 
may resist ICT adoption if they perceive any loss of autonomy, status, or change 
in their role as practitioners (Tanriverdi and Iacono, 1998; Hu et al., 2000; 
Lapointe et al., 2002). Furthermore, it is unknown how compatible telehealth will 
be with the physician’s clinical routines (Lehoux et al., 2002).  Thus, in order to 
match managerial needs with the health professional ones, health workers should 
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be involved in early stages of telehealth implementation. Otherwise, 
disagreements could provoke implementation of new telehealth policies to fail.  
 
2.4.1.2 Patients 
Patients are also stakeholders that play an active role in the acceptance of 
telehealth. Their expectations about living independently, especially in the group 
of older adults, are high and make telehealth very attractive. So far, the attitude of 
older people to telehealth has been reported positively (Levy et al., 2003).  
However, as suggested by Lahdenperä and Kyngäs (2000) if the patient feels that 
a telehealth service would detriment rather than benefit his or her treatment, then, 
the technology should not be used. For these reasons, considering the patient’s 
perspective for implementing telehealth should ensure that their needs are met. 
 
2.4.1.3 Relatives 
Last but not least, special attention should be given to a patient’s relatives since 
they play an important role in the provision of care. In recent studies, relatives 
have been actively involved in the telehealth process, especially for providing 
psychological support. Evidence shows that their opinion about telehealth has 
been overall positive (Sävenstedt et al., 2003; Bensink et al., 2006b; Engström et 
al., 2006). 
 
2.4.2 Organisational context  
“Many implementation difficulties relate more to the organizational and structural 
conditions within which telecare is deployed than the technology itself…The 
service redesign implications of telecare – including associated organizational and 
cultural issues – need to be addressed and a better understanding of the systemic 
effects of telecare over time is required.” (Barlow et al., 2005) 
 
“When IT is implemented, high failure rates may be related to individual and 
organisational factor…At its present volume, telemedicine generally fitted well into 
daily work routines. In the future…it may be necessary to distribute the 
telemedicine activity…[and] to limit the length of sessions and to plan breaks 
during sessions” (Aas, 2001). 
 
Understanding that the relation between cause and effect is often separated in 
time and space should help decision makers to prevent unintended organisational 
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consequences. Therefore, the field of eHealth requires some reasonable 
guidelines that help to identify and prevent or reduce organisational issues.  
 
In the managerial world, responses may be the consequences of the introduction 
of new policies, technologies, and work procedures (stimuli) in organisations. 
These stimuli may or may not provoke any organisational response. But, in case 
they do, appropriate evaluation frameworks are required to observe those effects. 
However, little work has been carried out in developing organisational models for 
telehealth.  
 
Organisational change theories have been proposed to evaluate alterations in the 
state of organisations. Stickland (2002) cites and summarises such theories in 
three perspectives:  
 Organisational level 
 Group level 
 Individual level 
  
According to Stickland, analysis of the changes at organisational level firstly 
implies a look at the organisation and its components (subsystems) as well as the 
interactions among them, and secondly, a look at the subsystem interactions with 
their external environment. This perspective allows analysis at the macro level, 
e.g., “changes in culture, corporate structure or high level business process” 
(Stickland, 2002).  
 
At the group level, as its name implies, it is focused on the group and team 
behaviour. Values, norms, and roles are involved in the change, which is seen as 
an expression of interactions, conflicts and relationships among groups. This 
perspective deals with the social and psychological aspects of organisations. 
 
Finally, the individual level concentrates on understanding individual needs and 
motivations which can help to prevent or minimise possible areas of resistance to 
change, and at the same time, to identify how to deal with them. “Emancipation, 
participation and ownership are considered key concepts to understanding 
effective change management” (Stickland, 2002). 
 
Organisational structures define the way in which organisations operate and 
perform. In order for telehealth to perform well, it is required to be “needs-driven” 
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rather than being driven by technology (Brebner et al., 2005). There is also a 
need for having enough finance and well established policies, procedures, 
protocols, and work practice as well as to provide patients and staff training. 
During implementation of new ways of delivering care, such as telehealth, special 
attention should be given to time spent with patients (McIntosh et al., 2003), 
where doctors and other healthcare providers may be already exhausted 
(Morrison and Smith, 2000). This can create additional strain. In these types of 
cases, telehealth may create conflicts rather than satisfying demand (Oldham, 
1999).   
 
2.4.3 Evaluation 
From this point of view, evaluation has to show positive clinical outcomes as well 
as proper economical analyses.  One could say that this is the “Achilles’ heel” of 
telehealth. Clinical and economic analysis led this issue.  
 
In clinical evaluation, the Randomised Controlled Trial (RCT) is the gold standard. 
Unfortunately, the majority of research trials omit this standard. From the 
economic evaluation side sustainability has to be shown.  
 
 Problems on evaluation can be summarised from Whetton (2005): 
 Weak study design 
 Insufficient or inadequate data  
 Focus on pilot projects and short perspective 
 Lack of information on broad health outcome 
 Emphasis on qualitative user satisfaction 
 Problems with the measurement of cost 
 Focus on descriptive rather than analytical evaluation criteria 
 Few comparisons of telemedicine with conventional service delivery 
 
Rapidly evolving technologies present additional problems for evaluation. As new 
technologies become available in healthcare, standard evaluation methods used 
in the past may be no longer applicable or appropriate. For example, clinical trials 
are usually dependent on a specific fixed technology. This can lead to a clinical 
trial that is in the verge of being technologically obsolete before it is even 
completed. Therefore, it is important to respond appropriately to such new 
technologies. Firstly, by identifying them through horizon scanning (word of 
mouth, published reports and the World Wide Web) and collective scanning 
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(regular meetings and surveys of sentinel groups of experts) (Stevens et al., 
1999). Secondly, by designing evaluation methods that take into account the 
evolution of technology, techniques, and additional information that routinely 
occurs. A good example of these methods comes from Lilford et al. (2000) who 
have suggested the used of “tracker trials”, a flexible method which allows 
different new treatments to be compared and evaluated. This method can be used 
for rapid detection of treatments that perform poorly or are potentially dangerous, 
to reject unpromising new treatments, and to provide maximum information as to 
which treatments are best (Lilford et al., 2000).  
 
According to Friedman and Wyatt (2006) evaluation “describes a range of data-
collection activities designed to answer questions ranging from the casual…to the 
more focused…”. They argue that reasons for performing evaluations in the 
“biomedical informatics field” are related to promotional, scholarly, pragmatic, 
ethical, and medico-legal circumstances. The idea of performing evaluations is to 
study the collection, processing, and communication of information related to 
health care, research, or health education.  
 
Telehealth evaluation should be created for the purpose of systematically 
documenting, collecting, and analysing in detail any evidence that answers 
questions concerning “the benefits and costs of alternative modalities and various 
dynamic combinations and configurations of technology, human resources and 
health applications” (Bashshur et al., 2005). Bashshur et al. argue that an agenda 
for programme evaluation in health care usually combines two components: 
“scientific requirements” (robust research design, reliable and valid measurement, 
and rigorous methods for collection and data analysis) and “political realities” 
(priorities of public policy and funding agencies and process of allocating research 
fund). According to them, these components are usually incompatible and part of 
the basic issues in evaluation.  
 
In fact, success may be influenced by political conditions, which are needed for 
starting any telehealth initiatives, but not totally necessary to guarantee success. 
Nevertheless, it is better to bear in mind that some political circumstances, e.g. 
governmental transitions, may provoke the failure of telemedicine implementation 
(Urtubey and Petrich, 2002).    
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Complexity seems to be inherent to healthcare and telehealth interventions (Finch 
et al., 2003; Campbell et al., 2007). That may explain why clinical evidence and 
cost-effectiveness studies are limited in telehealth and telecare. This has been 
highlighted by Aoki et al. (2003) who reviewed a hundred and four articles to 
investigate telehealth evaluation studies. They found that sixty four percent of 
evaluations were descriptive or “ad hoc”, twenty seven percent employed a 
statistical analysis, and eight percent performed cost analysis. They concluded 
that evaluation of telemedicine might require cooperation of multiple disciplines 
and methodologies. Bashshur et al (2005) also discussed the level of complexity 
that is inherent to health programme evaluation and classified it in two types: the 
ones concerned with testing efficacy, effectiveness and safety of new medical 
technology and the ones related to assessment of performance and 
achievements in terms of stated goals and objectives.  
 
However, one of the basic problems of telehealth evaluation, as observed by 
Harrison et al. (2002), seems to lie mostly in “conducting an evaluation before a 
particular technique has become stable and accepted into daily routine”. Another 
problem is present when pilot projects rely on volunteers or enthusiasts (Hebert, 
2001).  Consequently, the use of a suitable methodology or framework for dealing 
with the evaluation of telehealth systems is required. 
 
Carson et al. (1998), and Cramp and Carson (2000) suggest the use of System 
Methodology for dealing with such complex issues. Other researchers such as 
Campbell et al. (2007) also pointed out the need for modelling during evaluation 
of complex interventions. 
 
2.5 Summary 
In this chapter, it has been noted that technology is not the most important 
element of a telehealth system. Telehealth embraces human resources and 
health applications embedded in an organisation (Bashshur et al., 2005). 
Technology is a tool for enhancing the delivery of health care, but not the whole 
solution.     
 
Success of telehealth can be seen from many stakeholder perspectives and at 
different levels of resolution. Thus, it is important to define what tools can be 
acceptable for measuring success. 
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Evaluating the promises of telehealth requires looking into the patient’s health 
status, the relationships among stakeholders, and the interaction with technology 
There is no doubt that telehealth has the potential to bring enormous benefits. 
However, to do so, it will definitely require changes in both the way healthcare 
organisations are currently set up, and the way in which patients are traditionally 
involved in their own disease management.  
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Chapter 3. What the evidence says?  
 
 
3.1 Introduction 
A search for research papers was conducted in order to gather the best available 
evidence on telehealth interventions, specifically in home monitoring for patients 
who have diabetes, asthma, hypertension, and chronic obstructive pulmonary 
disease (COPD). The review was focused mainly on studies that were 
comparable to the REALITY project (REALITY Consortium, 2005b). 
 
This chapter reports the findings and presents the summaries of the telehealth 
studies extracted from three systematic reviews.  
 
3.2 Aim 
We reviewed a number of pieces of evidence available for home telehealth 
systems with the aim of determining clinical effectiveness and to find the best 
models for telehealth implementation. In order to achieve this aim, we analysed 
the existing systematic reviews considered to synthesise the best interventions 
available, and reviewed their primary studies in the case of diabetes, asthma, 
hypertension, and COPD.   
 
3.3 Search strategy 
A literature search was performed for identifying systematic reviews in home 
telehealth published between January 2000 and July 2007. To find out the 
relevant reviews, this study was conducted using the databases: PubMed, the 
Cochrane Library and ISI Web of Knowledge. Search keywords applied for 
extraction of reviews were: systematic AND review AND (telemedicine OR 
telecare OR telehealth OR telemonitoring OR telehome) AND home AND 
(outcome OR evidence or benefits) NOT (smart OR alarm). 
 
This strategy found 18 items in PubMed, 0 items in the Cochrane Library and 15 
items in ISI Web of Knowledge. After exclusion of 14 duplicated records, a total of 
19 articles were identified among the 3 databases. From these titles, 9 articles 
were judged to be potentially relevant and corresponding abstracts were retrieved 
online. Only 3 articles were downloaded for closer inspection and full text review. 
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3.4 Inclusion criteria (systematic review) 
A systematic review was selected when the study: 
 was written in English; 
 was described in detail to assess the type of telehealth interventions 
included; 
 attempted to show any evidence of clinical benefits; and 
 included cases with participants who were treated for asthma, diabetes, 
hypertension, or COPD.  
 
3.5 Exclusion criteria (systematic review) 
Systematic reviews were excluded when: 
 technology, education or economic impact was the main reason for 
performing such study; 
 the majority of primary studies within the review were not related to home 
telehealth or already covered in a more recently revision. 
 
3.6 Results 
 
3.6.1 Primary study extraction and synthesis 
Three systematic reviews met the inclusion criteria (Bensink et al., 2006a; Barlow 
et al., 2007; Pare et al., 2007). Mark Bensink kindly provided a full electronic 
reference of papers reviewed via email. In the case of the review by Barlow et al., 
the URL http://www.cat.csip.org.uk/index.cfm?pid=433 was used to contain the 
complete details of references; however, access to the URL is no longer 
available. Pare et al. cited all the primary studies in their original paper. Search 
terms, inclusion criteria and exclusion criteria of the 3 systematic reviews selected 
are shown in table 3.1. 
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Table 3.1. Comparison of search terms, inclusion and exclusion criteria. 
 Bensink et al. (2006a) Barlow et al. (2007) Pare et al. 
(2007) 
Search 
terms 
1. Telehomecare OR tele-
homecare 
2.Telemedicine OR remote 
consultation OR online 
health OR on-line health OR 
telepathology OR tele-
pathology OR telehealth OR 
teleHealth OR eHealth OR 
ehealth OR telecare OR tele-
care OR teledermatology OR 
tele-dermatology OR 
telepsychiatry OR tele-
psychiatry OR telesurgery 
OR tele-surgery OR 
teleconsult* OR tele-consult* 
OR telecardiology OR tele-
cardiology OR 
teleophthalmology OR tele-
ophthalmology OR 
teleoncology OR tele-
oncology OR teleradiology 
OR tele-radiology OR 
teleneurology OR tele-
neurology OR telemental 
health OR tele-mental health 
OR teleradiology OR tele- 
radiology OR e-mental 
health OR telemetry OR 
telegeriatric* OR tele-
geriatric* OR teledialysis OR 
tele-dialysis OR 
telerehabilitation OR tele-
rehabilitation. 
2 
Telecare, 
telemedicine, 
telehealth, 
telehomecare, 
ehealth, telephone 
monitoring, alerts, 
telephone support, 
telesecurity, 
community alarm, 
teleconsultation, 
teleconference, call 
centre, 
telecommunication
s, prevention, 
health-care 
delivery, frail 
elderly, long-term 
conditions, chronic 
condition, chronic 
care, heart failure, 
asthma, diabetes, 
depression, 
dementia, arthritis, 
stroke, 
hypertension, 
COPD, systematic 
review, randomized 
trial, names of key 
researchers 
Telemonitoring, 
telecare, 
telemedicine, 
telematics, 
telehealth, and 
telehomecare in 
conjunction with 
diabetes, 
hypertension, 
blood pressure, 
pulmonary 
diseases/conditi
ons, asthma, 
respiratory 
diseases/ 
conditions, 
cardiac 
diseases/ 
conditions, and 
heart failure. 
Inclusion 
criteria 
1. Studies that reported 
outcomes in terms of 
administrative changes, 
patient management 
decisions, patient outcomes, 
caregiver outcomes, 
economic impact, or social 
impact on patients. 
1. Examined home-
based telehealth 
services. 
2. Included 
telehealth as a core 
component, not 
merely one 
intervention among 
1. Have an 
experimental 
design involving 
direct data 
collection from 
patients with 
any of the four 
considered 
                                                 
2
 3. Home* OR home-care OR home health care* OR home nursing* OR home care agencies OR home care 
services* OR home dialysis OR home health agencies OR home monitoring OR rehabilitation OR home visits 
OR homebound patients OR homebound persons OR self help devices OR self administration OR self care OR 
self evaluation OR self help OR self medication 
4. Cost OR cost-effectiveness OR economic* OR cost analysis OR budget OR financial OR health care costs 
OR cost-benefit analysis OR cost of illness OR cost description OR cost minimization analysis OR cost-utility 
analysis 
5. Teleeducation OR tele-education OR teleteaching OR tele-teaching OR telelearning OR tele-learning 
6. 2 AND 3 
7. 1 AND 4 
8. 2 AND 3 AND 4 
9. 3 AND 5 
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many. 
3. Included 
information about 
individual or system 
wide effects. 
4. Included frail 
elderly people or 
adults of any age 
with long-term 
conditions. 
5. Comprised 
randomized trials of 
any size or 
observational 
studies with at least 
80 participants. 
chronic 
diseases, 
2. Be published 
in the English 
language and 
appear in 
peer-reviewed 
journals, and  
3. Documented 
telemonitoring 
effects. 
Exclusion 
criteria 
1. References without 
abstracts were excluded.  
2. Where duplicate 
publications were identified, 
i.e. papers reporting results 
on the same set of patient 
data in different journals or 
papers reporting preliminary 
results of a research project 
where a subsequent paper 
reported the full project 
results, the most 
comprehensive publication 
was selected for review.
   
   
1. Reviews, purely 
descriptive studies 
and those which 
focused only on 
implementation 
issues or 
satisfaction. 
2. Had insufficient 
methodological 
detail, focused on 
residential homes, 
prisons or other 
institutions, or 
3. Focused on 
terminal conditions.
  
1. Conference 
and poster 
abstracts, which 
do not 
present detailed 
studies 
2. General 
reviews, articles 
that focused on 
multipathology 
groups of 
patients, or did 
not involve 
telemonitoring 
experiments 
and timely 
transmission of 
data. 
3. Publications 
that focused on 
pregnant 
women, 
patients on 
dialysis, 
AIDS/HIV 
patients 
4. other 
locations than 
home 
(e.g., prisons) 
 
After collecting references, all primary studies covering diabetes, hypertension, 
asthma and COPD were identified and searched for. Articles were obtained and 
read by a single researcher (JA). After exclusion of duplicated records, a total of 
67 articles were obtained: 37 (55%) related to diabetes, 16 (24%) in hypertension, 
10 (15%) in asthma and 4 (6%) in COPD. 
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For each primary study, data were extracted according to the following categories: 
general study characteristics, patient characteristics, and PICO model. A 
complete list of items included in every category is displayed in table 3.2.  
 
Table 3.2. Information extracted by category. 
Category items 
I. General study characteristics:  first author 
 year 
 country of origin 
 objective 
 
II. Patient characteristics:  total sample size 
 age 
 gender 
 disease duration 
 interventions time 
 
III. PICO model:  population 
 intervention 
 comparison (control group) 
 outcome 
 
 
The studies were grouped by disease conditions and synthesised information is 
reported in sections 3.6.2, 3.6.3, 3.6.4 and 3.6.5 according to the items in table 
3.2. When available, continuous data (measurement of a numerical quantity) were 
extracted, analysed and directly plotted for quantifying the clinical effects using 
meta-analysis. 
 
3.6.2 Diabetes publications 
 
Author/Year: Ahring et al. (1992) 
Country: Canada 
Study objective: to assess if care accessibility by modem improved diabetes 
control. 
Total participants: 42 
Ageavg (yrs): 41.4 
Gender (% male): 47.1 
Disease duration (yrs): 11.5 
Intervention time (months):  3 
Population: diabetic patients with insulin dependency. 
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Intervention: 22 patients were provided with glucometers and telephone modems 
to monitor and send data once a week. Patients were contacted by telephone for 
insulin adjustments and food intake. 
Control: 20 patients collected glucose readings 5 times/day twice at week  and 
kept their data in a diary or in the glucometer’s memory. 
Outcome: researches reported that a better control of HbA1c was observed in 
the intervention group. 
 
Author/Year: Albisser et al. (1996) 
Country: USA 
Study objective: to design and evaluate an electronic system that facilitates 
improvement in blood glucose control. 
Total participants: 204 
Ageavg (yrs): NS 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: Patients with diabetes type 1 and 2. 
Intervention: Patients collected blood glucose, crisis events, lifestyle factor, and 
medication data. A touch-tone phone was used to transmit data to an electronic 
information system. A nurse supported the patients (medication adjustments and 
pertinent feedback) and a doctor reviewed printed reports on a weekly basis. 
Control: Patients not actively using the system. 
Outcome: researchers reported that HbA1c improvements in the intervention 
group were statistically significant. 
 
Author/Year: Bellazi et al. (2002) 
Country: Italy 
Study objective: to design, develop and evaluate a telehealth system for 
diabetes management. 
Total participants: 12 
Ageavg (yrs): 35 
Gender (% male): 54 
Disease duration (yrs): NS 
Intervention time (months): 18 
Population: 12 patients recruited in 4 medical centres (Italy, Spain and Finland). 
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Intervention: patients were provided with monitors to collect and send blood 
glucose data to a database in a hospital. The system assisted physicians in the 
definition of basal insulin regimen. 
Control: no control group. 
Outcome: researchers found that there was not a significant reduction in HbA1c 
but there was a significant reduction in insulin requirement. 
 
Author/Year: Bergenstal et al. (2005) 
Country: USA 
Study objective: to evaluate the impact of transferring blood glucose information 
via modem. 
Total participants: 47 
Ageavg (yrs): 44 
Gender (% male): 38 
Disease duration (yrs): NS 
Intervention time (months): 1 
Population: patients with diabetes type 1 and 2. 
Intervention: 24 patients were provided with a blood glucose meter. Data were 
sent to a fax machine using a modem at least once a week. 
Control: 23 patients collected blood glucose data in a booklet and reported 
results by telephone. 
Outcome: researchers reported that similar improvements in HbA1c were found 
among groups. Data reported by telephone had 6% error (0% error by modem). 
 
Author/Year: Biermann et al. (2000) 
Country: Germany 
Study objective: to asses the impact of a telehealth system in terms of clinical 
outcomes, economical savings and patient satisfaction. 
Total participants: 46 
Ageavg (yrs): 30.5 
Gender (% male): NS 
Disease duration (yrs): 9 
Intervention time (months): 8 
Population: patients with diabetes type 1. 
Intervention: 30 patients were provided with a blood glucose meter connected to 
a modem to transmit data from home to a diabetes centre every 1 to 3 weeks.  
Control: 16 patients were in conventional outpatient care with personal visits. 
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Outcome: researchers reported that similar improvements in HbA1c were found 
with no significant difference between the groups. 
 
Author/Year: Biermann et al. (2002) 
Country: Germany 
Study objective: to find out if there were any time and cost savings by using 
telehealth. 
Total participants: 43 
Ageavg (yrs): 30 
Gender (% male): NS 
Disease duration (yrs): 9.8 
Intervention time (months): 8 
Population: diabetic patients with insulin dependency. 
Intervention: 27 patients measured their blood glucose and transmitted their 
values by modem before visits or personal consultations for at least every 2 
weeks. Advice for insulin adjustment was provided by phone. 
Control: 16 patients received conventional care. All patients had diabetes training 
for dose adaptation. 
Outcome: researchers reported that HbA1c improved in the intervention group 
but was not significantly better than in the control group. Telehealth could help to 
save time and cost. 
 
Author/Year: Billard et al. (1991) 
Country: France 
Study objective: to study the use and effects of transmitting self monitoring BG 
to a central database for glucose monitoring. 
Total participants: 22 
Ageavg (yrs): 32 
Gender (% male): 36 
Disease duration (yrs): 13 
Intervention time (months): 3 
Population: diabetic patients with insulin dependency. 
Intervention: 11 patients were provided with glucometers. Data were sent to a 
central database throughout a telephone network by a minitel terminal. Patients 
could use their system on demand. 
Control: 11 patients were provided with glucometers and data were recorded in 
booklets. 
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Outcome: researchers reported that self monitoring of BG was feasible and 
metabolic control improved slightly. 
 
Author/Year: Chase et al. (2003) 
Country: USA 
Study objective: to determine the impact of modem transmission when used 
instead of clinical visits. 
Total participants: 70 
Ageavg (yrs): 17 
Gender (% male): 47 
Disease duration (yrs): 7.9 
Intervention time (months): 6 
Population: adolescent patients with diabetes type 1. 
Intervention: 35 patients had 2 clinic visits (0 and 6 months) and transmitted 
blood glucose data every 2 weeks via modem. A nurse reviewed data and called 
patients to provide feedback and made treatment changes if needed. 
Control: 35 patients had 3 clinic visits (at 0, 3, and 6 months) with the option of 
sending blood glucose data to a clinic through telephone or fax as desired.  
Outcome: researchers found that HbA1c decreased in both groups with not 
statistically significant difference. 
 
Author/Year: Chumbler et al. (2005a) 
Country: USA 
Study objective: to asses the effect of 2 different telehealth monitoring intensities 
for veterans. 
Total participants: 395 
Ageavg (yrs): 66.5 
Gender (% male): 97.5 
Disease duration (yrs): NS 
Intervention time 
(months): 12 
Population: patients with diabetes who had complex medication conditions and 
high risk factors for healthcare utilisation. 
Intervention: one group of patients was monitored weekly for aggressive wound 
management to promote healing. Patients (or caregivers) took pictures of their 
wounds and mailed them to a care coordinator who decided if patients required 
further evaluation. 
 47 
Control: the other group was monitored daily using handheld devices, 
telemonitors and videophones. A care coordinator monitored patient’s symptoms 
and needs related to chronic disease management. This was not a control group. 
Outcome: researchers found that there were not significant differences in the 
clinical outcomes between groups. However, hospital admissions and number of 
bed days of care deceased in the daily monitoring group. 
 
Author/Year: Chumbler et al. (2005b) 
Country: USA 
Study objective: to examine the effectiveness of a telehealth programme. 
Total participants: 800 
Ageavg (yrs): 64.8 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: diabetic patients at risk 
Intervention: 400 patients were provided with telehealth technology, that was 
used for answering questions related to their health status and monitor their BG.  
Data were received daily by a coordinator who called patients for follow up, if 
needed. 
Control: 400 patients with diabetes did not received the care coordination and 
telehealth. 
Outcome: researchers reported that there was a significant increase of demand 
in primary care visits in the intervention group which prevented health 
deterioration. 
 
Author/Year: Dansky et al. (2001) 
Country: USA 
Study objective: to asses the effects of telehealth and evaluate its financial cost. 
Total participants: 171 
Ageavg (yrs): 74.5 
Gender (% male): 27 
Disease duration (yrs): NS 
Intervention time (months): NS. 
Population: diabetic patients referred to nursing care. 
Intervention: 86 patients received video-visits in addition to nursing visits. 
Control: 85 patients received only nursing visits. 
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Outcome: researchers reported that the total cost per patient in the intervention 
group, including hospitalisation, was lower than in the control group. 
 
Author/Year: Edmonds et al. (1998) 
Country: Canada 
Study objective: to determine if a telephone call would be an acceptable method 
for communicating results of blood glucose to a central database. 
Total participants: 35 
Ageavg (yrs): NS 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): 6 
Population: patients with diabetes type 1. 
Intervention: patients were provided with a 350 vista telephone to record and 
send BG data to a clinical database in daily basis. 
Control: NS. 
Outcome: researchers concluded that the study confirmed feasibility and 
acceptability of the telephone system. 
 
Author/Year: Farmer et al. (2005) 
Country: UK 
Study objective: to determine weather a mobile phone based system can 
improve glycaemic control. 
Total participants: 93 
Ageavg (yrs): 24 
Gender (% male): 59 
Disease duration (yrs): 12.5 
Intervention time (months): 9 
Population: Young patients with diabetes type 1. 
Intervention: 47 patients were provided with a blood glucose monitor connected 
to a mobile phone for recording blood glucose, insulin dose, food intake, and 
activity levels. Results were automatically transmitted to a central server. A 
diabetes specialist nurse checked the readings fortnightly and provided advice 
and counselling. 
Control: 46 patients were provided with the same system as the intervention 
group. Data were sent to the same central server but were not available to the 
nurse. 
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Outcome: researchers reported that difference in change in HbA1c between 
groups was not statistically significant. Telehealth is feasible and acceptable to 
patients but did not improve glycaemic control. 
 
Author/Year: Gómez et al. (2002) 
Country: Spain 
Study objective: to evaluate a telehealth system as a tool for intensive 
management. 
Total participants: 10 
Ageavg (yrs): NS 
Gender (% male): NS 
Disease duration (yrs): 13.8 
Intervention time (months): 6 
Population: patients with diabetes type 2. 
Intervention: patients were provided with a blood glucose system and asked to 
send the data to doctors. Doctors analysed the data and provided feedback within 
24 hours. 
Control: Patients used a BG meter and registered the data in a logbook.  
Outcome: researchers found that there was a trend towards HbA1c improvement 
with no incidence in the number of hypoglycaemias.  
 
Author/Year: Howells et al. (2002) 
Country: UK 
Study objective: to evaluate self management in young patients 
Total participants: 79 
Ageavg (yrs): 16.5 
Gender (% male): 50 
Disease duration (yrs): 6.7 
Intervention time (months): 12 
Population: Young patients with diabetes type 1. 
Intervention: 25 patients received telephone calls (negotiated telephone 
support); to be assisted in problem solving every 2 to 3 weeks. 
Control: 28 patients received routine care management (regular attendance in 
clinic, standard advice and education, and support by telephone). 
Outcome: researchers reported that the intervention group did not improve their 
glycaemic control in comparison with the control group, but telephone 
conversations were appreciated and psychological measures improved. 
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Author/Year: Kim and Oh (2003) 
Country: South Korea 
Study objective: To research the effect of nurse telephone calls on HbA1c levels 
and adherence. 
Total participants: 50 
Ageavg (yrs): 60 
Gender (% male): 30 
Disease duration (yrs): 14 
Intervention time (months): 3 
Population: type 2 diabetic patients. 
Intervention: 20 patients received weekly telephone calls for education, 
reinforcing of diet and exercise, medication adjustments and blood glucose 
monitoring. 
Control: 16 patients were in routine care (visiting a physician every 3 months). 
Outcome: researchers reported that a significant difference was found in HbA1c 
between the intervention and control group. The intervention group also showed 
greater adherence to diet and blood glucose monitoring. 
 
Author/Year: Kirkman et al. (1994) 
Country: USA 
Study objective: to study if a telehealth intervention designed to improve 
glycaemic control improved coronary high risk factors with non-insulin dependent 
patients. 
Total participants: 275 
Ageavg (yrs): 63.7 
Gender (% male): 99 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: patients with non-insulin dependent diabetes. 
Intervention: 204 patients received telephone calls at least once a month to 
encourage medical regimen compliance and behavioural changes, and to 
facilitate dietitian or smoking cessation clinic referrals. 
Control: 71 patients receive usual care but not telephone calls. 
Outcome: researchers reported that no significant changes were found in 
adherence to diet, exercise, weight lost nor score for any serum lipid 
measurement.  
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Author/Year: Kruger et al. (2003) 
Country: USA 
Study objective: to determine if transmission of blood glucose data by pregnant 
woman provided faster communication of results and increased clinic work flow. 
Total participants: 72 
Ageavg (yrs): 31 
Gender (% male): 0 
Disease duration (yrs): NS 
Intervention time (months): 1.5 
Population: pregnant patients diagnosed with gestational diabetes. 
Intervention: patients were provided with a blood glucose system to transmit 
data on a weekly basis. The system included an interface modem. Nursing staff 
reviewed data and provided feedback by telephone each time data were received 
at the clinic. 
Control: patients transmitted blood glucose data over the telephone. 
Outcome: researchers reported that no significant differences in telephone 
consultation time, clinic workflow, efficiency or accuracy were found between 
groups. 
 
Author/Year: Lavery et al. (2004) 
Country:  USA 
Study objective: to assess the effectiveness of home monitoring of foot skin 
temperature to prevent ulcerations. 
Total participants: 85 
Ageavg (yrs): 55 
Gender (% male): 50 
Disease duration (yrs): 14 
Intervention time (months): 6 
Population: diabetic patients with diabetic foot risk category 2 and 3. 
Intervention: 44 patients were provided with handheld infrared skin 
thermometers to measure their temperature on the sole of their foot in mornings 
and evenings. When temperatures were elevated, patients were instructed to 
reduce their activity and contact a nurse. 
Control: 41 patients received therapeutic footwear, diabetic foot education and 
foot evaluation from a podiatrist every 10 to 12 weeks. Patients in the intervention 
group also received this usual care. 
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Outcome: researchers reported that the intervention group showed significantly 
evidence of fewer diabetic foot complications. The intervention group showed to 
be 10 times more likely to develop complications. 
 
Author/Year: Liesenfield et al. (2000) 
Country: Germany 
Study objective: to evaluate the influence of a telehealth programme on 
glycaemic control. 
Total participants: 61 
Ageavg (yrs): 13 
Gender (% male): 59 
Disease duration (yrs): 5.5 
Intervention time (months): 5 
Population: children and adolescent patients with diabetes type 1. 
Intervention: patients were provided with blood glucose meters and PDAs with 
integrated modem for daily collection of data (blood glucose, insulin doses, meal 
an exercise). Data were sent and automatically stored into a hospital database.  
Control: no comparison group. 
Outcome: researchers found that HbA1c improvements were statistically 
significant after the intervention. There was also a reduction of hypoglycaemic 
events.  
 
Author/Year: Marrero et al. (1995) 
Country: USA 
Study objective: to assess the efficacy of using a telehealth system  to assist 
paediatric patients. 
Total participants: 106 
Ageavg (yrs): 13.3 
Gender (% male): 59.4 
Disease duration (yrs): 6 
Intervention time (months): 12 
Population: paediatric patients with type 1 diabetes. 
Intervention: 52 patients transmitted blood glucose data to a hospital every 2 
weeks, where a nurse reviewed them and telephoned patients to discuss regimen 
adjustments. 
Control: 54 patients received usual care (visiting every 3 months to a clinic and 
care provided by a multidisciplinary team). 
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Outcome: researchers reported that no significant differences were found 
between groups for metabolic control, rates for hospitalisation or A & E 
admissions, psychological status, general family functioning, quality of life nor 
parent-child responsibility.   
 
Author/Year: Meneghihi et al. (1998) 
Country: USA 
Study objective: to assess the usage and safety of an electronic system 
designed to facilitate glycaemic control. 
Total participants: 184 
Ageavg (yrs): NS 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: patients with complicated and difficult to manage diabetes. 
Intervention: patients were asked to report daily blood glucose levels, 
hypoglycaemic symptoms and life style events to an electronic case manager 
using a touch tone telephone. Diabetes crises were identified by the electronic 
system and immediately flagged. 
Control: no control group. 
Outcome: researchers found that patients showed a significant reduction of 
diabetes crisis. There was also a significant reduction in HbA1c. 
 
Author/Year: Montori et al. (2004) 
Country: USA 
Study objective: to determine the efficacy of telehealth to support intensive 
insulin therapy. 
Total participants: 31 
Ageavg (yrs): 43 
Gender (% male): 32 
Disease duration (yrs): 17 
Intervention time (months): 6 
Population: patients with diabetes type 1 and inadequate glycaemic control. 
Intervention: 16 patients were provided with blood glucose meter and an 
interface modem to monitor blood glucose 4 times per day and transmit data 
every 2 weeks. Patients received feedback from a nurse 24 hours after data 
transmission. 
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Control: 15 patients were provided with the same system but did not receive 
nurse feedback unless they contacted her. 
Outcome: researchers reported that improvements in adherence to self 
monitoring and glycaemic control were observed in both groups. Telehealth has a 
small impact on glycaemic control. 
 
Author/Year: Oh et al. (2003) 
Country: South Korea 
Study objective: to research the effect of telephone calls on glycaemic control 
and  BMI 
Total participants: 50 
Ageavg (yrs): 60 
Gender (% male): 36 
Disease duration (yrs): 26 
Intervention time (months): 3 
Population: type 2 diabetes patients.  
Intervention: 25 patients received weekly telephone calls for education, 
reinforcing on diet and exercise, medication adjustments and blood glucose 
monitoring. 
Control: 25 patients were in routine care (visiting a physician every 3 months). 
Outcome: researchers reported that a significant change was found in the 
improvement of HbA1c in the intervention group, but there were no significance 
differences observed in the BMI between the 2 groups. 
 
Author/Year: Piette et al. (2000a) 
Country: USA 
Study objective: to evaluate the impact of telehealth among low income patients. 
Total participants: 248 
Ageavg (yrs): 54.5 
Gender (% male): 41.1 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: English and Spanish speaking patients with diabetes. 
Intervention: patients received automated calls for reporting health and self care 
information, receiving education, and appointment reminders every 2 weeks and 
nurse telephone follow ups in addition to usual care. 
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Control: patients received usual care with no contact to the automatic system or 
nurse follow ups. 
Outcome: researchers found that the intervention group reported fewer 
symptoms of depression and days in bed, and greater efficacy to conduct daily 
activities.  
 
Author/Year: Piette et al. (2000b) 
Country: USA 
Study objective: to evaluate the effect of automated calls and nurse follow ups.  
Total participants: 280 
Ageavg (yrs): 54.5 
Gender (% male): 41.5 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: patients with diabetes who spoke English or Spanish. 
Intervention: 124 patients received bi-weekly automated assessment and self 
care education calls with nurse follow ups.  Patients used the system for reporting 
BG levels. 
Control: usual care and some follow ups. 
Outcome: researchers found that the intervention group reported better 
glycaemic control, lower HbA1c levels, and better weight monitoring. 
 
Author/Year: Piette et al. (2001) 
Country: USA 
Study objective: to evaluate automated telephone disease management for 
improving diabetes treatment. 
Total participants: 272 
Ageavg (yrs): 60.5 
Gender (% male): 71 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: diabetic patients using hypoglycaemic medications. 
Intervention: 146 patients received biweekly automated telephone calls for 
health assessment and self care education calls, and telephone nurse follow ups. 
Control: 146 patients received usual care. 
Outcome: researchers reported that no significant changes were found in the 
improvement of HbA1c between groups. However the intervention group reported 
 56 
fewer symptoms of poor glycaemic control and increased their satisfaction with 
care. 
 
Author/Year: Shea et al. (2006) 
Country: USA 
Study objective: to conduct a randomised controlled trial comparing telehealth 
case management to usual care and to measure the intervention effects. 
Total participants: 1665 
Ageavg (yrs): NS 
Gender (% male): 37 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: patients with diabetes aged 55 or older and treated with diet, oral 
hypoglycaemic agent or insulin. 
Intervention: patients received a home telehealth unit consisting on a web 
enabled computer with modem connection to an existing telephone line. The unit 
provided videoconferencing, remote monitoring (glucose and blood pressure), dial 
up internet access and access to an educational website. A nurse case manager 
interacted through videoconferencing with the patients. Notes were supervised by 
a diabetologist and when a change in management was suggested, the primary 
care doctor was contacted by email, fax, letter o telephone.  
Control: patients remained under the care of their primary care providers. 
Outcome: researchers reported that after 1 year of follow up, mean HbA1c level 
decreased in the intervention group from 7.35% to 6.97% and in the control group 
from 7.42% to 7.17%. 
 
Author/Year: Shultz et al. (1992) 
Country: USA 
Study objective: to test the importance of transferring home monitoring 
information to health care providers. 
Total participants: 30 
Ageavg (yrs): NS 
Gender (% male): 85 
Disease duration (yrs): NS 
Intervention time (months): 18 
Population: diabetic patients using insulin. 
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Intervention: patients collected their blood glucose measurements twice daily 
and transferred them weekly to a laboratory via modem.  
Control: patients used a handwritten diary to record blood glucose data. 
Outcome: researchers reported that a significant change was found in the 
improvement of HbA1c in the intervention group. 
 
Author/Year: Thompson et al. (1999) 
Country: Canada 
Study objective: to investigate if insulin adjustment by telephone led to a better 
glucose control. 
Total participants: 46 
Ageavg (yrs): 48.75 
Gender (% male): 48 
Disease duration (yrs): 17 
Intervention time (months): 6 
Population: Diabetes patients (type 1 and 2) with poor glucose control. 
Intervention: Patients were provided with insulin, blood glucose meters and strip. 
They received regular telephone calls (average 3 per week) by a diabetes nurse 
educator for insulin adjustments and advice. 
Control: Patients received usual care (visiting their physician every 3 months and 
education through a diabetes educator). 
Outcome: researchers found that insulin adjustments improved glucose control in 
the intervention group. 
 
Author/Year: Tsang et al. (2001) 
Country: Hong Kong 
Study objective: to assess the impact of monitoring systems on glycaemic 
control and patient’s acceptance. 
Total participants: 19 
Ageavg (yrs): 32.5 
Gender (% male): 63 
Disease duration (yrs): 8.5 
Intervention time (months): 6 
Population: diabetic patients. 
Intervention: 10 patients stored data about their food intake and blood glucose in 
a handheld device and sent them to a computer system twice a week. Data were 
analysed automatically by the system and sent back to the handheld device.  
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Control: 9 patients had conventional care (follow up consultations with a diabetes 
team). 
Outcome: researchers reported that a significant change was found in the 
improvement of HbA1c in the intervention group. 
 
Author/Year: Vahatalo et al. (2004) 
Country: Finland 
Study objective: to evaluate the impact of transmission of blood glucose data by 
mobile phones. 
Total participants: 203 
Ageavg (yrs): 43 
Gender (% male): 56 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: patients with diabetes type 1. 
Intervention: patients were provided with a mobile phone to transfer blood 
glucose data to a database. Physicians monitored results weekly and sent text 
messages to patients with instructions. 
Control: patients continued with normal visits to their physician every 3 to 4 
months. 
Outcome: researchers found that there was not a significant difference in HbA1c 
between groups  
 
Author/Year: Weinberger et al. (1995) 
Country: USA 
Study objective: to examine the impact of nurse intervention by telephone non 
insulin dependent patients. 
Total participants: 275 
Ageavg (yrs): 64 
Gender (% male): 99 
Disease duration (yrs): 14 
Intervention time (months): 12 
Population: patients with diabetes type 2. 
Intervention: 204 patients received telephone calls on monthly basis for 
monitoring their health status, educational purposes, facilitating compliance and 
access to primary care. 
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Control: 71 patients received usual care (visiting a physician every 3 to 4 
months). 
Outcome: researchers reported that a significant change was not found in the 
improvement of QoL and HbA1c between groups. 
 
Author/Year: Welch et al. (2003) 
Country: USA 
Study objective: to asses the clinical impact of transferring blood glucose 
information via modem and educator phone calls. 
Total participants: 52 
Ageavg (yrs): 41.3 
Gender (% male): 36 
Disease duration (yrs): 21.6 
Intervention time (months): 12 
Population: patients with diabetes type 1, poorly controlled. 
Intervention: 26 patients were provided with a modem equipped blood glucose 
meter system to monitor and send data. Patients received diabetes educator 
phone calls for making any adjustment to insulin every 2 weeks. 
Control: 26 patients received usual care. 
Outcome: researchers reported that HbA1c improvements in the intervention 
group were statistically significant. 
 
Author/Year: Whitlock et al. (2000) 
Country: USA 
Study objective: to study the impact of telehealth on diabetic management. 
Total participants: 28 
Ageavg (yrs): 63 
Gender (% male): 39 
Intervention time (months): 3 
Population: patients with diabetes type 2. 
Intervention: 15 patients received video calls from a nurse for reviewing patient’s 
blood glucose, weight, and blood pressure once at week. 
Control: 13 patients received usual care. 
Outcome: researchers reported that significant changes were found in the 
improvement of HbA1c and weight reduction. 
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Author/Year: Wojcicki et al. (2001) 
Country: Poland 
Study objective: to evaluate the therapeutic effectiveness of telehealth for 
treatment of pregnant woman with diabetes type 1. 
Total participants: 32 
Ageavg (yrs): 26 
Gender (% male): 0 
Disease duration (yrs): 8.8 
Intervention time (months): 36 
Population: pregnant woman with diabetes type 1. 
Intervention: 17 patients were provided with a blood glucose meter. Readings 
were sent automatically to a database every night, a diabetologist reviewed them 
the morning after, and called the patient to modify her treatment if necessary. 
Control: 15 patients received clinical examinations every 3 weeks. 
Outcome: researchers found that general assessment showed better glycaemic 
control for the intervention group (based on mean blood glucose). However 
results were not statistically significant. 
 
Author/Year: Young et al. (2005) 
Country: UK 
Study objective: to determine the impact of telephone calls by nonmedical staff 
supported by a software programme for glycaemic control. 
Total participants: 591 
Ageavg (yrs): 67 
Gender (% male): 58 
Disease duration (yrs): 6 
Intervention time (months): 12 
Population: Patients with diabetes type 2. 
Intervention: 394 patients received telephone calls according to a protocol based 
on their last HbA1c level.  
Control: 197 patients received usual care (life style advice, drug treatment, 
continuing education programme and local guidelines). 
Outcome: researchers reported that a reduction of 1% of HbA1c was not 
achieved. 
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3.6.3 Asthma publications 
 
Author/Year: Bruderman and Abboud (1997) 
Country: Israel 
Study objective: to describe a new telehealth system and to assess the ability of 
the system to detect early signs of asthmatic deterioration. 
Total participants: 30 
Ageavg (yrs): 53 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): NS 
Population: 39 patients with moderate to severe asthma. 
Intervention: patients were provided with a spirometer to transmit pulmonary 
function test to a medical centre by placing a telephone handset on the 
spirophone speaker. 
Control: no control group. 
Outcome: researchers reported that in 49% of patients were possible to detect 
early signs of deterioration. 
 
Author/Year: Chan et al. (2003) 
Country: USA 
Study objective: to study the adherence and disease control associated with the 
use of a “store and forward” monitoring system for paediatric asthma patients. 
Total participants: 10 
Ageavg (yrs): 8 
Gender (% male): 50 
Disease duration (yrs): NS 
Intervention time (months): 6 
Population: paediatric patients with persistent asthma. 
Intervention: patients were provided with a computer system which included a 
video camera, a microphone and access to internet. A video of patients using the 
peak flow meter and inhalers was recorded twice at week. Videos and electronic 
diaries were sent to a case manager who reviewed them and emailed patients 
with his assessment. Education was provided online. 
Control: patients received education from the case manager during scheduled 
asthma visits.  
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Outcome: researchers found that there was not difference in outcomes between 
the intervention and control group. 
 
Author/Year: Farzanfar et al. (2004) 
Country: USA 
Study objective: to investigate to what extent interviews provide effective tools 
for usability testing of telehealth systems. 
Total participants: 5 
Ageavg (yrs): NS 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): 0.5 
Population: patients with asthma. 
Intervention: 5 patients were trained in how to perform spirometry measurements 
and use a personal digital assistant (PDA).  Patients performed regular lung 
function testing and answered clinical status questionnaire in the PDA. Patients 
received automatically messages via the PDA.  Patients received a follow up 
telephone interview at the end of a 2 week period. 
Control: no control group. 
Outcome: researchers reported that patients tended to evaluate the telehealth 
system on how it fit into their everyday lives and personal preferences. 
 
Author/Year: Finkelstein et al. (2000) 
Country: USA 
Study objective: to asses the validity of spirometry self-testing and to evaluate 
the acceptance of telecare system by asthmatic patients. 
Total participants: 31 
Ageavg (yrs): 42 
Gender (% male): NS 
Disease duration (yrs): 19 
Intervention time (months): 0.75 
Population: 31 patients with asthma. 
Intervention: patients were provided with a spirometer which was connected to a 
PDA for data transmission. They were trained and performed spirometries on a 
daily basis. The system automatically transmitted results, symptoms and patient’s 
notes to a medical centre. Patients were evaluated on their ability to perfom a 
self-testing spirometry by a medical professional by the end of the third week. 
 63 
Control: no control group. 
Outcome: researchers reported that there was not significant difference between 
unsupervised and supervised spirometry self-testing. Variability of FVC, FEV and 
PEF in the study was similar to other comparable studies. 
 
Author/Year: Guendelman et al. (2004) 
Country: USA 
Study objective: to study the effectiveness of a novel technology for self 
management of children with asthma in decreasing frequency of control problems 
and hospitalisations. 
Total participants: 134 
Ageavg (yrs): 12 
Gender (% male): 58 
Disease duration (yrs): NS 
Intervention time (months): 3 
Population: children with persistent or out of control asthma. 
Intervention: 66 patients received training on how to carry out peak flow reading, 
use medications, and make use of a handheld device programmed for recording 
asthma symptoms, PFR, functional status, medications and health service 
utilisation. Patients were asked to use the device once a day.  The device 
transmitted data to a nurse coordinator through a secure website.   
Control: 68 patients used a diary for tracking symptoms. All patients, including 
those in the intervention groups, were asked to return for 2 follow up visits at 6 
and 12 weeks. 
Outcome: researchers concluded that both groups reported a decrease in the 
number of control problems at the end of study (12 weeks). However at 6 weeks, 
the intervention group had a significantly lower mean number of control problems 
(2 with a SD of 1.6) in comparison to the control group (2.7 with a SD of 1.6). 
There was a significant short term impact. 
 
Author/Year: Kokubu et al. (1999) 
Country: Japan 
Study objective: to study the effectiveness of a new telehealth system in 
reducing frequency of hospitalisation. 
Total participants: 66 
Ageavg (yrs): 49 
Gender (% male): 41 
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Disease duration (yrs): 17 
Intervention time (months): 6 
Population: asthmatic patients at high risk for hospitalisation. 
Intervention: 32 patients performed daily peak flow (PEF) monitoring and 
transmitted measurements via modem to a database. A nurse provided regular 
follow ups to patients (under supervision of a physician) via telephone.  
Control: 34 patients monitored PEF and registered values in a diary at least twice 
a day. They had an outpatient visit every month. 
Outcome: researchers found that there was a significant reduction in 
hospitalisations (83%, p= 0.01) in the intervention group vs. the control group. 
PEF and symptoms also improved in the control group. 
 
Author/Year: Ostojic et al. (2005) 
Country: Croatia 
Study objective: to evaluate the feasibility of monitoring patients by mobile 
phone text messages and to determine its impact on asthma control. 
Total participants: 16 
Ageavg (yrs): 25 
Gender (% male): 57 
Disease duration (yrs): NS 
Intervention time (months): 4 
Population: patients with moderate persistent asthma. 
Intervention: 8 patients received a mini Wright and instructions to send their PEF 
results via text messages, on a daily basis, to a mobile telephone connected to a 
computer in a hospital. Patients received weekly instructions by text messages on 
adjustment of therapy and follow-up. 
Control: 8 patients received a mini Wright and were asked to register PEF 
measurements, medication use and symptoms in a paper diary.  
Outcome: researchers found that there was a significant change in reduction of 
PEF variability (p=0.049) in the control group (16.2 ± 6.93) vs. (27.24 ± 10.01) and 
slightly but not significant improvement in FEV1. 
 
Author/Year: Rasmussen et al. (2005) 
Country: Denmark 
Study objective: to explore the effects of using an internet based monitoring tool 
in comparison with conventional asthma treatment. 
Total participants: 300 
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Ageavg (yrs): 30 
Gender (% male): 37 
Disease duration (yrs): NS 
Intervention time (months): 6 
Population: patients with asthma. 
Intervention: 100 patients used an internet tool which included an electronic 
diary, an action plan and a decision support system.  They were given a peak flow 
meter and encouraged to use the system daily. A doctor contacted patients by 
email or telephone to adjust treatment. 
Control: 100 patients were sent to a specialist who taught patients how to adjust 
their medications. They were provided with a peak flow and an action plan. 
Another 100 patients were asked to contact their GP who decided, based on 
guidelines, their drug treatment. 
Outcome: researchers found that there was a significant improvement of 
symptoms, quality of life and lung function between the intervention group vs. 
specialist group and the intervention group vs. the GP group.  
 
Author/Year: Ryan et al. (2005) 
Country: UK 
Study objective: to evaluate patient’s compliance when using an electronic peak 
flow. 
Total participants: 91 
Ageavg (yrs): NS 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): 9 
Population: patients with stable asthma between 12 to 55 years who required 
treatment with steroids and bronchodilators. 
Intervention: 91 patients were provided with a handheld peak flow meter which 
was connected to a mobile phone. Patients were asked to monitor peak flow in 
the mornings and evenings and transmitted the readings to a server. Immediate 
feedback was sent back to the mobile in a form of trend analysis.   
Control: no control group (observational study). 
Outcome: researchers found that there was a high level of compliance in 64% 
patients. However, there was a poor compliance for reasons that were not 
identified. 
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Author/Year: Steel et al. (2002) 
Country: UK 
Study objective: to evaluate the feasibility of using an asthma monitoring system 
at home. 
Total participants: 33 
Ageavg (yrs): 34 
Gender (% male): 43 
Disease duration (yrs): NS 
Intervention time (months): 0.5 
Population: patients admitted with acute asthma between 17 and 50 years. 
Intervention: 33 patients were provided with an asthma monitor and a modem to 
monitor daily their asthma for 2 weeks from home. A nurse reviewed the data 
every day and contacted patients whether a clinical intervention was required, or if 
patients failed to transmit data. 
Control: no control group. 
Outcome: researchers reported that remote monitoring at home is feasible. 
Compliance with the use of the system was acceptable: 80% for monitoring and 
52% for modem transmission.  
 
 
3.6.4 Chronic obstructive pulmonary disease (COPD) publications 
 
Author/Year: Dale et al. (2003) 
Country: UK 
Study objective: to conduct a telehealth pilot study for patients with COPD. 
Total participants: 55 
Ageavg (yrs): NS 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): 3 
Population: patients with COPD. 
Intervention: 55 patients were provided with a pulse oximeter and a weight 
monitoring device. A nurse called patients every day to ask questions and 
capturing patients’ responses into decision support software.  A day-to-day 
assessment, reassurance, advice and education was offered. 
Control: no control group. 
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Outcome: researchers reported that the system shown capability of diagnosing 
sleep apnoea syndrome and therefore, reduce the rate of hospital admissions 
(50%). 
 
Author/Year: Pare et al. (2006) 
Country: Canada 
Study objective: to present the findings of an economic analysis of a telehealth 
programme for patients with COPD. 
Total participants: 30 
Ageavg (yrs): 70 
Gender (% male): 57 
Disease duration (yrs): NS 
Intervention time (months): 6 
Population: patients with COPD that required frequent home visits. 
Intervention: 20 patients received a web phone with an integrated touch screen 
and modem. Patients’ were trained for collecting and sending peak flow 
measurements, symptoms and medications over the internet.  Data were 
reviewed by a nurse on a daily basis and patient received an automatic response 
by the device or a call from the nurse. 
Control: 10 patients received usual care ((home visits). 
Outcome: researchers found that the telehealth programme caused savings 
reducing hospitalisations rates and less home visits. Overall net savings were 
found to be 15%. 
 
Author/Year: Ries et al. (2003) 
Country: USA 
Study objective: to evaluate a telephone based programme after pulmonary 
rehabilitation in patients with chronic lung disease. 
Total participants: 164 
Ageavg (yrs): 67 
Gender (% male): 54 
Disease duration (yrs): NS 
Intervention time (months): 24 
Population: patient with chronic lung disease. 
Intervention: 83 patients received a maintenance intervention which consisted in 
weekly telephone calls for verifying compliance with the care plan and recent 
health problems. Staff provided advice and assistance to patients when needed. 
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Patients also received monthly reinforcing sessions designed to review the 
information that was taught, re-evaluate treatment programmes and provide 
encouragement.  
Control: 81 received standard care, which included a referral back to primary 
care for continuous medical care, and a letter indicating the recommended home 
care rehabilitation programme. 
Outcome: researchers found that there was not significant difference between 
groups at the end of the study. However, some short term modest improvements 
were noticed before the first year in terms of exercise tolerance and overall health 
status with a reduction in hospital days. 
 
Author/Year: Wong et al. (2005) 
Country: Hong Kong 
Study objective: to determine if a nurse telephone programme can increase 
patients’ self-efficacy in patients with COPD. 
Total participants: 60 
Ageavg (yrs): 74 
Gender (% male): 78 
Disease duration (yrs): 7 
Intervention time (months): 0.75 
Population: patients with COPD. 
Intervention: 30 patients were provided with educational and supportive 
telephone follow-ups by a nurse. The patients received 2 calls on days 3-7 and 
14-20 for (i) assessment of patient’s clinical status and use of self-efficacy scale, 
(ii) patient management consisted in performance, verbal persuasion and 
emotional arousal, and (iii) evaluation with appropriate referral. 
Control: 30 patients received routine care without phone calls. 
Outcome: researchers reported that patients in the intervention group had some 
relatively higher score for some dimensions of the Chinese self-efficacy scale 
questionnaire (physical exertion and weather). A significant difference between 
groups in total scores was observed. 
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3.6.5 Hypertension publications 
 
Author/Year: Aris et al. (2001) 
Country: Malaysia 
Study objective: to develop a blood pressure monitor system for patient with 
hypertension. 
Total participants: 4 
Ageavg (yrs): 28 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): NS 
Population: subjects aged 24 to 30 years old. 
Intervention: subjects were provided with a device and asked to measure their 
blood pressure at home using the monitor. Measurements were sent to a 
database via the internet. Access to data were possible through a website. 
Control: no control group. 
Outcome: researchers reported that blood pressure readings rest within 3% 
error. The system was reported easy to use. 
 
Author/Year: Artinian et al. (2001) 
Country: USA 
Study objective: to test improvements in blood pressure groups with telehealth 
and community based monitoring vs. usual care. 
Total participants: 26 
Ageavg (yrs): 59 
Gender (% male): 12 
Disease duration (yrs): NS 
Intervention time (months): 3 
Population: adult patients with hypertension. 
Intervention: 6 patients were provided with blood pressure monitors and asked to 
measure their blood pressure 3 times a week. Data were sent every Friday 
through a modem interface by telephone. Every Monday, patients received a 
phone call from a nurse to provide feedback and counselling. 
Control: 9 patients received usual care. Other 6 patients were assigned to a 
community nurse that runs a blood pressure monitoring group. 
Outcome: researchers found that there was not any significant change between 
the intervention group and the community based group. However, blood pressure 
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improved in both groups, whereas, the usual group did not show any 
improvement.  
 
Author/Year: Bertera and Bertera (1981) 
Country: USA 
Study objective: to answer whether telephone counselling is as effective as face 
to face counselling, and whether is cost-effective. 
Total participants: 40 
Ageavg (yrs): 53 
Gender (% male): NS 
Disease duration (yrs): 2.6 
Intervention time (months): 6 
Population: patients with a history of high blood pressure. 
Intervention: 10 patients received regular counselling by telephone every 3 
weeks. 
Control: 10 patients received face to face counselling every 3 weeks and 20 
patients received usual care. 
Outcome: researchers reported that similar improvements in blood pressure 
control were found between the intervention group and the face to face 
counselling group.  
 
Author/Year: Bondmass et al. (2000) 
Country: USA 
Study objective: to determine the effect of telehealth monitoring on achievement 
of blood pressure control. 
Total participants: 33 
Ageavg (yrs): 52 
Gender (% male): 30 
Disease duration (yrs): NS 
Intervention time (months): 3 
Population: African American with uncontrolled blood pressure despite drug 
treatment. 
Intervention: patients were provided with a monitor to measure their blood 
pressure once or twice a day. Data were sent automatically by the monitor to a 
medical centre on a daily basis. Patients received education and medication 
adjustment over the phone. 
Control: no control group. 
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Outcome: researchers reported that compliance was achieved in 88% of 
patients. A significant decrease in both mean systolic (154 to 141 mmHg) and 
diastolic (90 to 83 mmHg) BP was observed. 
 
Author/Year: Friedman et al. (1996) 
Country: USA 
Study objective: to assess the effects of a telehealth intervention (monitoring 
and counselling) on patient adherence and blood pressure control. 
Total participants: 267 
Ageavg (yrs): 77 
Gender (% male): 23 
Disease duration (yrs): NS 
Intervention time (months): 6 
Population: patients with hypertension. 
Intervention: 133 patients were provided with an automatic monitor to measure 
their blood pressure. They reported blood pressure values to a computer system 
using their telephone keypad on a weekly basis. The system asked questions 
about the patient’s status and gave feedback to promote adherence to treatment. 
Control: 134 patients receive usual care. 
Outcome: researchers reported that there was not a significant difference in 
adherence between intervention and control group, but mean diastolic blood 
pressure decreased more in the intervention group as medication adherence 
improved. 
 
Author/Year: Menard et al. (1996) 
Country: France 
Study objective: to study the feasibility of sending self measurements from home 
to a doctor’s computer. 
Total participants: 96 
Ageavg (yrs): NS 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): NS 
Population: patients with hypertension. 
Intervention: patients were provided with a blood pressure monitor and asked to 
perform 3 consecutive measurements in the mornings and in the evenings. Data 
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were sent automatically to a computer server or a PC in the doctor’s office. 
Information was available in tabular or graphical form. 
Control: no control group. 
Outcome: researchers reported that self monitoring was possible. Variability of 
blood pressure under controlled conditions was demonstrated, which suggested 
that BP taken at a doctor’s office should not be used as a standard for 
hypertension management.  
 
Author/Year: Mengden et al. (2004) 
Country: Germany 
Study objective: to explore the feasibility of using telehealth in patients with 
uncontrolled hypertension treated with olmesartan medoxomil. 
Total participants: 53 
Ageavg (yrs): 58 
Gender (% male): 55 
Disease duration (yrs): 6 
Intervention time (months): 3 
Population: patients with untreated or uncontrolled hypertension. 
Intervention: patients were provided with a blood pressure monitor and asked to 
take their blood pressure at least twice a day. Data were automatically sent to a 
service centre every fortnight. Patients were prescribed with olmesartan 
medoxomil for 12 weeks. 
Control: no control group. 
Outcome: researchers concluded that telehealth allowed early identification of 
patients who responded to olmesartan medoxomil. Monitoring compliance 
declined towards the end of the study. 
 
Author/Year: Moller et al. (2003) 
Country: Denmark 
Study objective: to compare accuracy between clinic blood pressure and home 
measurements in treated hypertensive patients. 
Total participants: 362 
Ageavg (yrs): 58 
Gender (% male): 50 
Disease duration (yrs): NS 
Intervention time (months): NS 
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Population: patients with hypertension. 
Intervention: patients were provided with a BP monitor and a modem interface 
for automatic transmission of data to a server in a hospital. Measurements were 
taken 4 times a day. 
Control: clinic blood pressure was taken at a doctor’s office with a mercury 
sphygmomanometer. Ambulatory blood pressure was measured by an automatic 
device every 15 min from mornings to evenings and every 30 minutes at nights. 
Outcome: researchers concluded that patients can accurately measure their 
blood pressure at home. Progressive accuracy improvement was observed on the 
5ht day. Blood pressure accuracy was higher at home than at the clinic. 
 
Author/Year: Naef et al. (1998) 
Country: USA 
Study objective: to determine whether automated measurements of blood 
pressure was reliable for pregnant woman with hypertension. 
Total participants: 7 
Ageavg (yrs): NS 
Gender (% male): 100 
Disease duration (yrs): NS 
Intervention time (months): 3 
Population: pregnant woman with chronic hypertension. 
Intervention: 7 patients were provided with blood pressure monitors to take their 
blood pressure and pulse 4 times a day and transfer the data by telephone once a 
day. Printed reports were sent to a physician. 
Control: no control group. 
Outcome: researchers explained that mean blood pressure measurements at 
home were compared with values obtained in the clinic when patients had their 
prenatal visit every 2 weeks. The device was reported easy to use and 
measurements correlated well. 
 
Author/Year: Nakajima et al. (2006) 
Country: Japan 
Study objective: to report the development of a low cost BP monitoring system. 
Total participants: 10 
Ageavg (yrs): NS 
Gender (% male): NS 
Disease duration (yrs): NS 
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Intervention time (months): NS 
Population: elderly volunteers. 
Intervention: a wrist cuff BP monitor was provided to volunteers. BP was 
measured twice a day. Data were sent in a CSV file via internet to researchers.  
Control: no control group. 
Outcome: researchers reported that the system was easy to use and 
implementation was of low cost. 
 
Author/Year: Nakamoto et al. (2004) 
Country: Japan 
Study objective: to develop a telehealth system based on mobile phones and 
internet website to monitor BP in patients on continuous ambulatory peritoneal 
dialysis. 
Total participants: 20 
Ageavg (yrs): 44 
Gender (% male): 60 
Disease duration (yrs): NS 
Intervention time (months): 3 
Population: patients with hypertension in whom continuous ambulatory 
peritoneal dialysis were carried out.  
Intervention: patients were provided with a BP monitor and asked to measure 
their BP twice a day. Data were transferred to a mobile phone and then sent to a 
server. Patients were able to access their data using a mobile phone or a website. 
Control: no control group. 
Outcome: researchers found that blood pressure measurements in outpatient 
clinics were higher than the measurements at home. The systems helped to 
determine patients with “white coat” hypertension.  
 
Author/Year: Port et al. (2003) 
Country: Estonia 
Study objective: to study if self reported drug administration and self monitoring 
is useful for treatment adjustment. 
Total participants: 50 
Ageavg (yrs): 52 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): 12 
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Population: patients with essential mild to moderate hypertension. 
Intervention: patients were provided with a blood pressure monitor and a data 
collection device (handheld), and asked to measure their blood pressure twice a 
day. They entered blood pressure values, daily symptoms, stress level, and 
collected ECG into the handheld which sent data to a server. Data were accessed 
by doctors via internet. 
Control: no control group. 
Outcome: researchers found that 3 groups emerged: a group whose blood 
pressure (BP) decreased (16), one that showed no change (21) and another 
group whose BP increased (13). This study revealed different patterns of 
compliance and effectiveness. 
 
Author/Year: Port et al. (2005) 
Country:  Estonia 
Study objective: to evaluate self monitoring using a telecare system. 
Total participants: 43 
Ageavg (yrs): 52 
Gender (% male): 60 
Disease duration (yrs): NS 
Intervention time (months): 12 
Population: patients with moderately hypertension. 
Intervention: patients used a blood pressure monitor and a data collection unit 
for storing and transmitting data (sleep quality, BP, weight and ECG) to a central 
server. Doctors accessed the data by a secure internet connection.  
Control: no control group. 
Outcome: researchers found 2 phases of usage: “initial enthusiasm” and 
“personal convenience”. 3 patient groups were identified: one with an increasing 
blood pressure trend, another with decreasing blood pressure trend and the third 
with no consistency. 
 
Author/Year: Rogers et al. (2001) 
Country: USA 
Study objective: to find out the efficacy of a telehealth service in reducing blood 
pressure. 
Total participants: 121 
Ageavg (yrs): 53 
Gender (% male): NS 
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Disease duration (yrs): 2.5 
Intervention time (months): 2 
Population: patients with essential hypertension under evaluation for a change in 
drug therapy. 
Intervention: 60 patients were provided with a blood pressure monitor that 
transmitted data over analogue telephone line.  They were asked to monitor their 
blood pressure at least 3 times per week. Data from the monitor were sent 
automatically to a centre where reports that included mean systolic and diastolic 
blood pressure, and heart rate were created. Patients and doctors received the 
reports on a weekly basis. If elevated blood pressure was detected, the patient 
received a phone call from the doctor in order to adjust its antihypertensive 
medications. 
Control: 61 patients received usual care according to Joint National Committee 
on Prevention, Detection, and Treatment of High Blood Pressure in the USA.  
Outcome: researchers found that there was a significant difference in blood 
pressure between the intervention group and control group. Decrease of mean, 
diastolic and systolic blood pressure (2.8, 2, 4.9 mmHg respectively) were found n 
the intervention group vs. increase of mean and diastolic pressure (1.3 and 2.1 
mmHg) and decrease in systolic pressure (0.1 mmHg) in the control group. 
 
Author/Year: Rogers et al. (2002) 
Country: USA 
Study objective: to assess the efficacy of a telehealth service for the diagnosis of 
hypertension. 
Total participants: 74 
Ageavg (yrs): 56 
Gender (% male): 49 
Disease duration (yrs): NS 
Intervention time (months): 0.25 
Population: patients with suspected essential hypertension. 
Intervention: 37 patients used a BP monitor 3 times before having breakfast and 
3 times before going to bed every day. The monitor automatically transmitted the 
data to a central computer that printed summary reports on a weekly basis. The 
report included tabular as well as graphic formats of systolic and diastolic blood 
pressure and was faxed to patient’s doctor and patient (sent by post). 
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Control: 37 patients were followed up by doctors (as specified by national 
American guidelines) and considered to have essential hypertension if the doctor 
recorded the diagnosis or if the patients began antihypertensive therapy. 
Outcome: researchers reported that detection of essential hypertension improved 
in the intervention group (64%) in comparison to detection in the control group 
(26%).  
 
Author/Year: Roth et al. (1999) 
Country: Israel 
Study objective: to study if there is any “white coat” effect in a telehealth 
programme. 
Total participants: 30 
Ageavg (yrs): 59 
Gender (% male): NS 
Disease duration (yrs): NS 
Intervention time (months): 0.5 
Population: Patients with hypertension treated at least for 1 yr with medications, 
10 with  blockers (group b) and 10 with other antihypertensive medication (group 
c). 
Intervention: 20 patients received a monitor for automatic transmission of BP 
readings. Patients were asked to take 2 sets (3 measurements) of BP. One set 
was sent automatically by telephone to a data centre and analysed by a nurse 
who contacted patients if the readings were not within the expected range.  The 
other set was entered on a form and mailed to the centre at the end of the study. 
Control: 10 normotensive participants (group a) with no cardiovascular condition 
or other disease received a BP monitor and performed the same 2 sets. 
Outcome: researchers found that no blood pressure difference was observed 
among data sets with the same group. White coat effect was not present in this 
telehealth programme. 
 
 
3.7 Discussion 
 
3.7.1 Diabetes 
Mixed evidence for impact on clinical outcomes was found. In the case of 
diabetes, only Chumbler et al. (2005b) and Shea et al. (2006) had a large number 
of participants (800 and 1665, respectively) and both studies were randomised 
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controlled trials (RCT). These studies lasted for about 12 months, and reported 
significant statistical improvement in HbA1c. The study by Chumbler et al. (2005b) 
enabled patients to answer questions and monitor their blood glucose daily. A 
care coordinator called patients if it was needed and performed a follow up. In the 
case of Shea et al. (2006), a more complex technology was used including a 
computer with modem that provided videoconferencing, remote monitoring, dial 
up internet access and access to an educational website. In this case a nurse 
interacted with patients by videoconferencing under the supervision of a 
diabetologist.  
 
Nine studies in diabetes had more than 200 participants and less than 800 
(Kirkman et al., 1994; Weinberger et al., 1995; Albisser et al., 1996; Piette et al., 
2000a; Piette et al., 2000b; Piette et al., 2001; Vähätalo et al., 2004; Chumbler et 
al., 2005a; Young et al., 2005).  However, only Piette et al. (2000a), Piette et al. 
(2000b) and Albisser et al. (1996) reported positive or improvement effects. The 
intervention duration for these 3 studies was 12 months. The study design was 
declared to be RCT for both, Piette et al. (2000a) and Piette et al. (2000b). 
 
The remaining diabetes studies (in total 26) range from 10 participants (Gómez et 
al., 2002) to 186 participants (Meneghini et al., 1998).  Interestingly, 18 studies 
out of the 26 had less than 50 participants, in which half of them (8/16) reported 
positive findings or improvement effects (Ahring et al., 1992; Shultz et al., 1992; 
Edmonds et al., 1998; Thompson et al., 1999; Whitlock et al., 2000; Tsang et al., 
2001; Oh et al., 2003; Welch et al., 2003).  
 
In 22 out of the 37 studies enough HbA1c clinical data were found in order to 
analyse the effect of the intervention via meta-analysis. Meta-analysis is a 
statistical approach for combining data from multiple independent studies. The 
approach is typically used in areas of evidence based medicine and helps to 
explore conditions under which clinical effects occur.  Figure 3.1 shows the results 
of meta-analysis assuming a fixed effect. On this model, the approach assumes 
no heterogeneity3 between results of the 22 telehealth studies and estimated a 
common underlying treatment effect of -0.24 (-0.33, -0.15) with a 95% confidence 
interval. However, the value of I2 (70.7) indicated high heterogeneity; therefore, 
                                                 
3
 Heterogeneity in meta-analysis refers to the variation in study outcomes between studies. The I² index 
describes the percentage of variation across studies that is due to heterogeneity rather than chance (Higgins and 
Thompson, 2002). 
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the true effect size cannot be interpreted as a common true value since the I2 
index indicated inconsistency within the results in the studies.  
  
Study or Subgroup
Albisser et al. (1996)
Oh et al. (2003)
Tsang et al. (2001)
Kim et al. (2003)
Thompson et al. (1999)
Ahring et al. (1991)
Billiard et al. (1991)
Albisser et al. (1996b)
Weinberger et al. (1995)
Wong et al. (2004)
Montori et al. (2004)
Marrero et al. (1995)
Farmer et al. (2005)
Howells et al. (2002)
Shea et al. (2006)
Piette et al. (2000)
Piette et al. (2001)
Chase et al. (2003)
Wojcicki et al. (2001)
Vahatalo et al. (2004)
Biermann et al. (2001)
Maljanian et al. (2005)
Total (95% CI)
Heterogeneity: Chi² = 71.60, df = 21 (P < 0.00001); I² = 71%
Test for overall effect: Z = 5.40 (P < 0.00001)
Weight
1.2%
1.5%
0.3%
2.0%
2.8%
1.4%
1.2%
2.3%
1.5%
2.9%
0.9%
1.8%
2.3%
1.9%
41.8%
3.4%
10.0%
1.5%
1.8%
8.2%
1.2%
8.0%
100.0%
IV, Fixed, 95% CI
-1.50 [-2.28, -0.72]
-1.30 [-2.01, -0.59]
-1.21 [-2.81, 0.39]
-1.20 [-1.82, -0.58]
-1.10 [-1.62, -0.58]
-1.00 [-1.73, -0.27]
-0.80 [-1.61, 0.01]
-0.70 [-1.27, -0.13]
-0.60 [-1.31, 0.11]
-0.50 [-1.02, 0.02]
-0.40 [-1.33, 0.53]
-0.30 [-0.95, 0.35]
-0.30 [-0.87, 0.27]
-0.30 [-0.93, 0.33]
-0.20 [-0.33, -0.07]
-0.10 [-0.57, 0.37]
-0.10 [-0.38, 0.18]
0.00 [-0.72, 0.72]
0.10 [-0.54, 0.74]
0.10 [-0.20, 0.40]
0.30 [-0.50, 1.10]
0.30 [-0.01, 0.61]
-0.24 [-0.33, -0.15]
Mean Difference Mean Difference
IV, Fixed, 95% CI
-4 -2 0 2 4
Favours telehealth Favours usual care
 
Figure 3.1. Forest plot of 22 telehealth studies assuming a fixed effect model. 
 
Causes of heterogeneity have been investigated before. Glasziou (2002) 
attributed variations in studies due to the patient or the disease group, the 
intervention timing or intensity, other treatments that the patient received and the 
outcome of measurement and timing. Other factors can be associated to the 
quality of the design and conduction of the study, the extent of compliance with 
the intervention and the accuracy of the outcome measures (Glasziou and 
Sanders, 2002).  
 
In a similar meta-analysis that included 8 studies in diabetes, Montori et al.(2004) 
found that telehealth intervention was not significantly different from usual care. 
They found that HbA1c pooled effect changed from baseline 0.2 (-0.2, 0.6) with a 
95% confidence interval. They were not able to explain heterogeneity. Our meta-
analysis and Montori’s suggest that because of the complexity of interventions, 
heterogeneity is common in telehealth and it should be expected. 
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For the reasons above, a second model that fitted better with the data were 
considered. A random effects model is shown in fig. 3.2. The results show that the 
effects being estimated in the different studies are not identical, but follow some 
kind of distribution. A statistical significant (p<0.0001) overall effect lay on -0.41(-
0.61, -0.22) with a 95% confidence interval. Although the pooled effect was 
statistically significant, it remained as a question whether the association is 
clinically significant. The effect value of this finding is similar to the one reported 
by Polisena et al. (2009). They found that home telehealth monitoring had a 
positive effect by decreasing HbA1c, and their meta-analysis estimated a weighed 
mean difference effect of -0.21 (-0.35, -0.08) with 95% confidence interval 
(Polisena et al., 2009). 
 
Study or Subgroup
Albisser et al. (1996)
Oh et al. (2003)
Tsang et al. (2001)
Kim et al. (2003)
Thompson et al. (1999)
Ahring et al. (1991)
Billiard et al. (1991)
Albisser et al. (1996b)
Weinberger et al. (1995)
Wong et al. (2004)
Montori et al. (2004)
Farmer et al. (2005)
Marrero et al. (1995)
Howells et al. (2002)
Shea et al. (2006)
Piette et al. (2000)
Piette et al. (2001)
Chase et al. (2003)
Wojcicki et al. (2001)
Vahatalo et al. (2004)
Biermann et al. (2001)
Maljanian et al. (2005)
Total (95% CI)
Heterogeneity: Tau² = 0.13; Chi² = 71.60, df = 21 (P < 0.00001); I² = 71%
Test for overall effect: Z = 4.12 (P < 0.0001)
Weight
3.5%
3.9%
1.3%
4.4%
5.1%
3.8%
3.4%
4.7%
3.9%
5.1%
2.8%
4.8%
4.3%
4.4%
7.6%
5.4%
6.9%
3.8%
4.3%
6.7%
3.4%
6.6%
100.0%
IV, Random, 95% CI
-1.50 [-2.28, -0.72]
-1.30 [-2.01, -0.59]
-1.21 [-2.81, 0.39]
-1.20 [-1.82, -0.58]
-1.10 [-1.62, -0.58]
-1.00 [-1.73, -0.27]
-0.80 [-1.61, 0.01]
-0.70 [-1.27, -0.13]
-0.60 [-1.31, 0.11]
-0.50 [-1.02, 0.02]
-0.40 [-1.33, 0.53]
-0.30 [-0.87, 0.27]
-0.30 [-0.95, 0.35]
-0.30 [-0.93, 0.33]
-0.20 [-0.33, -0.07]
-0.10 [-0.57, 0.37]
-0.10 [-0.38, 0.18]
0.00 [-0.72, 0.72]
0.10 [-0.54, 0.74]
0.10 [-0.20, 0.40]
0.30 [-0.50, 1.10]
0.30 [-0.01, 0.61]
-0.41 [-0.61, -0.22]
Mean Difference Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours experimental Favours control
 
Figure 3.2. Forest plot of 22 telehealth studies assuming a random effects model. 
 
By grouping the studies together in the Forest plot (fig. 3.2), several aspects can 
be explored: 
 It can be easily seen which studies had a positive effect in favour of 
telehealth (the ones on the left) and which had no effects to telehealth (the 
ones on the right). 
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 Significant positive effects can be identified by finding those studies with 
confidence intervals on the left side of the no-effect line (Ahring et al., 
1992; Albisser et al., 1996; Thompson et al., 1999; Kim and Oh, 2003; Oh 
et al., 2003; Shea et al., 2006). 
 Significant effects favouring the control group can also be identified by 
finding those studies with confidence interval on the right side of the no-
effect line. The closest example to this was: (Meneghini et al., 1998). 
 Some studies showed positive effects in favour of telehealth but were not 
significant (Marrero et al., 1995; Piette et al., 2001; Tsang et al., 2001; 
Howells et al., 2002; Montori et al., 2004; Wittenberg et al., 2004; Wong et 
al., 2005). 
 Some studies showed positive effects in favour of the control group but 
were not significant (Wojcicki et al., 2001; Vähätalo et al., 2004). 
 
From the above, it can be concluded that the telehealth interventions that had 
better effects on reducing HbA1c were in the studies of Ahring et al. (1992), 
Albisser et al. (1996), Thompson et al. (1999), Oh et al. (2003), Kim and Oh 
(2003) and Shea et al. (2006). A common factor that these studies share was the 
contact with a health care provider, usually a nurse. These studies can be 
considered the best models for telehealth implementation, but only those of 
Albisser et al. (1996) and Shea et al. (2006) proved to be effective at 12 months. 
In general, home telehealth for diabetes management had positive effects, but the 
results must be interpreted with caution and as suggested by Polisena et al. 
(2009) further research, with a high methodological quality, is needed to 
demonstrate the potential clinical effectiveness of the telehealth intervention. 
 
3.7.2 Asthma  
In terms of research concerned to asthma, only 2 medium size studies were 
found.  Rasmussen et al. (2005) included 300 patients in their RCT study; the 
duration of the intervention was 6 months. On average the participants were 
young (mean age=30 yrs). The service was implemented using a computer for 
data transmission and electronic feedback. This study reported positive effects 
regarding asthma symptoms, quality of life and lung function. Rasmussen et al. 
found that fewer asthma symptoms were reported by patients in the intervention 
group. This group also reported better quality of life as well as better pulmonary 
function.  
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The other medium size study was that of Guendelman et al. (2004). Guendelman 
et al. reported some positive health changes in their study. The study included 
134 children with an average age of 12 yrs. The intervention consisted in sending 
electronic questions to children through an interactive communication device for 
self-management. The questions were regarding asthma symptoms, peak flow 
rates, functional status and use of medications and health services. They found 
that the intervention group was less likely to experience peak expiratory flow 
readings that indicated a severe exacerbation or poor asthma control. Significant 
effects were found at 6 weeks, but after 12 weeks the effects were not statistically 
significant.  
 
More positive results were reported in Ostojic et al. (2005) and in Kokubu (1999). 
But in Ryan et al. (2005), Farzanfar et al. (2004), Steel et al. (2002), Finkelstein et 
al. (2000) and Bruderman and Abbound (1997) the effectiveness of the telehealth 
intervention was difficult to evaluate. The main characteristics of the asthma 
studies are summarised in table 3.3. The majority of studies below (table 3.3) 
investigated the transmission of spirometry data via modem transmission or 
mobile technology with the aim of improving management and compliance with 
treatments. Most of the studies were pilot projects and feasibility studies. None of 
them were evaluated beyond 6 months. Even though some of these studies 
showed significant improvement in peak flow rates, reduction in the symptoms 
associated to asthma and improvements in quality of life, the results must be 
taken with caution because of the short term outcomes. These findings are 
aligned with a recent systematic review (McLean et al., 2010) in telehealth for 
asthma and a RCT study (Willems et al., 2008) . The review by McLean et al. 
(2010) included 21 studies and found that these types of interventions did not 
result in significant improvements from the quality of life point of view. Willems et 
al. (2008) also found not significant decrease in asthma symptoms nor medical 
consumption nor improved asthma-specific quality of life. Therefore, more 
research evaluating the effectiveness of asthma intervention in home monitoring 
is needed. 
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Table 3.3. Characteristics of the asthma studies found in the 3 systematic reviews. 
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Guendelman et 
al. (2004) 
 
134 12 58 NS 3    X 
Kokubu et al. 
(1999) 
 
66 49 41 17 6  X   
Ostojic et al. 
(2005) 
 
16 25 57 NS 4 X    
Rasmussen et 
al. (2005) 
 
300 30 37 NS 6 
 
 X  
Ryan et al. 
(2005) 
 
91 NS NS NS 9 X    
Steel et al. 
(2002) 
 
33 34 43 NS 0.5  X   
Chan et al. 
(2003) 
 
10 8 50 NS 6   X  
Farzanfar et al. 
(2004) 
 
5 NS NS NS 0.5   X  
Finkelstein et al. 
(2000) 
 
31 42 NS 19 0.7
5 
   X 
Bruderman and 
Abbound (1997) 
 
30 53 NS NS NS    X 
      NS= not stated 
 
 
3.7.3 COPD 
In the case of COPD, the only middle size study found was Ries et al (Ries et al., 
2003). The study was a randomised controlled trial that included 172 patients. 
Half of the patients were assigned to the telehealth intervention which included 
weekly telephone contacts and monthly supervised reinforcement sessions. At 12 
months of evaluation, exercise tolerance and overall health status were better in 
the intervention group, but no differences were found in pulmonary function, 
dyspnea, quality of life or health care use. Overall, the study indicated significant 
benefits in short term periods (8 weeks), but such benefits progressively 
disappeared.  
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The rest of studies were small trials and the interventions varied broadly in terms 
of study duration (see table 3.4).  
 
Table 3.4. Summary of the main characteristics of the COPD studies. 
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Ries et 
al. 
(2003) 
 
164 67 54 NS 24 X  
Wong 
et al. 
(2005) 
 
60 74 78 7 0.75 X  
Pare et 
al. 
(2006) 
 
30 70 57 NS 6  X 
Dale et 
al. 
(2003) 
55 NS NS NS 3 X  
 
There was not sufficient evidence reported in the studies (Dale et al., 2003; Ries 
et al., 2003; Wong et al., 2005; Pare et al., 2006) that supported clinical benefits 
for COPD telehealth interventions. This is not a new finding. For instance, Bolton 
et al. (2011) examined the effectiveness of telemonitoring interventions for adult 
patients with COPD. They conducted a systematic review of studies that have 
addressed the effectiveness of telemonitoring practices for patients with COPD. In 
their review, Bolton et al. (2011) criticised that the studies were typically 
underpowered, had heterogeneous patient populations and had a lack of detailed 
intervention descriptions and a lack of the care processes that accompanied 
telemonitoring. They concluded that the beneﬁts of telemonitoring for COPD has 
not yet been proven. 
 
3.7.4 Hypertension 
Finally, the relatively largest studies in hypertension were published by Montori et 
al. (2004) and Friedman et al. (1996). Montori et al. (2004) compared the 
accuracy of clinical blood pressure measurements with home telehealth blood 
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pressure (BP) measurements. For this, they recruited 362 patients. The 
researchers provided a blood pressure device with an interface for automatic 
transmission of BP data over analogue telephone lines. Patients had to take 
duplicate measurements four times a day for 5 consecutive days. Montori et al. 
(2004) found that telehealth home blood pressure provided a better prediction of 
BP than the conventional measurement in the clinic.  
 
Friedman et al. (1996) evaluated the effect of patient monitoring and counselling 
on patient compliance to medications and BP control. They implemented a 
randomised controlled trial and recruited 267 patients for this purpose. The 
duration of the intervention was for 6 months and consisted in transmitting BP 
data over the phone using the touch-tone key pad. A computer based system 
conversed with patients in their homes using computer synthesised speech. 
During the conversation, patients reported their BP readings, their understanding 
of prescribed medication regimen, their adherence to medications, and any 
symptoms known to produce side effects. The computer system provided 
education and motivational counselling. Friedman et al. (1996) noticed a non 
significant trend towards a drop in systolic blood pressure which was limited to 
subjects who were not adherent to their medication regime at baseline. For these 
subjects the mean systolic BP dropped by 12.8mmHg in comparison to 0.9mmHg 
in the control group (p=0.09). However, in the analysis of diastolic BP, the 
intervention group sustained a significant decrease of 5.2mmHg (p=0.02).  
 
In 11 out of the 16 hypertensive studies, the number of participants were less than 
55 (Bertera and Bertera, 1981; Naef et al., 1998; Roth et al., 1999; Bondmass et 
al., 2000; Aris et al., 2001; Artinian et al., 2001; Port et al., 2003; Mengden et al., 
2004; Nakamoto et al., 2004; Port et al., 2005; Nakajima et al., 2006). A mix of 
studies regarding BP monitoring, counselling diagnosis, compliance and cost 
demonstrated the heterogeneity of the studies reviewed. Furthermore, just a few 
of them were randomised controlled trials (Bertera and Bertera, 1981; Friedman 
et al., 1996; Artinian et al., 2001; Rogers et al., 2001; Rogers et al., 2002) and 
most of these were trials at small scale. These issues appear to be still valid. For 
instance, a recent study (Omboni and Guarda, 2011) evaluating the impact of 
telehome monitoring of blood pressure also suggested that because of the 
heterogeneity of published studies, more large scale and well design RCT studies 
are needed to demonstrate clinical effectiveness. 
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3.8 Summary 
This chapter identifies key research publications that addressed home monitoring 
in the management of diabetes, asthma, chronic obstructive pulmonary disease 
(COPD) and hypertension. 
 
Some important limitations were found in the evidence produced by the majority 
of the studies published in these telehealth subjects. Most importantly, it was 
noticed that the majority of studies tended to measure only short term clinical 
outcomes, usually carrying out assessments at 6 months or less. Therefore, little 
is known about whether initially observed effects can be sustained over long 
periods of time. Furthermore, the studies varied considerably in terms of trial 
duration, disease duration, number of participants, age and intervention type.  
 
It was also difficult to determine how much of the effects reported in these studies 
were due to telemonitoring as there are no study regimens and evaluation 
methods standardised. In addition to this, in the case of diabetes, the meta-
analysis suggested that small studies tended to produce higher effect sizes.  
 
Insufficient or incomplete sets of data made it difficult to establish which groups or 
subgroups and factors contributed to effectiveness in the case of asthma, COPD 
and hypertension. Therefore, no attempts were made for performing meta-
analysis. As suggested before, further high quality research is needed to 
demonstrate the clinical effectiveness of such telehealth interventions. 
 
The rapidity and scope of scientific studies and technological developments have 
led to new publications in telehealth that provide evidence that complements 
section 3.6. For instance, in terms of monitoring technology in heart failure, Maric 
et al. (2009) classified five groups of interventions: device based monitoring, 
telephone touch pad based telemonitoring, video consultation based, web site 
based monitoring and a combination of the previous telemonitoring modalities. A 
similar classification was also provided by Sutcliffe et al. (2011), who identified 
five categories of communication technologies to promote access and 
engagement of young patients with diabetes. Their classification included: video 
and teleconferencing, mobile telephony, telephone support, novel electronic 
communication and web based discussion boards. Although new communication 
technologies such as mobile telephony, social networks and Voice over Internet 
Protocol (VoIP) can potentially facilitate communication between healthcare 
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professionals and young patients with diabetes (or other chronic diseases), 
Sutcliffe et al. (2011) have found limited or no research involving these 
technologies in young populations. The lack of research may explain, in the 
current study, the telehealth results for this group, who may benefit from this, 
more sophisticated, technology. 
 
In terms of effectiveness, the reported evidence is still limited and inconsistent 
with regard to the monitoring of heart failure, diabetes and asthma, COPD, 
diabetes and hypertension (Ekeland et al., 2010; Wootton, 2012). However, 
recent systematic reviews have found small but significant improvements in cases 
such as BP home telemonitoring (Bray et al., 2010; Agarwal et al., 2011). The 
gaps in the evidence for effectiveness suggest that more systematic reviews in 
home telehealth are required (Bahaadinbeigy et al., 2010). 
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Chapter 4. Demographic and clinical profiles  
 
 
4.1. Introduction 
In this section, we present the clinical and demographic circumstances found 
among patients who were enrolled in the REALITY project, a telehealth study 
involving three EU countries. This case study exemplifies a wide variability of 
conditions carried by those patients with chronic diseases who could potentially 
be in need of additional medical support and closer follow up by means of 
telehealth.  
 
Understanding in isolation the complexity of a patient’s medical conditions 
appears not to be enough for managing patients through telehealth. As will be 
discussed in later chapters, our case study shows that not all the clinically ill 
subjects exposed to telehealth may be able to use the service properly or to 
experience any clinical benefit. The reasons for that are unclear, but one 
explanation can be attributed to unmet patient needs. As a consequence of that, 
this chapter provides the starting point towards understanding those needs, 
recognising in the first place the chronically ill patient as a whole. 
 
The figures appearing in this report are derived from data collected by the 
REALITY consortium financially supported from the European Union. Therefore, 
some of the information presented in this chapter was previously reported to the 
5th Framework Program of R&D of the European Commission in 2005 (REALITY 
Consortium, 2005b). Yet, to compare and analyse the demographic composition 
of the recruited groups, we have extracted and reorganised the raw data that 
were originally collected in the electronic forms by the consortium. 
 
4.2. REALITY background 
Between 2004 and 2005, more than 190 patients with different chronic diseases, 
from locations in the UK, Estonia and Portugal, took part in an EU-funded project 
called REALITY (representative evaluation of evolving remote home-based 
patient monitoring delivery – QLG7-CT-2002-02657). This was a telecare project 
implemented as a remote clinical monitoring service for the care of patients with 
chronic diseases staying at home. The project aimed to provide a socio-economic 
evaluation of a telecare service including the perspectives of patients, doctors and 
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healthcare managers. Four clinical partners based in: a GP practice (London), a 
University Hospital (Tartu), and two other Hospitals (Lisbon and Evora) recruited 
patients with diabetes and hypertension, asthma, heart conditions, and pulmonary 
diseases. Patients who met the criteria given in table 4.1 (REALITY Consortium, 
2004) and agreed participation were recruited, trained and provided with medical 
devices based on the patients’ primary health condition.   
 
The project included a technical partner who provided a system designed for the 
management of patients with long term conditions. This consisted of a web 
service for doctors’ interaction with both the data collected and their patients, and 
a handheld device for home data collection. On a regular basis, patients recorded 
their clinical and quality of life data using the handheld and other third party 
products such as glucometers, blood pressure monitors, peak flow meters and 
pulse oximeters. Subsequently, physiological measurements and health related 
data were sent automatically from local homes to a central server over standard 
phone lines. Using a PC, doctors were able to access the information collected by 
patients from their local healthcare facilities via the internet. 
 
Table 4.1. Criteria for patient selection and method of recruitment. 
 London Tartu Lisbon Evora 
Inclusion 
criteria 
Patients with: 
 Diabetes and 
hypertension 
 Bronchial asthma 
 Age: 25+ 
 
Patients with:  
 Chronic heart 
failure 
 
Patients with: 
 Chronic 
respiratory 
failure   
 Long-term 
oxygen therapy 
and/or non-
invasive 
ventilation 
 
Patient with: 
 Bronchial asthma 
 Chronic respiratory 
failure 
Patient or immediate 
carer/family able to 
read. 
Patient with severe or 
moderate disease 
category. 
Patient located 
close/far away from 
Evora. 
Only patients 
interested in the 
evaluation 
 
Exclusion 
criteria 
 Visually impaired 
 Patients who 
cannot read 
 Pregnant woman 
 Patients with no 
telephone line 
 
Not stated  Patient/family 
illiteracy 
 Patients with 
pacemaker 
 Patients with no 
telephone line 
 Patients with no 
telephone line 
Method of 
recruitment 
Local advertisement 
posters, flyers and 
leaflets 
Not stated Not stated Not stated 
 
To collect data and provide a comprehensive evaluation from the patients and 
doctors perspectives, the research consortium developed different electronic 
questionnaires (forms 1 to 4).  Forms were distributed to patients or answered as 
 90 
appropriate by clinical partners at 3 stages of the project: recruitment and training, 
interim visit and final visit (fig. 4.1).  
 
Form 1 Form 2 Form 4a
Form 4b
Form 3
End of 
study
RECRUITMENT 
& TRAINING
SERVICE IN 
OPERATION
(INTERIM VISITS)
SERVICE IN 
OPERATION
(FINAL VISIT)
Chronically ill 
patients
 
Figure 4.1. REALITY process and the stages at which the electronic forms were 
distributed for the project evaluation. 
 
4.3. Patient’s demographics 
 
4.3.1 Total patients per study site  
A total of 193 cases were retrieved from the patients recruitment form: 
 62 patients in London  
 60 patients in Tartu  
 38 patients in Lisbon and 
 33 patients in Evora.       
 
4.3.2 Age distribution 
As illustrated in fig. 4.2, the youngest patients were recruited in London and Tartu 
with an average age of 53.1 years (SD=15.5) and 55.5 years (SD=9.9) 
respectively. The mean age in Lisbon was 70.6 years (SD=9).  Average age in 
Evora was 60.9 years (SD=14.3). 
London Tartu Lisbon Evora
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Figure 4.2. Box plot displaying the difference in age among the 4 sites. 
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To the Shapiro-Wilk normality test (W>0.05), the participants’ age in London, 
Tartu and Lisbon followed a normal distribution (elimination of an outlier was 
needed in Lisbon).  Evora displayed a left skewed age distribution with a large 
proportion of recruited patients between 70 to 75 years old. The normality test 
suggests no recruitment preference for any specific (target) age group at least in 
3 out of the 4 sites. It also suggests that genuine patient participation for 
telehealth studies can be achieved normally distributed by age, allowing an 
unbiased estimator of the population mean and possible generalisability of future 
local studies.  
 
As indicated in table 4.2, 26.9% of the total participants were between 61-70 
years old, followed by the groups 71 to 80 (23%), 41 to 50 (18.1%) and the 51 to 
60 years old (17.6%). Only 3.1% of the total participants were younger than 31 
years or older than 80.  Almost 50% of the recruits in London were younger than 
51 years. The majority of participants in Lisbon (92%) were older than 60 years. 
Tartu had almost equal proportion of participants in the intervals 41-50, 51-60 and 
61-70 years. There was a significant association between the age of participants 
and the location of recruitment (Cramer’s V=0.342, p<0.001).  
 
Table 4.2. Distribution of age by class intervals. 
 Clinical  site  
 London Tartu Lisbon Evora Total 
Age: (n= 62) (n=60) (n=38) (n=33)  
<= 30 8.1%   3.0% 3.1% 
31 – 40 16.1% 5.0% 2.6% 9.1% 8.8% 
41 – 50 24.2% 26.7%  12.1% 18.1% 
51 – 60 12.9% 30.0% 5.3% 18.2% 17.6% 
61 – 70 22.6% 30.0% 34.2% 21.2% 26.9% 
71 – 80 12.9% 8.3% 47.4% 36.4% 22.3% 
81+ 3.2%  10.5%  3.1% 
Total 100.0% 100.0% 100.0% 100.0% 100.0% 
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4.3.3 Gender 
An equal proportion of male and female participants were recruited in the four 
clinical sites (see fig. 4.3). As a whole, there was no significant preference for 
participation in the trial by male (53.7%) or female (46.3%) subjects (2=1.032, 
df=1, p=0.310). 
 
Figure 4.3. Gender distribution per clinical site. 
 
4.3.4 Education level 
The education level of participants by the four sites is shown in table 4.3. Tartu 
showed the highest proportion of adults who had completed either college (20%) 
or university (46.7%), followed by the group in London (16.9 and 28.8% 
respectively). Notably, Evora had the highest proportion of participants with no 
education at all. As a whole, 31% of the total participants declared to have 
completed high/secondary school. There was a strong association between 
education level and the location of recruitment (Cramer’s V=0.505, p<0.001) 
 
Table 4.3. Education level. 
 Clinical  site  
 London Tartu Lisbon Evora  
Education: (n
*
= 59) (n= 60) (n
*
= 37) (n=33 ) Total 
None 6.8%  2.7% 24.2% 6.9% 
Primary School  5.0% 78.4% 39.4% 23.8% 
High / Secondary School 47.5% 28.3% 18.9% 24.2% 31.7% 
College 28.8% 20.0%   15.3% 
University 16.9% 46.7%  12.1% 22.2% 
Total 100.0% 100.0% 100.0% 100.0% 100.0% 
  n
*
 reports only the valid cases. Missing or not recorded answers: London= 3; Lisbon=1 
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4.3.5 Marital status 
In total, 132 participants were married (70.2%), 30 were single (16%), 12 divorced 
(7.3%) and 14 widowed (7.4%). As illustrated by fig. 4.4, Tartu and Evora had the 
largest and almost equal proportion of married cases (78.3 and 78.8% 
respectively). The largest percentage of widowed participants was recorded in 
Lisbon (21.6%) whereas London had the largest proportion of singles (27.6%). A 
moderate but significant association was found between the participant’s marital 
status and the clinical site (Cramer’s V=0.223, p=0.001). 
 
 
Figure 4.4. Marital status per clinical sites (5 cases missing). 
 
4.3.6 Occupation 
Altogether, manual labour accounted for the main current or most recent 
occupation (26.9%), followed by technical/administrative profession (22.9%) and 
service occupation (19.4%). For Tartu (see table 4.4), subjects were more likely to 
be in the category of technical/administrative profession or manager/highly trained 
profession, whereas subjects in London were either in the service occupation or 
seeking employment category. In Evora, more than 50% of the subjects reported 
to be manual labourers as well as one third of the subjects in Lisbon. A significant 
relationship was observed between occupation and the site of recruitment 
(Cramer’s V=0.400, p<0.001). 
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Table 4.4. Current or most recent occupation. 
 Clinical  site  
 London Tartu Lisbon Evora  
Current or most recent occupation: (n
*
=50) (n
*
=56) (n
*
=36) (n=33 ) Total 
Manual labour 10.0% 21.4% 33.3% 54.5% 26.9% 
Mid-level technical/administrative profession 12.0% 37.5% 19.4% 18.2% 22.9% 
Seeking employment 18.0% 1.8%   5.7% 
Senior manger / highly trained profession 8.0% 30.4%  12.1% 14.3% 
Service occupation 36.0% 5.4% 25.0% 12.1% 19.4% 
Skilled labour 16.0% 3.6% 22.2% 3.0% 10.9% 
Total 100.0% 100.0% 100.0% 100.0% 100.0% 
 n
*
 reports only the valid cases. Missing or not recorded answers: London=12; Tartu=4; Lisbon=1 
 
4.3.7 Activity of retired patients 
The total percentage of subjects inactive either as a result of illness or by choice 
is shown in fig. 4.5. Almost all subjects from Lisbon were inactive due to illness 
(33/36). Subjects from Evora were reported to be either active (14/33) or inactive 
due to illness (15/33). In Tartu, subjects were more likely to be inactive by choice 
(12/23) whereas in London subjects were more likely to be inactive due to illness 
(13/25). There was a significant association between being active or inactive and 
the clinical site (Cramer’s V=0.463, p<0.001).  
 
Figure 4.5. Activity if patient has reached retirement age. 
 
4.3.8 Literacy in local language 
As evident from fig. 4.6, all participants in Tartu were literate in the local language 
whereas a considerable proportion of participants (24.2%) in Evora were not 
literate. Less than 3% of the Lisbon and London groups were not literate (one 
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case in each site). There was an association between literacy in local language 
and the place of recruitment.  
 
Figure 4.6. Percentage of literate participants per clinical site. 
 
4.3.9 Ethnicity  
Patients in London were more likely to come from a cultural or ethnic minority 
group with a large participation of Black Afro Caribbeans. In Tartu, participants 
were predominantly White Caucasians with only one participant reporting coming 
from an unspecified background. The other two sites did not specify any ethnic 
minority background within their living areas. Further details can be consulted in 
table 4.5. There was a significant association between ethnicity and the clinical 
sites (Cramer’s V= 0.597, p<0.001). 
 
Table 4.5. Ethnic Groups. 
 Clinical  site  
 London Tartu Lisbon Evora  
Ethnic group: (n=62 ) (n=60 ) (n
*
= 37) (n= 33) Total 
Asian: Indian 3.2%    1.0% 
Asian: Pakistani 1.6%    0.5% 
Black: Afro Carribbean 62.9%    20.3% 
White: Caucasian 17.7% 98.3%  93.9% 52.6% 
Other    3.0% 0.5% 
Not specified 14.5% 1.7% 100.0% 3.0% 25.0% 
Total 100.0% 100.0% 100.0% 100.0% 100.0% 
  n
*
 reports only the valid cases. Missing or not recorded answers: Lisbon=1 
 
4.3.10 Location of the patient’s home 
Fig.4.7 shows the general location of the patient’s home (only the valid cases) at 
each clinical site. As can be seen, all patients in London lived in the urban area. 
Patients in Tartu were living in different locations, but almost 80% of them lived in 
either the inner or the outer city. The majority of patients in Lisbon (65%) lived in 
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the outer city whereas in Evora, patients lived either in towns (55.5%) or rural 
areas (45.5%).  There was a significant association between the location of 
patient’s home and the clinical sites (Cramer’s V=0.597, p<0.001).  
 
Figure 4.7. General location of patient’s home. 
 
4.3.11 Household 
The patient’s status within the household is shown in table 4.6. At least 50% of all 
patients owned the property where they lived. Almost 30% of patients were an 
equal representative householder among people in the same property and 18% of 
patients were the main householder’s partner.  No association was found between 
the patient’s status within the household and the clinical site (Cramer’s V=0.148, 
p=0.220). 
 
Table 4.6. Household status per clinical site. 
 Clinical  site  
 London Tartu Lisbon Evora  
Patient’s status within the household: (n
*
=54) (n=60 ) (n
*
=35) (n=33 ) Total 
Patient is the main householder 48.1% 60.0% 60.0% 39.4% 52.7% 
Patient is the main householder’s partner 16.7% 16.7% 8.6% 33.3% 18.1% 
Patient is a representative householder 
(equal among people in the same house) 
33.3% 23.3% 31.4% 27.3% 28.6% 
Patient is representative of other patients 
in the care/nursing home or sheltered 
accommodation 
1.9% 
   
0.5% 
Total 100.0% 100.0% 100.0% 100.0% 100.0% 
 n
*
 reports only the valid cases. Missing or not recorded answers: London=8; Lisbon=3 
 
The majority of patients lived either with their partners (39%) or with family or 
friends (46%) in all sites. However, almost 20% of the patients in London and 
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Portugal lived alone.  An association was found between with who the patient 
lived and the site of recruitment (Cramer’s V=0.493, p<0.001).  
 
4.3.12 Main income of the household 
Overall, 55% of patients stated that the main income of their households came 
from a monthly salary, followed by State benefits in 43% of all cases. Individually, 
as illustrated by fig. 4.8, Lisbon had the highest proportion of patients who were 
reliant on State benefits (almost 92%), whereas Tartu had the lowest proportion 
(13.5%) for the same category. There was an association between main income 
of the household and the clinical site (Cramer’s V=0.344, p<0.001). 
 
 
Figure 4.8. Main income of household. 
 
4.3.13 Living accommodation 
In general, patients were more likely to declare reasonable conditions for their 
quality of living accommodation in 40% of the cases, followed by the category of 
good condition (33%) and reduced conditions (22%). Patients in Tartu rated “good 
condition” in 76.7% of the cases while majority of patients in Evora (45.5%) rated 
their accommodations condition as reduced. Patients in London and Lisbon rated 
their living accommodation as reasonable almost in 60% of the cases. Full details 
are listed in table 4.7. There was an association between the quality of living 
accommodation and the clinical site (Cramer’s V= 0.426, p<0.001).  
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Table 4.7. Quality of living accommodation. 
 Clinical  site  
 London Tartu Lisbon Evora  
Quality of living accommodation: (n
*
=51 ) (n= 60) (n= 37
*
) (n= 33) Total 
Inadequate conditions 5.9%  2.7% 3.0% 2.8% 
Reduced conditions 25.5%  29.7% 45.5% 21.5% 
Reasonable conditions 58.8% 18.3% 59.5% 27.3% 39.8% 
Good conditions 9.8% 76.7% 5.4% 21.2% 33.1% 
Very good conditions  5.0% 2.7% 3.0% 2.8% 
Total 100.0% 100.0% 100.0% 100.0% 100.0% 
  n
*
 reports only the valid cases. Missing or not recorded answers: London=11; Lisbon=1 
 
4.4 Existing services and support from carers 
 
4.4.1 Access to local medical and social care services 
There was a clear difference in the answers from patients living in London and 
Tartu in contrast to the ones living in Lisbon and Evora. As illustrated by fig. 4.9, 
patients living in Portugal were quite likely to have an existing care provision and 
access to local medical and social care service, whereas patients living in the UK 
and especially in Estonia were unlikely to have an existing care provision in place.  
There was a strong association between existing services and support from 
carers and the local sites (Cramer’s V= 0.856, p<0.001). 
 
 
Figure 4.9. Existing care provision and access to local medical and social care services 
(only data for the valid cases are shown). 
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4.4.2 Main carer had also any medical condition? 
The proportion of answers including missing or not recorded data is displayed in 
fig. 4.10. Lisbon reported 18 cases (47%) where the main carer also had a 
medical condition, followed by 6 cases (18%) in Evora and 3 cases (5%) in 
London.  
 
 
Figure 4.10. Cases reported where the main carer also had a medical condition. 
 
4.4.3. Carer’s availability and level of support 
In Lisbon, 18 patients were stated to have a carer available at home all day, 10 
patients had a carer at home only at night and 7 patients had a carer that paid 
occasional visits. In London, a carer was available at home all day for 5 patients 
and a carer paid occasional visits to another 3. In Evora, 4 patients had a carer 
available at home only at nights. A large proportion of data was missing or not 
recorded for Tartu and London (see fig. 4.11 and 4.12). 
 
   
            Figure 4.11. Carer’s availability.          Figure 4.12. Carer’s level of support. 
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Patients in Lisbon were more likely to depend on the support of their carers with 
21 cases requiring a carer only for helping in some tasks and 9 cases requiring a 
carer for helping in most tasks. Five patients in Evora and six in London required 
either help in some tasks or help in most tasks. Only 2 cases in Tartu were 
declared to require support from a carer in some tasks. 
 
4.5 Baseline clinical conditions 
The medical conditions reported by the 193 patients are presented below: 
 London included 35 patients with diabetes and hypertension, and 27 
patients with bronchial asthma; 
 Tartu consisted of 19 patients with chronic heart failure and 41 patients 
with hypertension; 
 Lisbon included 38 patients with chronic respiratory failure; and 
 Evora consisted of 21 patients with bronchial asthma and 12 patients with 
chronic respiratory failure. 
 
4.5.1 Disease duration 
Fig. 4.13 contains box plots for each independent disease in 3 out of the 4 sites 
(data were not available from Lisbon). The bottom of each box represents the 
25th percentile and the top the 75th percentile of disease duration in years. 
Median values are represented for the line in the middle and mean years of 
diseases are shown in square dots. Additional information about the dispersion of 
data is shown by the whiskers (extreme values). As can be seen, mean and 
median disease duration varied significantly (F=4.06, p=0.0007) among the 
primary medical conditions in all clinical sites.  
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Figure 4.13. Distribution of patient’s disease duration per site (no data available from 
Lisbon). 
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Patients with respiratory diseases (London and Evora) were the ones with greater 
median years of living with a medical condition since diagnosis (10.01yr, 10.55yr, 
and 6.92yr respectively), followed by those with hypertension in Tartu (6.78yr), 
and diabetes and hypertension in London (4.28yr and 4.13yr respectively). As a 
disease category, patients with chronic heart failure were the ones more recently 
diagnosed (3.99yr). Numerical details, including sample size, mean, standard 
deviation and median are displayed in table 4.8. 
 
Table 4.8. Patient’s disease duration. 
Diagnosis N Mean(yr) SD(yr) Median(yr) 
Asthma (Evora) 20 12.08 11.63 6.92 
Chronic respiratory failure (CRF, Evora) 12 12.43 6.36 10.55 
Chronic heart failure (CHF, Tartu) 19 4.85 5.52 3.99 
Hypertension (Tartu) 57 11.55 10.92 6.78 
Asthma (London) 26 12.48 10.09 10.01 
Hypertension (London) 26 4.98 4.22 4.13 
Diabetes (London) 32 6.62 6.37 4.28 
 
4.5.2 Aetiology 
Causes or origin of disease for patients living in London were divided in two 
groups. Those related to diabetes and hypertension; 30/35 cases with diabetes 
type 2 and 1/35 cases with diabetes type 1 (4 cases not recorded) and for the 
same group 32/35 cases with hypertension (2 cases not recorded and 1 declaring 
not to have hypertension). The other group was the asthmatic patients who 
accounted for 27 cases. In terms of of asthma severity (GINA classification), 5/27 
patients fell in the intermittent category (asymptomatic), 9/27 in the mild persistent 
(attacks might affect activity), 8/27 in the moderate persistent (attacks affected 
their activity) and 5/27 in the severe persistent category (limited physical activity).  
 
In Tartu, 41 patients had hypertension and 19 patients had heart failure. Out of 
the 19 patients with heart failure, 16 also had a medical history of hypertension, 4 
a history of cardiomiopathy, 2 a history of dyslipidemia, 2 a history of ischemic 
heart disease, and 1 a history of myocarditis.  
 
In Lisbon, the origin of respiratory failure was related to chronic obstructive 
pulmonary disease (COPD) in 15/38 patients, to tuberculosis (TB) sequelae in 
13/38 patients and in 10/38 to other origin. The respiratory function was classified 
as mixed for 13 patients, obstructive for 14 patients and restrictive for the last 11 
patients. 
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Evora had 12 patients with respiratory failure for which their aetiology was related 
to COPD in 9 cases, lung fibrosis in 2 and TB sequelae in 1 patient. There were 
also, 21 patients with bronchial asthma. In terms of the severity of disease (GINA 
classification for those with asthma) 12/21 patients were classified as moderate 
persistent (attacks affected their activity) and 9/21 as severe persistent (limited 
physical activity). For those patients with respiratory failure, their respiratory 
function condition were classified in 6/12 cases as obstructive, in 3/12 as 
restrictive and in the last 3/12 cases as mixed. 
 
4.5.3 Disease related symptoms and special therapies use at home 
Out of the 35 patients with diabetes, 12 patients had a history of retinopathy, 8 
patients a history of nephropathy and 1 patient had diabetic foot ulceration. For 
their diabetes control, 18/35 patients required oral drugs, 8/35 patients needed 
diet and oral drugs, 4/35 patients required insulin and only 1/35 required diet (4 
cases were missing).  
 
In Tartu, 2/60 patients had a history of previous myocardial infarction, 32/60 
patients had symptoms of dyspnoea (shortness of breath), 20/60 had symptoms 
of peripheral oedema (soft tissue swelling due to the accumulation of fluid in the 
limbs), 48/60 had symptoms of fatigue. For those patients with heart failure, 7/19 
reported no symptoms and no limitations in ordinary physical activity, and 11/19 
had mild symptoms of shortness of breath and slight limitation during ordinary 
activities.  
 
Table 4.9 contains the characterisation of breathlessness for those patients with 
asthma or respiratory failure in London (27 cases), Lisbon (38) and Evora (33). As 
can be seen, 30% of the patients in Evora, 24% in Lisbon and 15% in London 
were breathless at rest or minimal effort. In London, the majority of patients 
(66.6%) were able to keep up with people of similar ages, but not on hills or stairs.  
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Table 4.9. Characterisation of breathlessness. 
 Clinical  site 
 London
* 
Lisbon Evora 
 n (%) n (%) n (%) 
Breathless only during asthmatic attacks  2(7.4)  11(33.3) 
Persistent mild/moderate breathlessness  2(7.4)  6(18.1) 
Breathless at rest or on minimal effort  4(14.8) 9(23.6) 10(30.3) 
Able to walk about 100 yards (91m) on the level   19(50) 4(12.1) 
Able to walk for 1 mile (1600m) on the level at own pace, unable to keep up with people of 
similar age  
  
10(26.3) 
 
2(6) 
Able to keep with people of similar age but not on hills or stairs 18(66.6)   
* 1 case missing 
 
Almost 95% of patients in Lisbon (36/38) and 37% in Evora (12/33) needed 
oxygen therapy.  In addition, 29/38 patients in Lisbon (76%) and 2/33 in Evora 
(6%) also required non invasive home ventilation.  
 
4.5.4 Comorbidity 
In addition to the primary disease condition, the presence of other disorders was 
recorded. Note that for the categories of diabetes and hypertension some patients 
from London and Tartu have been excluded as shown in table 4.10 (see note a, b 
and c). In total, 68/193 cases had Cor pulmonale (35%), 19/158 patients had 
diabetes (12%), 43/101 patients had hypertension (46%), and 40/193 patients had 
coronary heart disease (21%).  
 
Table 4.10. Comorbidities by clinical site. 
  Clinical  site  
  London Tartu Lisbon Evora Total 
Cor Pulmonale Yes 35 1 24 8 68 
No 26 59 14 25 124 
 Missing 1    1 
Diabetes Yes 3
a 
5 7 4 19 
No 24 55 31 29 139 
Hypertension Yes 4
b 
 0
c 
25 14 43 
No 21 3 13 19 56 
 Missing 2    2 
Coronary Heart Disease Yes 8 16 11 5 40 
No 50 44 26 28 148 
 Missing 4  1  5 
 a, b 35 patients were not considered as their primary diagnostic were diabetes with hypertension 
  c
 57 patients were not included as their primary diagnostic were hypertension
 
 
Pulmonary heart disease (Cor Pulmonale) was a condition predominant in the 
London (35/68) and Lisbon (24/68) site whereas hypertension was predominant in 
Lisbon (25/43) and Evora (14/43).  Coronary heart diseases were more common 
in Tartu (16/40) and Lisbon (11/40).  
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In addition to table 4.10, 6 patients with diabetes reported to have a peripheral 
artery disease and 2 more chronic renal failures.  
 
An association was found between the clinical sites and the presence of Cor 
Pulmonale (Cramer’s V=0.546, p<0.001) as well as the presence of hypertension 
(Cramer’s V= 0.404, p<0.001). 
 
4.5.5 Body Mass Index  
According to their Body Mass Index (BMI, WHO classification4), a large proportion 
of patients in Tartu (53%), Evora (52%), London (42%) and Lisbon (29%) were 
obese (see fig. 4.14 for further details). Only a small proportion of cases fell in the 
normal weight category including an equal proportion of cases in Lisbon and 
Evora (21%), followed by 16% of cases in London and a tiny proportion in Evora 
(5%). 
 
The mean BMI value for patients in London was 30.25 kg/m2 (SD=5.28, n=55), for 
Tartu 31.01 kg/m2 (SD=4.97, n=58), Lisbon 28.94 kg/m2 (SD=6.63, n=36) and in 
Evora 29.45 kg/m2 (SD=5.24, n=33). There was not a significant BMI difference 
among the groups (F=1.237, df=3, p=0.298). 
 
 
Figure 4.14. BMI in kg/m
2
: underweight (<18.5), normal (18.5-24.99), overweight (25-
29.99 ) and obese (30+). 
 
                                                 
4
 Available at: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html  [Accessed  17 February 2011] 
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4.5.6 Impairment  
There were 4 types of disabilities consistently recorded at the clinical sites: hand 
movement, vision, hearing and cognitive impairments.  
 
33% of patients in Evora, 27% of patients in London and 11% of patients in 
Lisbon reported finger or hand reduced movement. Notably, 100% of patients in 
Tartu had no hand problems (see fig. 4.15).  
 
Patients reported either moderated or reduced vision in 45% of cases at Tartu, 
36% at Evora, 27% at London and 5% at Lisbon. Evidence for this is shown in fig. 
4.16. 
 
Except for London (76%), as can be observed in fig. 4.17, the rest of the clinical 
sites reported at least in 91% of the cases normal hearing.  
 
In relation to learning disabilities or memory problems, 58% of the cases in Lisbon 
and 42% of cases in Evora had cognitive problems (fig. 4.18).  
 
 Figure 4.15. Hand movement impairment. 
 
         Figure 4.16. Vision impairment. 
 
 
       Figure 4.17. Hearing impairment.           
 
Figure 4.18. Learning disabilities or 
memory problems. 
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4.6 Discussion 
At baseline, the characteristics of patients across the four clinical sites were found 
statistically significantly different (confirmed by Cramer’s V test) with respect to 
age, education, marital status, occupation, activity, literacy, ethnicity, location, 
main income, living accommodation, access to social care, carer’s availability and 
level of support. All differences, among and within the REALITY groups (clinical 
sites), reflect the situational context and complexity in which patients with long 
term conditions live. Such differences also represent a realistic scenario for which 
telehealth interventions must be designed and implemented. To ensure that these 
interventions are well-defined, good knowledge and understanding about the 
overall status of patients are required. Although, understanding patients’ needs 
can be complex they should not be based solely on the patients’ illness, but also 
based on other factors that surround the patients’ way of living in which coping 
with long term conditions take place (Kelley, 2009; Lindsay and Vrijhoef, 2009). 
 
Indeed, previous studies support the view that socio-economic and daily living 
conditions are important aspects that should be taken into account for design and 
evaluation of telehealth interventions. For example, in one study, Levy et al. 
(2003) found important associations between age, mobility status, home 
ownership, house type,  household composition, quality of health service, and the 
presence of positive or negative attitudes to telehealth. In another study, 
Laviolette (2009) used “type of housing” as the criterion for interviewing a group of 
cardiac patients with the intention of investigating domestic use of space and 
participants’ expectations to telecare. Finally, in a third study,  Darkins et al. 
(2008) remarked on the importance of addressing “the complex biopsychosocial 
care needs of” patients. They criticised the fact that healthcare systems are 
inadequate adapted to deal with such needs and suggested the adoption of their 
approach for “marring health and social elements of care (Darkins et al., 2008).  
 
Another important demographic aspect to be considered during the design of 
telehealth interventions is the users’ age. Age-related changes can affect the 
requirements of telehealth (Stronge et al., 2007). For instance, telehealth services 
are in general linked with the care of older populations (typically 65yr old and 
over)  since prevalence of long term conditions increases over time (Christensen 
et al., 2009). However, medical conditions such as diabetes and asthma are also 
manifested in younger age groups (see table 4.2) and thus the youngest groups 
could be supported by telehealth too. Nevertheless, for this to happen, a careful 
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evaluation of requirements is essential as older and younger generations tend to 
have different needs, interests, expectations and ways of interacting with 
technology (Weinschenk, 2008).  
 
In relation to the use of complex technologies (small multi-functional electronic 
devices), Kang and Yoon (2008) have studied user behaviour differences 
between young adults (20 to 29yrs old) and middle-aged adults (46 to 59yrs old). 
They found that age affects the performance of users in terms of the frequency of 
errors made, the number of steps needed to perform a task, the frequency of 
repetitive actions with no meaningful outcomes, the success of physical operation 
methods, and the perception of an increase in workload. These findings may help 
to explain why some REALITY patients, especially the oldest, found themselves in 
real difficulty trying to work out how to use or carry out tasks with the technology 
supplied even after retraining.  
 
For example, patient 4886 (75yr, female) decided to withdraw from the study even 
after additional training as she stated that the: 
“Handheld unit is too difficult to use”. 
 
Other patients found not the handheld unit complicated to operate but the 
measurement physiological devices as patients 8442 (75yr, male) and 8701 (72yr, 
male) commented:  
“the oximeter, cables and connections were very difficult to use”. 
 
In other cases, not only the patient (pt 8536, 71yr, female) but also the carers had 
similar issues in managing the devices as one of the clinicians in Portugal 
commented: 
“patient and her family found the equipment too difficult to use”. 
 
Thus, technology must be made not just available but also usable for older 
patients and their carers. On usability,  Hawthorn (2000) has studied the 
implications of ageing and human computer interface design for older users. He 
reviewed the effects of age on users’ relevant abilities and suggested that 
designers need to pay attention to visual, speech, and hearing impairments, as 
well as to psychomotor abilities, attention capacity, automated response, memory, 
learning, intelligence and expertise. Reasons for such considerations are related 
to the fact that sensory, motor and cognitive abilities tend to decline (Stronge et 
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al., 2007) with the process of ageing or as a consequence of some degenerative 
diseases. Reduction or deterioration of such abilities cannot just be ignored or put 
aside for future service design since evidence shows that impairment conditions 
are not rare among the chronically ill (see Section 4.5.6). In fact, visual 
impairments (45% of cases in Tartu, 36% in Evora, and 27% in London) and 
learning or memory disabilities (58% of cases in Lisbon and 42% in Evora) were 
commonly identified in the oldest REALITY groups.  
 
In addition to Hawthorn’s usability considerations, Kurniawan (2008) has 
suggested that mobile phones for older people need to be designed with the 
intention to minimise unintended user actions. Furthermore, safety considerations 
and haptic support should be also part of the user interface design. These 
considerations are important in telehealth. As people get older and sicker, health 
monitoring becomes more frequent in the community, which includes monitoring 
physical and emotional conditions (Gao and Koronios, 2010).  Such monitoring 
applications need to be designed for users with different capabilities and needs, 
which include different levels of usability, due to the diversity in sensory, motor 
and cognitive abilities of people aged 50 or older (Lorenz and Oppermann, 2009). 
Although, we cannot quantify their direct impact, comments quoted below give 
indications that patients with learning disabilities and memory problems faced 
major limitations when they interacted with technology. Patient 8248 (76yr, 
female) expressed that: 
“It was too much difficult to learn how to use the handheld unit” 
 
Another similar example can be taken from the comment made by patient 6554 
(76yr, male) who had decreased movement in his hands, reduced vision and 
reduced hearing, but no reported any learning disabilities or memory problems. 
He mentioned: 
“I could not understand and remember how to use it”. 
 
These couple of citations give indications that not only patients with cognitive 
impairment, but also other impairment groups found difficulties in how to use this 
particular technology. Similarly, a last quotation given by a Portuguese clinician in 
reference to his patient (patient 8112, 77yr, female), who in addition to cognitive 
impairment also had reduced vision: 
“The patient found she had memory difficulties that interfere with the use of this 
equipment” 
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In fact, patient 8112 stayed for 50 days on the trial, a period in which she used the 
system for only 9 days (18% usage). As can be noticed from the citations above, 
all these patients required appropriate support that encouraged the use of their 
sensory, motor and cognitive capabilities in the best way so they could take care 
of themselves. 
  
More conclusions about the importance of demographics for understanding 
patients’ conditions, and therefore the requirements for telehealth, can be derived 
from the reports published by the Commission on Social Determinants of Health  
WHO  (WHO, 2008) and the Department of Economic and Social Affairs of the 
United Nations (DESA, 2009).  These reports discussed the social determinants 
of health responsible for what is known as health inequalities. Such inequalities 
are usually measured in terms of socio-economic classes and unfortunately 
present everywhere, even in the wealthiest countries (HC, 2009). Factors such as 
lifestyle (smoking, nutrition, exercise among others), gender, ethnicity, education, 
employment, income, social status, disabilities, social support, physical 
environment and access to healthcare are all usually mentioned as health 
determinants (WHO, 2008; DESA, 2009; HC, 2009). 
 
Not all the demographic characteristics may be equally important to be 
considered in a telehealth intervention. To explore their property values and 
impact on the use of technology, the REALITY’s demographic data have been 
correlated with a selection of performance indicators from the evaluation forms. 
The results of the association between demographics and those indicators are 
presented in the next chapter.  
 
 
4.7 Summary 
Although complex and challenging, one of the first activities for a proper 
assessment of requirements is to recognise the actual user health needs, their 
socio-economic conditions and kind of support they need to receive at home. 
Sections above have provided a wide picture of the diverse characteristics among 
patients in the 4 clinical sites and shown some of the essential information 
needed to understand the contextual situation of the REALITY patients. 
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Some patients may not comply with monitoring (and treatments) if they do not 
understand the intervention or see it as appropriate to their particular 
circumstances; especially if technology is complex or difficult to use. To facilitate a 
more user centred approach for the design of telehealth interventions, 
demographic characteristics must therefore be considered in the design and 
implementation of the treatment intervention.  
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Chapter 5. Test for associations 
 
 
5.1 Introduction 
The previous chapter provided a description of the demographics and health 
characteristics of participants in REALITY. We have discussed earlier that the 
social and economic conditions are important factors to be considered in the 
design of interventions for telehealth. As shown in chapter 4, some of the oldest 
patients found it difficult to use the devices provided even after additional training. 
To investigate whether there was any association between patients’ 
demographics and their performance during the project, we carried out a series of 
cross tabulations and statistical tests for association.  
 
The purpose of this chapter is to present the findings of associations between 
demographics and a selection of items collected at the interim visit.  
 
 
5.2 Measures 
A number of questions and their respective answers collected from the 
REALITY’s Form 1 (Patient recruitment) and Form 2 (record of patient's progress 
at a clinical visit) were selected. Specifically, from Form 2, we retrieved questions 
from the following subdivisions: 
 
1. Patient's understanding, skills and home support 
2. Decisions and actions 
3. Actions for continuing patients 
4. Additional training  
 
In the following subsections, we show details of the items and the summary of 
data retrieved. 
 
5.2.1 Patient's understanding, skills and home support.  
The original assessment of this subdivision was measured by a 9-item 
questionnaire. However, for the final analysis of association, 2 questions that 
were not considered relevant for the assessment of patient performance were 
eliminated. The final 7-item questionnaire included: 
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Q1. “Understanding of the booklet, and other support material, and how to use 
them”,  
Q2. “Understanding about the technical support help line and how to use it”,  
Q3. “Skills in the use of the handheld unit and its built in sensors”,  
Q4. “Skills to use other (third party) measurement equipment and sensors”,  
Q5. “Skills to link the handheld unit to the telephone line and send data”,  
Q6. “Skills to access and understand guidance messages sent by clinicians via 
the handheld unit”,  and 
Q7. “The patient finds encouragement from family and friends to use the service”  
 
As illustrated by fig. 5.1, patients were more likely to have either a reasonable 
(40%) or good understanding (34%) of the material printed and how to use it, 
whereas 15% of the responding patients (25/193) were stated to have a poor 
understanding. 
 
 
Figure 5.1. Q1.Understanding of the booklet, other support material and how to use them. 
 
One hundred and thirteen of the 193 responding patients (59%)  had a 
reasonable understanding about the technical support line, 18% a good 
understanding (35/193) and only 10% of them (20/193) stated to have a poor 
understanding. Further details for this item are shown below (fig. 5.2). 
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Figure 5.2. Q2.Understanding about the technical support help line and how to use it. 
 
In respect to the skills in the use of the handheld unit and its built in sensors (fig. 
5.3), 44% of the responding patients (84/193) were stated to have reasonable 
skills to use the handheld device and sensors, whereas 20% of them (39/193) 
were stated to have poor skills. 
 
 
Figure 5.3. Q3.Skills in the use of the handheld unit and its built in sensors. 
 
In relation to third party equipment and sensors (fig. 5.4), patients were more 
likely to have either reasonable (44%) or good (28%) skills to use the third party 
devices and sensors.  
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Figure 5.4. Q4.Skills to use other (third party) measurement equipment and sensors. 
 
Patients were more likely to have either good (37%) or reasonable (35%) skills to 
link the handheld device to the telephone line and send data, whereas 11% of the 
total responding patients (21/193) had poor skills. Further details can be seen in 
fig. 5.5. 
 
Figure 5.5. Q5.Skills to link the handheld unit to the telephone line and send data. 
 
In relation to guidance messages sent by clinicians via the handheld unit (fig. 5.6), 
almost equal proportions of patients had reasonable (34%, 65/193) or good (31%, 
60/193) skills to access and understand the message sent by the clinicians. 
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However, at least 17% (33/193) of the total participants had poor skills to manage 
the messages.  
 
Figure 5.6. Q6.Skills to access and understand guidance messages sent by clinicians via 
the handheld unit. 
 
In relation to support from relatives and friends (fig. 5.7), 40% (77/193) of the total 
responding patients found unnecessary the encouragement from their family and 
friends to use the services, whereas 32% of the total participants (62/193) found 
encouragement from relatives helpful. Ten percent (20/193) of responses were 
missing. 
 
Figure 5.7. Q7.The patient finds encouragement from family and friends to use the 
service. 
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5.2.2 Decisions and actions 
A single item measured whether patients were able to continue with the telehealth 
service and under what conditions (if any). The item was Q8: “Decision to 
proceed” (1 = “Patient withdrawn from the programme by clinicians”, 2 = “Patient 
decided to withdraw from the programme”, 3 = “Further training required before 
the patient continues to use any part of the service independently”, 4 = “Patient 
allowed to proceed with special monitoring of data quality by clinicians”, and 5 = 
“Patient allowed to proceed without additional precautions”). Summary details of 
this item are shown in fig. 5.8. 
 
Sixty two out of the 193 patients (32%) were allowed to proceed without additional 
precautions at the interim visit, whereas 25% (49/193) were allowed to proceed 
with special monitoring of data quality. At this point, 20% of the total recruits 
decided to withdraw from the service (see fig. 5.8). 
 
 
Figure 5.8. Q8.Decision to proceed. 
 
5.2.3 Actions for continuing patients 
Actions included the replacement of selected equipment. The 2-item 
questionnaire version included Q9: “Replacement of handheld unit + accessories” 
and Q10: “Replacement of third party devices” (1 = “Not required”, 2 = “Yes”).  
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Officially, there was a need to replace the handheld device in at least 12% of the 
cases (23/193), but 16% of responses (31/193) were missing for this item (fig. 
5.9). 
 
Figure 5.9. Q9.Replacement of handheld unit + accessories. 
 
As shown by fig. 5.10, the majority of participants (75%) did not need replacement 
of third party devices.  However, an important proportion of data (22%) was 
missed for this item. 
 
 
Figure 5.10. Q10.Replacement of hhird party devices. 
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5.2.4 Additional training  
The need for retraining was evaluated by 6 items in the following areas:   
Q11.“Measurement using handheld/accessories”,  
Q12. “Measurement using third party devices”,  
Q13. “Transfer of data using telephone line”,  
Q14. “Completion of EQ5D questionnaire”,  
Q15. “Use of messages from clinician” and  
Q16. “Use of telephone help line”. 
 
Fig. 5.11 shows that a large proportion of patients (48%, 92/193) required 
retraining in how to use the handheld device and its accessories.  
 
Figure 5.11. Q11.Measurement using handheld/accessories. 
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Only 20% of the patients (39/193) required retraining in the use of third party 
devices (fig. 5.12).  
 
 
 
Figure 5.12. Q12.Measurement using third party devices. 
 
Additional training for transferring data using a telephone line was required in 31% 
of the total cases (fig. 5.13).  
 
 
Figure 5.13. Q13.Transfer of data using telephone line. 
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As can be seen from fig. 5.14, 73 out of the 193 patients (38%) required retraining 
in the completion of the EQ5D questionnaire.  
 
 
Figure 5.14. Q14.Completion of EQ5D questionnaire. 
 
A large proportion of patients (48%, 92/193) required retraining in how to use 
messages from clinicians (see fig. 5.15).  
 
 
 
Figure 5.15. Q15.Use of messages from clinician. 
 
Additional training in the use of the telephone help line was required in 22% 
(43/193) of the cases (fig. 5.16).  
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Figure 5.16. Q16.Use of telephone help line. 
 
5.3 Statistical analysis 
A method based on a joint frequency distribution that establishes an 
interdependent relationship between two variables displayed in a table known as 
cross tabulation or contingency table was used. However, different statistical 
approaches can be used to explore the association between two variables on a 
frequency table. According to Macnabb (2008) the selection of an appropriate 
nonparametric relationship test depends on the type of variable (eg. nominal, 
ordinal, etc.) and the shape of tables (square or rectangular). Kendall’s tau-c and 
Cramer’s V test were selected to compare the dependent variables (Q1 to Q16) 
with the independent demographic variables (eg. age, gender, marital status, etc) 
and to find any possible relationship, known as measurement of association.  
 
Kendall’s tau-c test is a statistical technique used when both variables in the 
contingency table are ordinal and the size of the table is rectangular (M x N), i.e. 
when the number of rows and columns are not the same. This is a symmetric 
measurement which can take any value from -1 to +1. It provides both the 
direction (positive or negative) and strength of the association. 
 
Cramer’s V is a test that computes a nonparametric correlation coefficient number 
that ranges from 0 to 1. A “0” value means no relationship and “1” value 
represents a perfect relationship. The test is appropriate when at least one of the 
variables is nominal (regardless of the table size). Since nominal variables have 
no direction, this test only determines the strength and not the direction of a 
relationship.  
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Coefficient index values over 0.5 are usually rare. For that reason we followed the 
guideline described by Healey (2009) in table 5.1. The table presents only 
estimate values for interpreting strengths of correlations. 
 
Table 5.1. The relationship between the value of nominal level measures of association 
and the strength of the relationship (general guidelines only) (Healey, 2009) 
 
Absolute value Strength of relationship 
Less than 0.1 Weak 
Between 0.11 and 0.3 Moderate 
Greater than 0.3 Strong 
 
To compare variables to one another and look for a relationship between them, 
we selected all the socio-economic factors and support at home items already 
presented in Chapter 4. Every demographic item was considered an independent 
variable for the construction of contingency tables. Thus, the independent 
variables were: age, gender, marital status, education, occupation, activity if 
retired, literacy, ethnicity, location, quality of accommodation, care provision, care 
availability and care support.  
 
5.4. Results and discussion 
An example of a cross tabulation is shown in table 5.2. The joint frequency 
distributions of cases are omitted since showing all tables (182 in total) was 
impractical. Instead, the statistical measures of association were summarised 
from SPSS (table 5.3) and made available in the following subsections. 
 
Table 5.2. Cross tabulation of the understanding of the booklet, other support material and 
how to use them * Age. 
 
Age 
Total <= 30 31 - 40 41 - 50 51 - 60 61 - 70 71 - 80 81+ 
Understanding of the 
booklet, other 
support material and 
how to use them 
Poor 0 0 1 1 4 14 5 25 
Requires assistance 
(not available at 
Home) 
0 0 0 0 0 2 0 2 
Requires assistance 
(available at home) 
0 0 0 0 2 7 0 9 
Reasonable 0 6 16 14 27 14 1 78 
Good 5 7 15 17 17 4 0 65 
Total 5 13 32 32 50 41 6 179 
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Table 5.3. Measure of association for the understanding of the booklet, other support 
material and how to use them * Age. 
  
Value Approx. Sig. 
Nominal by Nominal Phi .712 .000 
Cramer's V .356 .000 
Ordinal by Ordinal Kendall's tau-c  -.408 .000 
N of Valid Cases 179 
 
 
5.4.1 Age 
Except for Q7, Q9, Q10 and Q15, there were significant associations (p<0.05) 
between age and the rest of the items in table 5.4. In total 12 out of the 16 items 
(75%) were statistically significant and the majority of the relationships were found 
to be from moderate to strong (see table 5.1 for classification). The correlation 
with highest coefficient of association existed between age and the evaluation for 
retraining in “measurement using third party devices” (V=0.48) and “measurement 
using handheld/accessories” (V=0.456). Significant negative associations were 
found from Q1 to Q6, and Q8.  The lowest, but significant measurement of 
association were found in Q8 (tau-c=-0.201), Q15 (V=0.28) and Q16 (V=0.288). 
The negative values (Q1-Q8) reveal that as patients get older their understanding 
and skills get poorer.  
 
Table 5.4. Association between age and 16 items extracted from the patient's progress at 
a clinical visit. 
Association between age and: N valid in 
% 
Measure of 
Association 
Value p 
Q1. Understanding of the booklet, other support material and how to use 
them  
92.70 tau-c -0.408 0.000 
Q2. Understanding about the technical support help line and how to use it  92.70 tau-c -0.335 0.000 
Q3. Skills in the use of the handheld unit and its built in sensors  91.70 tau-c -0.385 0.000 
Q4. Skills to use other(third party) measurement equipment and sensors  84.50 tau-c -0.293 0.000 
Q5. Skills to link the handheld unit to the telephone line and send data  89.60 tau-c -0.324 0.000 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  
86.50 tau-c -0.306 0.000 
Q7. The patient finds encouragement from family and friends to use the 
service  
89.60 tau-c -0.043 0.487 
Q8. Decision to proceed  88.60 tau-c -0.201 0.001 
Q9. Replacement of handheld unit + accessories  83.90 V 0.176 0.541 
Q10. Replacement of third party devices  78.20 V 0.213 0.334 
Q11. Measurement using handheld/accessories  83.90 V 0.456 0.000 
Q12. Measurement using third party devices  78.20 V 0.48 0.000 
Q13.Transfer of data using telephone line  83.90 V 0.371 0.001 
Q14. Completion of EQ5D questionnaire  83.90 V 0.359 0.002 
Q15. Use of messages from clinician  82.40 V 0.28 0.052 
Q16. Use of telephone help line  84.50 V 0.288 0.035 
Ntotal = 193; Kendall's tau-c =  tau-c ; Cramer's V = V 
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5.4.2 Gender 
No significant relationship was found between gender and the items in table 5.5. 
The only item that got close enough to be considered significant (but is not) was 
the “measurement using handheld/accessories” (Q11, p=0.059). This finding 
reveals no association between gender and the patients’ understanding nor skills 
needed to use the service, nor the need for additional training.  
 
Table 5.5. Association between gender and 16 items extracted from the patient's progress 
at a clinical visit. 
Association between gender and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  91.2 V 0.066 0.942 
Q2. Understanding about the technical support help line and how to use it  
91.2 V 0.133 0.538 
Q3. Skills in the use of the handheld unit and its built in sensors  
90.2 V 0.219 0.079 
Q4. Skills to use other(third party) measurement equipment and sensors  
83.4 V 0.136 0.559 
Q5. Skills to link the handheld unit to the telephone line and send data  
88.1 V 0.086 0.868 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  85 V 0.145 0.483 
Q7. The patient finds encouragement from family and friends to use the 
service  88.1 V 0.22 0.083 
Q8. Decision to proceed  
87 V 0.194 0.177 
Q9. Replacement of handheld unit + accessories  
82.4 V 0.036 0.654 
Q10. Replacement of third party devices  
77.2 V 0.076 0.353 
Q11. Measurement using handheld/accessories  
82.4 V 0.15 0.059 
Q12. Measurement using third party devices  
77.2 V 0.127 0.123 
Q13.Transfer of data using telephone line  
82.4 V 0.085 0.283 
Q14. Completion of EQ5D questionnaire  
82.4 V 0.037 0.641 
Q15. Use of messages from clinician  
80.8 V 0.098 0.221 
Q16. Use of telephone help line  
82.9 V 0.022 0.784 
Ntotal = 193; Cramer's V = V 
 
5.4.3 Marital status 
Only 4 out of the 16 items (25%) can be associated to marital status.  
“Understanding of the booklet, other support material and how to use them” 
(p=0.034), “understanding about the technical support help line and how to use it” 
(p<0.001), “skills to use of the handheld unit and its built in sensors” (p=0.019) 
and “the patient finds encouragement from family and friends to use the service” 
(p=0.004).  As can be seen from table 5.6, the coefficient of association ranged 
from 0.207 to 0.272 and the strength of association for the 4 items (Q1, Q2, Q3 
and Q7) was moderate.  
 
Table 5.6. Association between marital status and 16 items extracted from the patient's 
progress at a clinical visit. 
Association between marital status and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  90.2 V 0.207 0.034 
Q2. Understanding about the technical support help line and how to use it  
90.2 V 0.272 0.000 
Q3. Skills in the use of the handheld unit and its built in sensors  
89.1 V 0.217 0.019 
Q4. Skills to use other(third party) measurement equipment and sensors  
82.4 V 0.2 0.089 
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Q5. Skills to link the handheld unit to the telephone line and send data  
87 V 0.178 0.194 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  84.5 V 0.154 0.477 
Q7. The patient finds encouragement from family and friends to use the 
service  87.6 V 0.239 0.004 
Q8. Decision to proceed  
86 V 0.112 0.903 
Q9. Replacement of handheld unit + accessories  
81.3 V 0.149 0.321 
Q10. Replacement of third party devices  
76.2 V 0.132 0.464 
Q11. Measurement using handheld/accessories  
81.9 V 0.185 0.145 
Q12. Measurement using third party devices  
76.2 V 0.161 0.281 
Q13.Transfer of data using telephone line  
81.3 V 0.178 0.175 
Q14. Completion of EQ5D questionnaire  
81.3 V 0.157 0.276 
Q15. Use of messages from clinician  
79.8 V 0.139 0.398 
Q16. Use of telephone help line  
81.9 V 0.129 0.449 
Ntotal = 193; Cramer's V = V; p values < 0.001 are reported as 0.000 
 
5.4.4 Education 
There was a significant association between education and 14 of the 16 items 
(88%) except for “the patient finds encouragement from family and friends to use 
the service” and the need for “replacement of handheld unit + accessories” (see 
table 5.7). The correlation with the highest coefficients existed between education 
and the need for additional training in the item of “measurement using third party 
devices” (V=0.517), followed by “completion of EQ5D questionnaire” (V=0.488) 
and “measurement using handheld/accessories” (V=0.414). Strong 
measurements of associations were found for items Q1, Q4-Q6, and Q10-Q15, 
whereas moderate associations were found for Q2, Q3, Q8 and Q16. The positive 
association from Q1 to Q8 indicates that as the level of education goes higher, the 
understanding and skills needed to use the service get better.  
 
Table 5.7. Association between education and 16 items extracted from the patient's 
progress at a clinical visit. 
Association between education and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  90.7 tau-c 0.349 0.000 
Q2. Understanding about the technical support help line and how to use it  
90.7 tau-c 0.278 0.000 
Q3. Skills in the use of the handheld unit and its built in sensors  
89.6 tau-c 0.236 0.000 
Q4. Skills to use other(third party) measurement equipment and sensors  
82.9 tau-c 0.355 0.000 
Q5. Skills to link the handheld unit to the telephone line and send data  
87.6 tau-c 0.336 0.000 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  84.5 tau-c 0.356 0.000 
Q7. The patient finds encouragement from family and friends to use the 
service  87.6 tau-c 0.034 0.587 
Q8. Decision to proceed  
86.5 tau-c 0.235 0.000 
Q9. Replacement of handheld unit + accessories  
81.9 V 0.068 0.948 
Q10. Replacement of third party devices  
76.7 V 0.388 0.000 
Q11. Measurement using handheld/accessories  
81.9 V 0.414 0.000 
Q12. Measurement using third party devices  
76.7 V 0.517 0.000 
Q13.Transfer of data using telephone line  
81.9 V 0.388 0.000 
Q14. Completion of EQ5D questionnaire  
81.9 V 0.488 0.000 
Q15. Use of messages from clinician  
80.3 V 0.372 0.000 
Q16. Use of telephone help line  
82.4 V 0.255 0.035 
Ntotal = 193; Kendall's tau-c =  tau-c ; Cramer's V = V; p values < 0.001 are reported as 0.000 
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5.4.5. Current or most recent occupation 
There were 12 items (12/16, 75%) associated with the most recent activity in 
which the participants were engaged. Except for items Q8-Q10 and Q16, the rest 
of items were significant correlated  to the most recent occupation (see table 5.8).  
The highest measurement of associations were found in the subsections for 
additional training in items “measurement using third party devices” (Q12, 
V=0.358), “measurement using handheld/accessories” (Q11, V=0.347), 
“Completion of EQ5D questionnaire” (Q14, V=0.31) and “transfer of data using 
telephone line” (Q13, V=0.308). Strong relationships were only found in items 
Q11-Q14 (V>0.3), the rest of significant association were classified as moderate 
for Q1-Q7, and Q15.  
 
Table 5.8. Association between occupation and 16 items extracted from the patient's 
progress at a clinical visit. 
Association between current or  most recent occupation and: N valid in 
% 
Measure of 
Association 
Value p 
Q1. Understanding of the booklet, other support material and how to use 
them  84.5 V 0.262 0.001 
Q2. Understanding about the technical support help line and how to use it  
84.5 V 0.267 0.001 
Q3. Skills in the use of the handheld unit and its built in sensors  
83.4 V 0.247 0.006 
Q4. Skills to use other(third party) measurement equipment and sensors  
76.7 V 0.251 0.01 
Q5. Skills to link the handheld unit to the telephone line and send data  
81.3 V 0.246 0.009 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  78.8 V 0.286 0.000 
Q7. The patient finds encouragement from family and friends to use the 
service  81.3 V 0.224 0.05 
Q8. Decision to proceed  
80.8 V 0.178 0.466 
Q9. Replacement of handheld unit + accessories  
77.2 V 0.159 0.586 
Q10. Replacement of third party devices  
72 V 0.263 0.086 
Q11. Measurement using handheld/accessories  
77.7 V 0.347 0.003 
Q12. Measurement using third party devices  
72 V 0.358 0.003 
Q13.Transfer of data using telephone line  
77.2 V 0.308 0.015 
Q14. Completion of EQ5D questionnaire  
77.2 V 0.31 0.014 
Q15. Use of messages from clinician  
75.6 V 0.298 0.023 
Q16. Use of telephone help line  
77.7 V 0.239 0.128 
Ntotal = 193; Cramer's V = V; p values < 0.001 are reported as 0.000 
 
5.4.6. Activity if retired 
Only 4 items (25%) in table 5.9 can be significantly associated to the patient’s 
activity. Two items have strong associations “Measurement using third party 
devices” (Q12, V=0.492) and “the patient finds encouragement from family and 
friends to use the service” (Q7, V=0.305). The other 2 associations 
“understanding of the booklet, other support material and how to use them” (Q1, 
V=0.273) and “transfer of data using telephone line” (Q13, V=0.248) were 
significantly moderate.  
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Table 5.9. Association between activity if retired and 16 items extracted from the patient's 
progress at a clinical visit. 
Association between activity and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  59.1 V 0.273 0.03 
Q2. Understanding about the technical support help line and how to use it  
59.1 V 0.23 0.147 
Q3. Skills in the use of the handheld unit and its built in sensors  
58 V 0.192 0.412 
Q4. Skills to use other(third party) measurement equipment and sensors  
51.3 V 0.208 0.381 
Q5. Skills to link the handheld unit to the telephone line and send data  
56 V 0.231 0.172 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  53.4 V 0.222 0.252 
Q7. The patient finds encouragement from family and friends to use the 
service  56.5 V 0.305 0.009 
Q8. Decision to proceed  
57 V 0.209 0.296 
Q9. Replacement of handheld unit + accessories  
51.8 V 0.126 0.45 
Q10. Replacement of third party devices  
46.6 V 0.187 0.207 
Q11. Measurement using handheld/accessories  
51.8 V 0.213 0.103 
Q12. Measurement using third party devices  
47.2 V 0.492 0.000 
Q13.Transfer of data using telephone line  
52.3 V 0.248 0.044 
Q14. Completion of EQ5D questionnaire  
52.3 V 0.178 0.202 
Q15. Use of messages from clinician  
50.8 V 0.21 0.116 
Q16. Use of telephone help line  
53.4 V 0.12 0.475 
Ntotal = 193; Cramer's V = V; p values < 0.001 are reported as 0.000 
 
5.4.7 Literacy in local language 
Nine out of the 16 items (56%) were found significantly associated to literacy in 
local language (table 5.10). Strong associations were found between literacy and 
items Q1 (V=0.715), Q2 (V=0.702), Q3 (V=0.738), Q4 (V=0.558), Q5 (V=0.788), 
Q6 (V=0.704), Q7 (V=0.46) and Q10 (V=0.4). A moderate association was found 
in Q12 (V=0.233).  The rest of items were not statistically significant. 
 
Table 5.10. Association between literacy and 16 items extracted from the patient's 
progress at a clinical visit. 
Association between literacy and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  89.1 V 0.715 0.000 
Q2. Understanding about the technical support help line and how to use it  
89.1 V 0.702 0.000 
Q3. Skills in the use of the handheld unit and its built in sensors  
88.1 V 0.738 0.000 
Q4. Skills to use other(third party) measurement equipment and sensors  
81.3 V 0.558 0.000 
Q5. Skills to link the handheld unit to the telephone line and send data  
86 V 0.788 0.000 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  82.9 V 0.704 0.000 
Q7. The patient finds encouragement from family and friends to use the 
service  86 V 0.46 0.000 
Q8. Decision to proceed  
84.5 V 0.135 0.562 
Q9. Replacement of handheld unit + accessories  
80.8 V 0.067 0.401 
Q10. Replacement of third party devices  
75.6 V 0.4 0.000 
Q11. Measurement using handheld/accessories  
81.3 V 0.144 0.071 
Q12. Measurement using third party devices  
76.2 V 0.233 0.005 
Q13.Transfer of data using telephone line  
81.3 V 0.13 0.104 
Q14. Completion of EQ5D questionnaire  
81.3 V 0.142 0.076 
Q15. Use of messages from clinician  
79.8 V 0.123 0.126 
Q16. Use of telephone help line  
81.9 V 0.08 0.313 
Ntotal = 193; Cramer's V = V; p values < 0.001 are reported as 0.000 
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5.4.8 Ethnicity 
Half of items (8/16) in table 5.11 were significantly associated with the patients’ 
ethnicity. The association with the highest coefficient existed between ethnicity 
and “understanding about the technical support help line and how to use it” (Q2, 
V=0.392). Moderate significant association were found in Q3 (V=0.268), Q4 
(0.247), Q8 (V=0.236), Q11 (V=0.212), Q14 (V=0.252) and Q15 (0.292) and 
strong associations in Q2 (V=0.392) and Q7 (V=0.329). The rest of items were not 
statistically significant.  
 
Table 5.11. Association between ethnicity minority and 16 items extracted from the 
patient's progress at a clinical visit. 
Association between ethnic minority and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  89.1 V 0.227 0.064 
Q2. Understanding about the technical support help line and how to use it  
89.1 V 0.392 0.000 
Q3. Skills in the use of the handheld unit and its built in sensors  
88.1 V 0.268 0.016 
Q4. Skills to use other(third party) measurement equipment and sensors  
81.3 V 0.247 0.049 
Q5. Skills to link the handheld unit to the telephone line and send data  
86 V 0.238 0.052 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  82.9 V 0.129 0.614 
Q7. The patient finds encouragement from family and friends to use the 
service  86 V 0.329 0.001 
Q8. Decision to proceed  
84.5 V 0.236 0.06 
Q9. Replacement of handheld unit + accessories  
80.8 V 0.116 0.146 
Q10. Replacement of third party devices  
75.6 V 0.038 0.645 
Q11. Measurement using handheld/accessories  
81.3 V 0.212 0.008 
Q12. Measurement using third party devices  
76.2 V 0.039 0.64 
Q13.Transfer of data using telephone line  
81.3 V 0.002 0.981 
Q14. Completion of EQ5D questionnaire  
81.3 V 0.252 0.002 
Q15. Use of messages from clinician  
79.8 V 0.292 0.000 
Q16. Use of telephone help line  
81.9 V 0.116 0.146 
Ntotal = 193; Cramer's V = V; p values < 0.001 are reported as 0.000 
 
5.4.9 General location of patient home 
Moderate significant associations were found between location of the patient’s 
home and 10 out of the 16 items (62%) in table 5.12. The association with the 
highest coefficient existed between location and “completion of EQ5D 
questionnaire” (Q14, V=0.282). The other moderate significant associations were 
found in Q1 (V=0.129), Q2 (V=0.19), Q3 (V=0.162), Q4 (V=0.252), Q5 (V=0.134), 
Q8 (V=0.222), Q9 (V=0.26), Q12 (V=0.244) and Q15 (V=0.266). 
 
Table 5.12. Association between location and 16 items extracted from the patient's 
progress at a clinical visit. 
Association between location and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  88.6 tau-c 0.129 0.012 
Q2. Understanding about the technical support help line and how to use it  
88.6 tau-c 0.19 0.000 
Q3. Skills in the use of the handheld unit and its built in sensors  
87.6 tau-c 0.162 0.004 
Q4. Skills to use other(third party) measurement equipment and sensors  
80.8 tau-c 0.252 0.000 
Q5. Skills to link the handheld unit to the telephone line and send data  
85.5 tau-c 0.134 0.024 
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Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  82.4 tau-c 0.094 0.114 
Q7. The patient finds encouragement from family and friends to use the 
service  85.5 tau-c -0.074 0.208 
Q8. Decision to proceed  
84.5 V 0.222 0.019 
Q9. Replacement of handheld unit + accessories  
80.3 V 0.26 0.015 
Q10. Replacement of third party devices  
75.1 V 0.211 0.091 
Q11. Measurement using handheld/accessories  
80.8 V 0.143 0.36 
Q12. Measurement using third party devices  
75.6 V 0.244 0.033 
Q13.Transfer of data using telephone line  
80.8 V 0.141 0.379 
Q14. Completion of EQ5D questionnaire  
80.8 V 0.282 0.006 
Q15. Use of messages from clinician  
79.3 V 0.266 0.013 
Q16. Use of telephone help line  
81.3 V 0.092 0.721 
Ntotal = 193; Kendall's tau-c =  tau-c ; Cramer's V = V; p values < 0.001 are reported as 0.000 
 
5.4.10 Quality of living accommodation 
Except for “replacement of handheld unit + accessories” and “use of messages 
from clinician”, there were statistically significant associations between quality of 
living accommodation and the rest of items (14/16, 88%) in table 5.13. The 
association of measurement with the highest coefficient and strongest association 
existed between accommodation and “transfer of data using telephone line” (Q13, 
V=0.41) followed by “use of telephone help line” (Q16, V=0.341) and 
“replacement of third party devices” (Q10, V=0.305). The rest of the significant 
associations (Q1- Q8, Q11, Q12, and Q14) were moderate.  
 
Table 5.13. Association between quality of living accommodation and 16 items extracted 
from the patient's progress at a clinical visit. 
Association between quality of living accommodation and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  87 tau-c 0.255 0.000 
Q2. Understanding about the technical support help line and how to use it  
87 tau-c 0.159 0.002 
Q3. Skills in the use of the handheld unit and its built in sensors  
86 tau-c 0.122 0.03 
Q4. Skills to use other(third party) measurement equipment and sensors  
79.3 tau-c 0.209 0.000 
Q5. Skills to link the handheld unit to the telephone line and send data  
83.9 tau-c 0.29 0.000 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  80.8 tau-c 0.283 0.000 
Q7. The patient finds encouragement from family and friends to use the 
service  83.9 tau-c 0.142 0.02 
Q8. Decision to proceed  
82.9 tau-c 0.189 0.002 
Q9. Replacement of handheld unit + accessories  
78.8 V 0.149 0.498 
Q10. Replacement of third party devices  
73.6 V 0.305 0.01 
Q11. Measurement using handheld/accessories  
79.3 V 0.288 0.013 
Q12. Measurement using third party devices  
74.1 V 0.38 0.000 
Q13.Transfer of data using telephone line  
79.3 V 0.41 0.000 
Q14. Completion of EQ5D questionnaire  
79.3 V 0.273 0.023 
Q15. Use of messages from clinician  
77.7 V 0.144 0.541 
Q16. Use of telephone help line  
79.8 V 0.341 0.001 
Ntotal = 193; Kendall's tau-c =  tau-c ; Cramer's V = V; p values < 0.001 are reported as 0.000 
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5.4.11 The patient has existing care provision and access local medical and 
social care 
Fifteen out of the 16 items (94%) in table 5.14 were significant associated with the 
existing of care provision. The association of measurement with the highest 
coefficient was between existing of care provision and “decision to proceed” (Q8, 
V=0.618) followed by “skills to use other (third party) measurement equipment 
and sensors” (Q4, V=0.516), “measurement using third party devices” (Q12, 
V=0.511) and “completion of EQ5D questionnaire” (Q14, V=0.508). The other 
items that had a strong relationship with care provision were Q1 & Q2, Q5-Q7, 
Q11, Q13 and Q15. Moderate association were found in Q3 (V=0.285), Q10 
(V=0.195) and Q16 (V=0.211). 
   
Table 5.14. Association between care provision and 16 items extracted from the patient's 
progress at a clinical visit. 
Association between care provision and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  85 V 0.426 0.000 
Q2. Understanding about the technical support help line and how to use it  
85 V 0.475 0.000 
Q3. Skills in the use of the handheld unit and its built in sensors  
83.9 V 0.285 0.011 
Q4. Skills to use other(third party) measurement equipment and sensors  
77.2 V 0.516 0.000 
Q5. Skills to link the handheld unit to the telephone line and send data  
81.9 V 0.408 0.000 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  78.8 V 0.377 0.000 
Q7. The patient finds encouragement from family and friends to use the 
service  81.9 V 0.389 0.000 
Q8. Decision to proceed  
81.3 V 0.618 0.000 
Q9. Replacement of handheld unit + accessories  
77.7 V 0.016 0.848 
Q10. Replacement of third party devices  
72.5 V 0.195 0.021 
Q11. Measurement using handheld/accessories  
78.2 V 0.324 0.000 
Q12. Measurement using third party devices  
73.1 V 0.511 0.000 
Q13.Transfer of data using telephone line  
78.2 V 0.435 0.000 
Q14. Completion of EQ5D questionnaire  
78.2 V 0.508 0.000 
Q15. Use of messages from clinician  
76.7 V 0.33 0.000 
Q16. Use of telephone help line  
78.8 V 0.211 0.009 
Ntotal = 193; Cramer's V = V; p values < 0.001 are reported as 0.000 
 
5.4.12 Carer’s availability 
Only 2 out of the 16 items (13%) in table 5.15 were significantly associated with 
carer’s availability. There were strong associations between carer’s availability 
and “replacement of third party devices” (Q10, V=0.468, p=0.042), and “use of 
telephone help line” (Q16, V=0.405, p=0.034). The rest of items were not statically 
significant.  
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Table 5.15. Association between carer’s availability and 16 items extracted from the 
patient's progress at a clinical visit. 
Association between carer’s availability and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  95.9 tau-c 0.117 0.389 
Q2. Understanding about the technical support help line and how to use it  
95.9 tau-c 0.201 0.117 
Q3. Skills in the use of the handheld unit and its built in sensors  
93.9 tau-c 0.198 0.12 
Q4. Skills to use other(third party) measurement equipment and sensors  
69.4 tau-c 0.075 0.628 
Q5. Skills to link the handheld unit to the telephone line and send data  
87.8 tau-c 0.096 0.476 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  83.7 tau-c 0.22 0.096 
Q7. The patient finds encouragement from family and friends to use the 
service  87.8 tau-c 0.006 0.963 
Q8. Decision to proceed  
95.9 tau-c 0.14 0.301 
Q9. Replacement of handheld unit + accessories  
79.6 V 0.088 0.861 
Q10. Replacement of third party devices  
59.2 V 0.468 0.042 
Q11. Measurement using handheld/accessories  
81.6 V 0.361 0.074 
Q12. Measurement using third party devices  
61.2 V 0.249 0.394 
Q13.Transfer of data using telephone line  
81.6 V 0.354 0.081 
Q14. Completion of EQ5D questionnaire  
81.6 V 0.248 0.294 
Q15. Use of messages from clinician  
77.6 V 0.371 0.073 
Q16. Use of telephone help line  
83.7 V 0.405 0.034 
Ntotal = 49; Kendall's tau-c =  tau-c ; Cramer's V = V 
 
5.4.13 Carer’s level of support 
Only 1 item (1/16, 6%) was significantly associated with carer’s level of support: 
“measurement using handheld/accessories” (Q11, V=0.369, p=0.029). The 
associations in the rest of items in table 5.16 were not statistically significant. 
 
Table 5.16. Association between carer’s level of support and 16 items extracted from the 
patient's progress at a clinical visit. 
Association between carer’s level of support and: N valid in 
% 
Measure of 
Association 
Value P 
Q1. Understanding of the booklet, other support material and how to use 
them  95.3 V 0.194 0.82 
Q2. Understanding about the technical support help line and how to use it  
95.3 V 0.452 0.078 
Q3. Skills in the use of the handheld unit and its built in sensors  
93 V 0.315 0.411 
Q4. Skills to use other(third party) measurement equipment and sensors  
67.4 V 0.435 0.241 
Q5. Skills to link the handheld unit to the telephone line and send data  
86 V 0.139 0.95 
Q6. Skills to access and understand guidance messages sent by clinicians 
via the handheld unit  83.7 V 0.444 0.131 
Q7. The patient finds encouragement from family and friends to use the 
service  86 V 0.352 0.332 
Q8. Decision to proceed  
95.3 V 0.305 0.433 
Q9. Replacement of handheld unit + accessories  
79.1 V 0.268 0.118 
Q10. Replacement of third party devices  
58.1 V 0.253 0.205 
Q11. Measurement using handheld/accessories  
81.4 V 0.369 0.029 
Q12. Measurement using third party devices  
60.5 V 0.015 0.94 
Q13.Transfer of data using telephone line  
81.4 V 0.076 0.652 
Q14. Completion of EQ5D questionnaire  
81.4 V 0.019 0.908 
Q15. Use of messages from clinician  
76.7 V 0.182 0.297 
Q16. Use of telephone help line  
83.7 V 0.229 0.169 
Ntotal = 43; Cramer's V = V 
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5.5 Summary  
The results presented in this chapter showed a consistent degree of association 
between the demographics variables (13 independent variables in total) and the 
dependent variables (Q1 to Q16) which were extracted from the evaluation of 
patients’ progress using the telehealth service.  
 
Tables 5.4 to 5.16 show that at least 50% of the dependent variables were 
associated with an important proportion of the independent variables except in the 
case of marital status, activity if retired, carers availability, carers level of support 
and gender. In line with the classification of strength in table 5.1, the largest 
number of strong relationships was found in the following order: 
1. Existing care provision and access local medical and social care (11/16, 69%) 
2. Education (10/16, 63%) 
3. General location of patient’s home (10/16, 63%) 
4. Age (9/16, 56%) 
5. Literacy in local language (8/16, 50%) 
6. Quality of living accommodation (4/16, 25%) 
7. Current or most recent occupation (4/16, 25%) 
8. Marital status (4/16, 25%) 
9. Ethnicity (2/16, 13%) 
10. Activity if retired (2/16, 13%) 
11. Carers availability (2/16, 13%) 
12. Carer level of support (2/16, 13%)) 
13. Gender (0/16, 0%) 
 
Based on the ranking and strength of the relationship, we considered that at least 
the first five conditions listed above were important factors influencing the 
adoption of the service. In general, the patients who had already existing care 
provision and access to local medical and social care had also poor 
understanding and poor skills in the use of the telehealth service which included 
the utilisation of telehealth units, some sensors and other third party 
measurement equipment. These patients also required additional training for the 
correct operation of the telehealth units and for the completion of EQ5D 
questionnaires as well as for the use of messages from clinicians.  
 
The level of the patient’s education also appeared to play an important role in the 
adoption of service. Patients with the lowest level of education were more likely to 
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require additional help and further training before they were able to continue using 
any part of the service independently. For them, it was more complicated to learn 
how to use the devices effectively. They were allowed often to proceed with the 
service with special monitoring of data quality by the clinicians. 
  
In terms of the location, patients that lived in inner cities had better skills and 
understanding in how to use the technology, access the clinical data and to 
retrieve messages sent by the clinical staff. They were more likely to be allowed 
to proceed with no additional precautions during the interim visit. Difficulties with 
the technology were rare in this group. 
 
The performance of patients using the service also differed between different age 
groups. That can be probably explained by the effects of the natural ageing 
process and the fact that the oldest participants were sicker than the youngest. In 
general, the patients in the group of 60 year old and over required more 
assistance as they had poorer skills and understanding of the service. They were 
also more likely to withdraw from the service and to be retrained. In most of 
cases, they considered that learning to use the equipment was very difficult. 
 
Patients lacking literacy in the local language were more likely to require 
additional help and further training before they continued to use independently 
any part of the service. It was also noticed that the replacement of third party 
devices were significantly higher in this group. Without literacy skills, the ability to 
solve problems and to use telehealth technology are not the only concerns. Low 
literacy is also associated with several poor health outcomes (DeWalt et al., 
2004). Therefore, better understanding between general literacy, health literacy 
and information technologies are required for patients to be effectively engaged in 
telehealth interventions. 
 
In summary, the mechanisms through which the economic and social conditions 
of patients influenced the telehealth service seem to be multiple. More research 
needs to be done to fully understand the underlying mechanisms that determine 
performance and adoption of telehealth interventions. However, this chapter has 
shown that the demographics of patients influences uptake of telehealth. 
Therefore, socio-economic conditions must be considered during the design and 
implementation of telehealth services. 
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Chapter 6. Clinical outcomes  
 
 
6.1 Introduction 
This chapter briefly introduces the concept of clinical effectiveness. The following 
main discussion is centred on the analysis of results generated by the clinical 
outcomes collected from the REALITY case study. 
  
6.2 Clinical effectiveness  
The Department of Health has defined clinical effectiveness as “the application of 
the best knowledge, derived from research, clinical experience and patient 
preferences to achieve optimum processes and outcomes of care for patients.  
The process involves a framework of informing, changing and monitoring 
practice”(NHS Executive, 1996).  
 
Clinical effectiveness provides an opportunity for healthcare providers to 
understand what really works the clinical practice. To find out the clinical 
effectiveness of an intervention, a number of medical and health care procedures 
are being put in place, in order that a desired effect can be reproduced and that 
the beneficial changes of the given intervention can be measured. Nowadays, the 
best way of evaluating the effectiveness of an intervention is through clinical trials 
and systematic reviews. These studies usually provide robust, consistent and 
systematic evidence. Historically, some entities have been better positioned than 
others to produce and access good quality evidence that supports the use of 
specific interventions for prevention, treatment or rehabilitation. According to 
Jacobson (2007) in the USA the majority of the clinical effectiveness studies came 
from academic research (58%); private institutions (30%); pharmaceutical 
companies (7%) and government (5%).  
 
Improving healthcare services using the best evidence available for health and 
social care has been a key component of the UK Government’s strategy led by 
the National Institute for Clinical Excellence (NICE), nevertheless, this is not the 
only institution concerned with clinical standards. Other groups have been 
established with the aim to carry out national audits, produce evidence on clinical 
and cost effectiveness and develop evidence based guidelines; for instance, that 
is the case of the Clinical Effectiveness Unit (CEU) of the the Royal College of 
 135 
Surgeons (RCS), the Clinical Effectiveness and Evaluation Unit (CEEU) at the 
Royal College of Physicians and the Centre for Reviews and Dissemination at 
University of York among others.  
 
In practice, a series of conditions need to be met in order to make a clinical 
effectiveness study useful. Such conditions must include relevant research in the 
clinical area of interest, methods to translate the research into practice, methods 
to monitor changes in the outcomes, and clinicians prepared to consider change 
to practice (Cape, 2000). Without meeting these conditions, a mismatch between 
the available research evidence and the current clinical practice can happen. 
Unfortunately, it is not rare that mismatches can occur due to the lack of research 
funding, lack of interest from particular practitioner groups and the complexity of 
the intervention. 
 
6.3 Effectiveness of telehealth 
In recent years, there has been an increasing interest in the implementation of 
telehealth services for managing patients with long term conditions. These 
services are considered to be important because in ageing societies it is expected 
that people can live independently in their own homes by providing access to 
appropriate home services and technologies. 
 
As a consequence, several research and evaluation studies have investigated the 
effectiveness of telehealth. In doing so, the majority of studies used multiple 
measures which in some cases can be difficult to interpret (Bergmo, 2009). These 
measures varied from diagnostic accuracy, blood glucose levels, anxiety and 
depression levels, physical capacity and health-related quality of life (HRQL) to 
life-years gained (LYG) and quality-adjusted life-years (QALYs).  
 
Although in some cases research has demonstrated the benefits of telehealth, it is 
still common to find in the published literature limited and inconsistent levels of 
evidence supporting the effectiveness of telehealth (Ekeland et al., 2010). 
Therefore, more evidence is needed with larger clinical trials, proper study quality 
and scientific rigour (Bensink et al., 2006a).  
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6.4 Results 
Amongst the measures collected at baseline and at the end of the REALITY 
project, we collected clinical data such as peak expiratory flow, blood pressure 
and haemoglobin A1c (HbA1c). With such data, a before and after clinical 
evaluation was conducted using paired samples t-tests. 
 
The results presented below rely on the data collected at recruitment (pre-study) 
and final clinical visit (post-study). 
 
Lisbon. A paired samples t-test was conducted to compare the peak expiratory 
flow (PEF) value in patients from Lisbon, before and after the telehealth 
intervention (fig. 6.1).  
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Figure 6.1. Initial and final peak expiratory flow values of 31 patients: paired comparison. 
 
There was not a significant difference between the mean PEF values for pre (M1= 
216.13, SD1=64.17) and post-study (M2=221.77, SD2=76.08) among patients at 
the Lisbon clinical site; t(30)=-0.599, p=0.553. This result confirms that the 
intervention did not have any effect on the primary outcome variable.  
 
Evora. Similarly, the differences between the PEF values pre and post 
intervention (fig. 6.2) for the group at Evora were tested by the paired samples t 
test. No significant difference was found between the mean PEF values for pre 
(M1=382.5, SD1=136.26) and post (M2=381.5, SD2=130.51) telehealth 
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intervention; t(19)=0.071, p=0.944. Specifically, this result shows that the patients’ 
ability to breathe out air did not also improve for patients at Evora. 
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Figure 6.2. Initial and final peak expiratory flow values of 20 patients: paired comparison. 
 
Lisbon. The difference between mean blood pressure (MBP) values before and 
after the intervention (fig. 6.3) was tested by using paired t test.  
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Figure 6.3. Initial and final mean blood pressure values of 25 patients: paired comparison. 
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The paired t test results showed no significant differences between MBP at 
baseline (M1=103.86, SD1=10.654) and final clinical visit (M2=103.93, SD2=8.216); 
t(24)=-0.033, p=0.973. For patients at Tartu, the mean blood pressure did not 
improve as a consequence of the telehealth intervention. 
 
London. The difference between the initial haemoglobin A1c (HbA1c) values and 
the values after the last clinical visit (fig. 6.4) was determined using paired 
student's t-tests. 
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Figure 6.4. Initial and final haemoglobin A1c values of 27 patients: paired comparison. 
 
There was not a significant difference between the mean HbA1c level for pre 
(M1=8.34, SD1=1.890) and post-study (M2= 8.63, SD2=1.725); t(26)=-0.681, 
p=0.501 The mean HbA1c difference did not show any improvement in the 
metabolic control for patients with diabetes. 
 
For this site, it was also tested the difference between mean blood pressures 
(MBP) values before and after the intervention (fig. 6.5) by using paired t test. 
 
There was not significant differences between MBP at baseline (M1=104.18, 
SD1=9.817) and final clinical visit (M2=100.01, SD2=9.294); t(30)=-1.972, p=0.057. 
For patients with hypertension, the mean blood pressure did not improve as a 
consequence of the telehealth intervention. 
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Figure 6.5. Initial and final mean blood pressure values of 32 patients: paired comparison. 
 
Finally, the differences between the PEF values pre and post intervention (fig.6.6) 
for asthmatic patients in London were tested by the paired samples t test. No 
significant difference was found between the mean PEF values for pre 
(M1=335.92, SD1=147.908) and post (M2=379.92, SD2=136.291) telehealth 
intervention; t(12)=-1.389, p=0.189. The regular monitoring of PEF did not lead to 
significant improvement in asthma patients. 
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Figure 6.6. Initial and final peak expiratory flow values of 13 patients: paired comparison. 
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6.5 Discussion and conclusions 
Overall, there were no significant differences in the pre and post- test of the 
primary outcomes for any of the four clinical sites. These statistical results 
indicate no clinical improvements after the telehealth intervention. The results are 
a challenge to interpret but not necessarily atypical. For instance, in a telehealth 
randomised controlled trial of 123 young patients with diabetes type 1, Nunn et al. 
(2006) found that the mean HbA1c level  did not change (no significant difference) 
between the treatment and control group after 7 months of intervention. In another 
diabetes study, Farmer et al. (2005) found no significant difference in HbA1c 
changes between the telehealth and control groups at either 4 or 9 months of 
evaluation.  Similarly, in a year long telehealth monitoring study in children with 
asthma Deschildre et al. (2012) found no significant changes between the control 
and intervention group for lung function. In the same context, Ostojic et al. (2005) 
found no significant difference in the PEF values between the telehealth group 
(short message service) and the control group for the 16-week randomised 
controlled study.  Finally, in the case of hypertension, a videoconferencing system 
for the treatment of patients with hypertension was studied (Nilsson et al., 2009). 
Nilsson et al. (2009) found no significant difference in systolic and diastolic blood 
pressure between the intervention group and control group after 21 months. 
 
The interpretation of the t-test results and the above studies suggests that there is 
insufficient clinical evidence to support the use of telehealth for home monitoring 
of patients with diabetes, asthma, COPD and hypertension. However, as pointed 
out by Stoltz et al. (2009) “Insufficient evidence of effectiveness is not evidence of 
no effectiveness”. We already discussed in section 3.8 that the problem of 
evidence can be related to the difficulty of evaluating these types of complex 
interventions in short trials with small and heterogeneous groups in which the 
intervention type varies. Furthermore, the statistical analysis of aggregated data 
may be inadequate for showing individual cases in which the intervention has 
worked.  
 
For instance, in fig. 6.5 we observed improvements in the mean blood pressure 
(MBP) for patients 6402 and 6635, who showed a reduction of MBP from 110 
mmHg to 88 mmHg approximately. In the same way, a drop of at least 5% (from 
12% to 7%) in HbA1c was observed in patients 6389 and 6567 (see fig. 6.4); and 
improvements of peak expiratory flow (more than 100 L/min) were observed in 
patients 8358 (fig. 6.1) and 8808 (fig. 6.2). All these observations are based on 
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baseline and final values, but some other examples with full data collection have 
been previously reported  (REALITY Consortium, 2005a). In fact, data collection 
of MBP for patient ID 6457 (62 years old, male, diabetic with hypertension) have 
been plotted in fig. 6.7; noticeable changes and gradual improvements in MBP 
can be seen over time (see tracked mean line).  
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Figure 6.7. Improvement of mean blood pressure over time for patient 6457 (REALITY 
Consortium, 2005a). Demographics: 62, male, divorced, education level college, 
profession senior manager/highly trained profession, literate in local language, Afro 
Caribean, living alone in inner city, he is the main householder, depends on monthly 
salary, accommodation in reasonable conditions. 
 
Another real example of what can be achieved with a telehealth intervention is 
shown in fig. 6.8. On this figure, progressive improvements in the peak expiratory 
flow for a 61 years old male patient with chronic respiratory condition can be 
observed. 
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Figure 6.8. Changes of peak expiratory flow over time for patient 8138 (REALITY 
Consortium, 2005a). Demographics: 61yrs old, male, single, education primary school,  
profession skilled labour, active, literate in local language, living outer city with 
family/friends on state benefits, living accommodation reasonable conditions, carer at 
home only at night. 
 
The fact that we could not find improvement in clinical outcomes does not mean 
that telehealth cannot offer any benefit. In fact, despite the discouraging findings 
already mentioned, new evidence from the world's largest research trial regarding 
the effect of telehealth and telecare has demonstrated promising results. As 
stated in section 1.1, the WSD programme findings showed that if used correctly, 
telehealth can reduce deaths by 45%, emergency visits by 20%, A&E visits by 
15%, elective admissions and bed stays by 14% and tariff cost by 8% (DH, 2011). 
The full results on the use of secondary care and mortality have recently been 
published by Steventon et al. (2012). Interestingly, Steventon et al. (2012) 
discussed that service utilisation did not necessarily correlate with health status, 
and they recommended that multidimensional analysis is required for the 
assessment of the intervention.  
 
The assessment of clinical effectiveness for the  WSD trial was proposed by 
looking at improvement in quality of life, well being, self care, and carer burden 
(Bower et al., 2011). Data were available from 98% of participants (Steventon et 
al., 2012). In our case study, we have chosen the clinical measures for those 
persistent patients whose paired data were available (less than 50%), which as a 
result may have had a negative impact on the statistical results. 
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In conclusion, some individual cases have shown improvements in their health 
outcomes, as it can be observed in figures 6.7 and 6.8. However, in general, it 
was evident that through our case study we were not able not find any conclusive 
clinical evidence that supports whether these kind of interventions work. These 
discouraging findings are consistent with the results of other telehealth  studies 
(Farmer et al., 2005; Ostojic et al., 2005; Nunn et al., 2006; Nilsson et al., 2009; 
Deschildre et al., 2012). However, this interpretation requires us to consider that, 
overall, detectable changes in patients’ health status were rare. This can be 
associated with the fact that almost half of the cohorts in London and Tartu 
withdrew, which created considerable gaps in the intended daily and weekly 
clinical collection of data, and loss of statistical power as a result. This was also 
due to the fact that retraining needs were not detected in time and equipment 
problems were often experienced, which subsequently led to discouraging 
patients in using the equipment, particularly in the Lisbon group. In some other 
cases, patients were too sick to use the equipment. To avoid similar findings as 
presented in section 6.4, future studies that aim to demonstrate the clinical 
effectiveness of telehealth interventions should include: 
 close patient follow-up, 
 observations on severity of disease,  
 early detection of retraining needs, and  
 mature technology that has been in use long enough so that most of its 
initial faults have been removed or reduced. 
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Chapter 7. Discussion and recommendations  
 
 
7.1 Introduction 
Each chapter is discussed separately, limitations of this research are outlined, 
and recommendations are made in order to design a framework for telehealth 
interventions. 
 
7.2 Overview 
We have already argued in chapter 1 that the access and consumption of 
technologies in everyday life represents improvements to the quality of life and 
also progress towards equity in our societies. For this reason, the global tendency 
has been to consider telehealth as a key service for future delivery of care. It 
promises lowering the cost of care, improving quality, and mitigating provider 
shortages, making it attractive as a clinical tool (Speedie et al., 2008). However, 
the evidence in chapter 3 and chapter 6 shows that telehealth interventions do not 
work in every case. Therefore, fundamental questions about how we should 
design, understand and implement new healthcare services based on ICT are 
raised. 
 
Often, organisational and cultural issues are mentioned as fundamental to the 
failure of telehealth (Barlow et al., 2005). Telehealth may still fail if success 
depends on behaviour and organisational change, even if the evidence shows 
reduction in cost and utilisation. For that reason, it is important to understand what 
causes organisational changes.  
 
Researchers have classified types of stimuli affecting organisations and their 
respective responses (Feibleman and Friend, 1945). Understanding these 
phenomena may be a real challenge, especially given the fact that, as we have 
seen in Section 3.7, telehealth interventions may, or may not, generate clinical 
effects.  
  
Feibleman and Friend (1945) classified stimuli in (see fig. 7.1): 
 Negligible; 
 Destructive; 
 Effective. 
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Figure 7.1. Stimuli to and responses from organisations (Feibleman and Friend, 1945). 
 
A negligible stimulus is the one that does not trigger any organisational reaction. 
That is because it is below a threshold. A destructive stimulus, as the negligible, 
generates no response, but destroys the organisation; this stimulus can be 
excessively strong. Contrary to negligible and destructive stimuli, an effective 
stimulus is the kind that triggers a response in the system. This last stimulus is the 
one that interests us. 
 
Effective stimuli can be divided in to three types (Feibleman and Friend, 1945): 
minimal, optimal and drastic. A minimal stimulus, as its name implies, is the 
minimum stimulus needed for exceeding the threshold and subsequently 
generation of a response. An optimal stimulus is considered the best for triggering 
change, whereas a drastic stimulus is on the boundaries of destructive stimuli.   
 
Given an effective stimulus, the behaviour or organisational response may be one 
of the three following forms (Feibleman and Friend, 1945):  
 Tenacious, a response that tends to conserve its original organisational 
state. As a mechanism of defence, it generates resistance to change.  
 Elastic, a response capable of adopting a new state while the stimulus 
remains, but returning to its initial organisational state once the stimulus 
ceases.  
 Self-determinative, a response that allows change, adapting elements of 
the stimulus and transforming them to suit itself. 
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It is not uncommon that people resist change when they perceive it as a threat. In 
general, resistance to change is a factor of concern in telehealth (Debnath, 2004; 
Hebert et al., 2006; Jones et al., 2006; Lee et al., 2011). Resistance can also be 
present when the burden of treatment for patients with complex illnesses reduces 
their capacity to collaborate in their own care (May et al., 2009). To overcome this 
issue, May et al. (2009) suggested that we need to implement minimally disruptive 
structures for effective treatment and service provision. 
 
Essentially, clinical trials and pilot projects are implemented to demonstrate and 
evaluate the feasibility of studies before establishing operations on a large scale. 
The effects of pilot projects and research trials can be considered to be of the 
type of elastic response due to their temporary nature, as they seldom move from 
such stages to routine service delivery. 
 
To avoid tenacious and elastic responses and move telehealth into the 
mainstream of medical practice as a self-determinative response, effective health 
care processes are needed in place before any changes are attempted (Jennett 
et al., 2005).  Also, good acceptance and satisfaction are required from health 
care professionals, patients, caregivers, and other users, as well as solving any 
issues related to staff, skills, learning and training needs (Zanaboni and Lettieri, 
2011). Definition of leadership, roles and responsibilities need to take place and 
be communicated among health care staff. Beyond the boundaries of the 
organisation, collaboration, cooperation, partnership and networks with other 
health care providers and stakeholders are also required (Zanaboni and Lettieri, 
2011).  
 
But, before telehealth can occur routinely, a number of processes have to be put 
in place (Jennett et al., 2005). One important element that needs to be considered 
is the collection of information that will be sent to a healthcare provider. From 
section 3.6, we already know that the information that needs to be transmitted 
within a telehealth system depends on the patient’s specific disease. This can be 
divided in to: 
 Physiological data (blood pressure, glucose, ECG, peak flow, oxygen 
saturation, among others), 
 Health-related data (sleeping quality, quality of life (QoL), weight, 
symptoms, medication taken, daily stress,  etc), 
 Text data (patient id, automatic reports, and text messages to patients) 
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 Audio (voice, electronic  stethoscope, etc), 
 Video (images in real time), 
 Others (still images). 
 
From section 3.6, we also know that in telehealth patients are supported by some 
biomedical technologies, which enable the acquisition, displaying, and coding of 
clinical and health-related information (the message). The information travels from 
and through the telecommunication system available at the patient’s home, to a 
healthcare facility (either directly or indirectly) where a healthcare provider with 
the support of some technologies (ICTs) stores, decodes, displays, and interprets 
the information sent. In their workplace, the healthcare provider can have further 
discussion with other colleagues or carers before decision making and other 
support (feedback) takes place. This description makes information an important 
component of the care practice in telehealth.  
 
However the process of collecting useful information requires different actions 
from stakeholders and can be very complex. As a rule of thumb, the more 
information, the more difficult and time consuming it is to obtain useful medical 
information. Usefulness of medical information can be expressed by the equation 
(Shaughnessy et al., 1994): 
Usefulness of medical information = 
work
validityrelevance
 
where:   
 relevance means that information has to be relevant to everyday practice;  
 validity implies that information has to be correct; and  
 work denotes that medical information must require to be obtained with 
fairly little work. 
 
Therefore, gathering relevant and valid information should be part of the 
information design.  From all the information created in healthcare, the fraction of 
the total number of transactions that implies interpersonal interaction, e.g. face to 
face conversations, telephone calls, letters, faxes, and emails, is known as “the 
communication space” (Coiera, 2006). Coiera (2006) argued that such 
communication space in clinical settings tends to be interruption-driven (multiple 
interruptions by clinical colleagues and others, either face to face or through call 
events), contain deficiencies in its communication systems, and result in poor 
practice (Coiera and Tombs, 1998; Coiera, 2006).  
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In the REALITY case study, some indications of poor communication and 
information design were found. As one of the clinicians (PG) from the London site 
commented at the end of the study: 
“Problems with the handheld units, not as user friendly or clear as originally 
stated. Lots of technical issues and feedback form website were extremely poor. 
At times it appeared to just be a data gathering exercise”  
 
Another clinician (IM) from Portugal was also disappointed with the system: 
“I have not enough time to analyse data; I expected the results from oximeter 
could be more useful; I also expected to have more efficient technical support”  
 
One more clinician (SW) commented: 
“[there were] Problems with the handheld units, not linked to the clinical system so 
it seemed isolated. Data overload as a result” 
 
Clinicians found it difficult to understand the status of their patients and make any 
decisions as there was too much information to deal with. One question that still 
needs to be answered is whether they really needed or wanted to have access to 
all of the data generated by telemonitoring. 
 
7.3 Main findings 
The purpose of this research was to develop a generic framework that is 
applicable to a broad spectrum of telehealth interventions for patients with long 
term conditions. In order to accomplish the aim of this research, we systematically 
first looked at the evidence available for home telehealth interventions focused on 
diabetes, hypertension, COPD and asthma. This was done to determine the 
clinical effectiveness of the studies and to find the best models for telehealth 
implementation. Secondly, we looked at the profiles of patients from a real case 
study since we argued that other factors such as socio-economic and living 
conditions are important determinants to be considered for appropriate service 
implementation. Then, we tested whether there was a statistical relationship 
between demographics and the performance of patients during the telehealth 
case study. Finally, we performed a series of tests to evaluate the effectiveness of 
the telehealth case study. The main findings are summarised below. 
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7.3.1 What the evidence says (Chapter 3) 
Mixed evidence was found regarding the effects of home telehealth on clinical 
outcomes. The evidence found reflects the variability of studies and the lack of 
standards for these types of interventions. The small sample size and inadequate 
length of the intervention (typically less than 6 months) for most of the studies 
included in this review limited our results. On the one hand, sample size is 
important because of its effect on the probability that a statistical test will indicate 
a significant difference when there truly is one (Eng, 2003). On the other hand, a 
change in a clinical outcome can be attributed to a temporal effect (due to 
changes over time) that not necessarily have to be related to the intervention 
(Nelson, 2011). For instance, we found temporal improvements in some patients 
from the REALITY project. Fig. 48 shows a reduction in the blood glucose levels 
(elastic response) of patient ID 6460 from day 50 to day 100. The improvement 
was not sustained in the long term and by the end of the study blood glucose level 
went back to its initial state. For this reason, the length of interventions in 
telehealth should be sufficient to determine temporary and long term effects. 
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Figure 7.2. Changes of blood glucose over time (patient 6460). 
 
It is important to note, that one of the findings during this review is the 
inconsistency in the way that primary outcomes were reported in telehealth 
studies (except for the diabetes studies). A lack of sufficient data to estimate final 
mean values and standard deviations, as well as lack of common outcome 
measures for the reviewed cases of asthma, hypertension and COPD, made it 
impossible to assess the effectiveness of such interventions by meta-analysis. In 
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order to facilitate research in telehealth, standardisation of interventions and 
outcome measures is needed (Ekeland et al., 2012).  
 
Although meta-analysis is difficult to achieve, there is a current trend to utilise this 
statistical method for home telehealth research studies (DelliFraine and Dansky, 
2008; Polisena et al., 2009; Polisena et al., 2010; Omboni and Guarda, 2011) 
since it is the only way to evaluate clinical effectiveness. In this research, we 
attempted to use meta-analysis to determine the best case studies with a 
quantitative approach. In the meta-analysis of diabetes studies, we found six 
studies with significant positive effects in favour of telehealth (Ahring et al., 1992; 
Albisser et al., 1996; Thompson et al., 1999; Kim and Oh, 2003; Oh et al., 2003; 
Shea et al., 2006). Some common factors were found among these studies. The 
study design was predominantly a randomised control trial, except in Albisser et 
al. (1992). In all interventions, patients were contacted at least once a week for 
education, counselling or medication adjustment and were supported by a nurse 
(except in Ahring et al., 1992). The technology at the patient’s home was complex 
in Shea et al. (2006) who used web-based technology and videoconference, 
whereas, in the rest of studies a telephone based system was the technology 
available at home. In relation to patient characteristics, mean age of participants 
ranged from 41 to 60 years (unknown in Albisser et al., 1996) and mean duration 
of disease was greater than 11 years except in Shea et al. (2006) and in Albisser 
et al. (1996). These summarised the common factors that may be worth 
investigating in future research. 
 
Furthermore, telehealth interventions involving nurses were mentioned at least in 
twenty diabetes papers (Kirkman et al., 1994; Marrero et al., 1995; Weinberger et 
al., 1995; Albisser et al., 1996; Thompson et al., 1999; Piette et al., 2000a; Piette 
et al., 2000b; Whitlock et al., 2000; Dansky et al., 2001; Piette et al., 2001; Chase 
et al., 2003; Kim and Oh, 2003; Kruger et al., 2003; Oh et al., 2003; Lavery et al., 
2004; Montori et al., 2004; Bergenstal et al., 2005; Chumbler et al., 2005b; 
Farmer et al., 2005; Shea et al., 2006), in two asthma papers (Kokubu et al., 
1999; Steel et al., 2002), in 3 hypertension studies (Roth et al., 1999; Bondmass 
et al., 2000; Artinian et al., 2001) and in three COPD papers (Dale et al., 2003; 
Wong et al., 2005; Pare et al., 2006). Whereas, interventions by doctors were less 
common in diabetes ((Billiard et al., 1991; Shultz et al., 1992; Meneghini et al., 
1998; Biermann et al., 2000; Liesenfeld et al., 2000; Biermann et al., 2002; 
Gómez et al., 2002; Vähätalo et al., 2004) and more common in hypertension 
 151 
studies (Friedman et al., 1996; Naef et al., 1998; Rogers et al., 2001; Rogers et 
al., 2002; Port et al., 2003; Mengden et al., 2004; Port et al., 2005). This shows a 
preference in having nurses in the frontline of telehealth as they can provide 
education, support, follow up and referral to other health professionals.  
 
7.3.2 Demographics and clinical profiles (Chapter 4) 
This chapter explored the demographics and clinical conditions of individuals who 
participated in a telehealth EU project. Such conditions describe the general 
environment in which patients with chronic diseases need to cope with their 
medical conditions at home. From our analysis, we found statistically significant 
differences amongst the participants of the four clinical groups in terms of age, 
education, marital status, occupation, activity, literacy, ethnicity, location, main 
income, living accommodation, access to social care, carer’s availability and level 
of support. We argued that each difference represents a different condition that 
needs to be taken into account during the telehealth intervention design (we 
tested that hypothesis in chapter 5). For instance, we found that half of the 
participants in London were less than 51 years old, a relatively young population 
likely to have their vision, hearing, psychomotor or cognitive abilities intact. No 
evidence was found that this group reported problems in using the technology. 
However, in the comments quoted from patients ID 8248, 6554, and 8112, in 
section 4.6, a tendency in reporting difficulties when using the technology was 
found. All these patients had in common one factor; they were older than 71 
years. This shows that age can be an important factor when designing telehealth 
interventions.  
 
There is not enough research done to determine the impact of socioecomic 
variables on telehealth. None of the papers reviewed in chapter 3 discussed 
anything related to this matter. However, Or and Karsh (2009) have performed a 
systematic review of patient acceptance of consumer health information 
technology. They found in the majority of studies (with significant relationships) 
that age was negatively associated with acceptance. Or and Karsh also found that 
acceptance increased with higher education and that gender did not show any 
effect. Other socio-economic variables were examined in their study but 
inconclusive conclusions were found. These results may be not surprising, but 
they are important to be studied and evaluated. In our case study, it was found 
that Evora was the group with the poorest social and economical conditions: lower 
education, less skill (manual labour), less active, lower level of literacy, highest 
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proportion of people living in rural areas and reduced conditions in the quality of 
their living condition, whereas the group from Tartu had the best socio-economic 
conditions: higher education, highly trained professionals, inactive by choice, 
literate in the local language, less dependent on state benefits and having good 
quality of living accommodation. By looking at these findings one question 
remains, are socio-economic conditions a limiting factor when adopting 
telehealth? 
 
In addition to the demographics factors, the treatment of chronic diseases can get 
more complicated in the presence of other medical conditions (DeBusk et al., 
1999). In the REALITY project, patients with diabetes, hypertension, chronic heart 
failure, bronchial asthma and chronic respiratory failure were recruited. Apart from 
their primary disease conditions, it was found that patients also suffered from 
other medical conditions (comorbidities). Cases with pulmonary heart disease 
(68/193), hypertension (43/193), diabetes (19/193) and coronary heart disease 
(40/193) were recorded in the four clinical sites. It was also found that some 
patients from the diabetes group also had a history of retinopathy, nephropathy or 
foot ulceration (one case). In Tartu, patients also presented a history of 
myocardial infarction, symptoms of dyspnoea, peripheral oedema or symptoms of 
fatigue. A considerable proportion of the groups with asthma and respiratory 
failure were breathless at rest or minimal effort. The majority of the patients at 
Lisbon and a large proportion at Evora needed oxygen therapy. Notably, more 
than 70% of the patients were either overweight or obese, in whom a significant 
body mass index (BMI) difference was not found (F=1.237, df=3, p=0.298) among 
the four clinical sites. This is an interesting finding, as the analysis showed that 
BMI was independent of the geographic location and of the primary disease 
condition. But it also indicated the need for obesity and weight control 
programmes in the intervention for patients with long term conditions. Under these 
scenarios, the challenge is to deliver appropriate telehealth interventions 
according to specific needs. Therefore, we need to consider not only the primary 
disease conditions, but also to consider comorbidities  in  the process of 
monitoring and treating patients (Gijsen et al., 2001). 
 
Finally, daily life actions can be restricted by the presence of physical, sensory or 
mental impairments, which at the same time can affect the way patients interact 
with technology. The usability of telemonitoring devices especially for individuals 
with reduced mobility or cognitive impairment has been argued as a significant 
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problem (Hardisty et al., 2011). We found that finger and hand movement as well 
as limited vision were common in three out of the four REALITY sites. Hearing 
impairments were common in London, whereas learning disabilities and memory 
problems were common in Portugal. Some patients with learning disabilities and 
memory problems faced major limitations when they interacted with the handheld 
technology. Therefore, another factor to be considered in the design of telehealth 
intervention should include the specific needs of users with psychomotor, 
cognitive, and sensory disabilities. In this way, patients can have access to such 
interventions regardless of their disabilities or severity of their impairments. This is 
in line with the one of the design recommendations for sustainable medical 
informatics given by Ianculescu et al. (2012). 
 
From what we observed in this chapter, the design of telehealth interventions 
needs to take into account four main factors: primary disease conditions, 
demographics and socio-economic status, comorbidities and other health related 
problems, and any other impairments.  
 
7.3.3 Tests for associations (Chapter 5) 
In this chapter, we investigated the association between patient’s demographics 
and patient’s progress during a telehealth project. The progress was evaluated in 
four domains: (i) patient’s understanding, skills and home support (Q1-Q7), (ii) 
decision to proceed with the telehealth service (Q8), (iii) actions for continuing 
patients (Q9-Q10) and (iv) evaluation of additional training (Q11-Q16). We found 
that more than half of the dependent variables (Q1-Q16) were associated with an 
important proportion of the demographic and socio-economic variables presented 
in chapter 4 (except for marital status, activity if retired, carer’s availability, carer’s 
level of supports and gender). These results provide significant evidence that 
support the theory that demographics and socio-economic variables can affect the 
patient’s performance during a telehealth intervention. The strongest statistical 
examples include the existing care provision and access local medical and social 
care, education, general location of patient’s home, age and literacy in local 
language. Notably, patients who had already access to local medical and social 
care were the ones with poorer understanding and skills in the use of the 
technology, also required retraining. In terms of level of education, it was found 
that higher education levels had a positive relationship with the understanding and 
skills needed for patients to use the service (the use of the handheld unit, help 
line, third party devices, etc.). It was also noticed that patients who lived in inner 
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cities had better skills and understanding in how to use the technology, access 
the clinical data and to retrieve messages sent by the clinical staff, and no 
additional precautions were imposed to this group. Finally, it was also found that 
older groups required more assistance, and were more likely to withdraw or 
required retraining. 
 
We found weak, moderate and strong relationships among the demographics and 
socio-economic conditions in different proportions (section 5.4). The findings from 
this chapter support the idea that the performance of patients during a telehealth 
intervention can be associated with patients’ living circumstances and other social 
conditions. As a hypothesis, it has been suggested before that “ home telehealth 
monitoring would work most effectively for patients of higher socio-economic 
status” (Bonne et al., 2008). Our results show presence and strengths of some 
associations, but the mechanisms through which patients’ demographics 
influenced the telehealth service seem to be multiple and more research needs to 
be done. However, the associations found have shown that the demographics of 
patients influences uptake of telehealth. Therefore, socio-economic conditions 
must be considered during the design and implementation of telehealth services. 
 
7.3.4 Clinical outcomes (Chapter 6) 
Paired samples t-tests were conducted to compare the peak expiratory flow (PEF) 
value in patients from Lisbon, Evora and London. Similarly, the difference 
between mean blood pressure (MBP) values before and after the intervention was 
tested by paired t test in patients from Tartu and London. Also any difference 
between HbA1c values before and after the last clinical visit in London was 
tested. None of the t-test results were statistically significant. These results 
indicated that there was not any effect in the patients’ clinical outcomes at the end 
of the telehealth intervention. Similar results have also been found by Farmer et 
al. (2005), Ostojic et al. (2005), Nunn et al. (2006), Nilsson (2009) and Deschildre 
et al. (2012). However, the lack of statistical significance did not mean that 
individual patients had not experience any improvement. Patient 6457 and 8138 
illustrated the kind of response it is expected from telehealth interventions.  
 
We have previously tried to explain why this intervention did not work (REALITY 
Consortium, 2005b). Some real as opposed to ideal circumstances were found 
during the project. Although the motivational level at recruitment stage was high; 
87% of the participants were either very interested (37%) or moderately interested 
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(50%), a few indifferent (4%) or reluctant (3%) and some did not know (6%), by 
the end of the project it was noticed that a large proportion of the patients in 
London (32/62) and Tartu (35/60) did not continue using the system (not more 
than 4 months) unlike patients from Lisbon (30/38) and Evora (22/35) who were 
the slightly more persistent. Reasons for lower service usage and withdrawals 
were not clear. As this was not anticipated, the evaluation forms did not have 
specific questions for explaining this behaviour  (REALITY Consortium, 2005b). 
The four sites had some equipment problems (failure rate up to 24%)  and  it was 
reported (REALITY Consortium, 2005b) that delays and resolving equipment 
problems led to withdrawals.  Some comments from patients related to technology 
and general aspects of the telehealth service are summarised in table 7.1. These 
comments are indicative of the overall situation that patients faced. Technical 
difficulties, lack of time, need for travel or relocation, family circumstances, and 
anxiety caused by the use of the technology were common explanations among 
the clinical sites.  
 
Table 7.1. Patients' comments on technology and general usage [adopted from (REALITY 
Consortium, 2005b)]. 
 Example explanations for 
withdrawals/gaps in home-data 
What didn't work as well as 
expected? 
London * Recent diagnosis of cancer has   
overtaken. 
* My asthma got better therefore not 
use device any more. 
* I became sick so did not use it. 
* Not able to use device abroad. 
* Wanted to do it but I work shifts. 
* My husband died. 
* I do not have the time. 
 
* Patient said too difficult. 
* Feedback was a problem, don't really 
* know what I've entered. 
* Telephone support not helpful.  
* Problems with the telephone line 
Tartu * Patient travels a lot. Inconvenient 
to take the handheld unit with him. 
* Patient moved far away. 
* Health parameters are good and 
he doesn't need frequent monitoring 
anymore. 
* Lack of time. 
* The handheld unit is too difficult to 
use. 
* Inconvenient to travel with the 
handheld unit, unnecessarily large and 
the battery lasts only some hours. 
* ECG registration too slow. Electrodes 
will not last. 
* Measurements take too much time. 
* Feedback - weekly report difficult to 
understand. 
 
Lisbon * Patient and family found the 
equipment too difficult to use. 
* No oximeter at home. 
* Patient was admitted in another 
hospital. 
* Child at home who could have an 
accident with the unit. 
* Found she Had memory difficulties 
that interfered 
* Expected it would be easier. 
* Sending data to the hospital, 
particularly data from oximeter.  
* Connection with the oximeter. 
* Couldn't see the pictures and words 
on the screen. 
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Evora * Patient and carer could never work 
with the oximeter. 
* Had family problems and thought 
this will bring more. 
* Patient's son died on a car 
accident. 
* When I feel good I don't remind the 
device. 
* Patient uses the device only at 
night. In the morning she is very 
busy. 
* Difficult to use device because I'm 
so depressed 
* Device problems. Phone line 
problems. 
* Oximeter very difficult to use (the 
cables and connections). 
 
While several conditions listed in table 7.1 were not the most ideal, patients from 
Portugal had the higher rate of persistency (they were also the sicker and older). 
Lisbon was the group who had the highest rate of persistence (30/38) among the 
four groups and felt more supported by the service while a large proportion of 
patients from Evora (22/35) also continued. Notably, the latter was the group with 
the poorest social and economical conditions: lower education, less skill (manual 
labour), less active, lower level of literacy, highest proportion of people living in 
rural areas and reporting reduced conditions in the quality of their living condition. 
These findings reinforce the idea that factors surrounding the patients’ 
environment play an important role in telehealth. 
 
7.4 Limitations of the research 
Two specific limitations of the research are evident. First, the methods used to 
collect, collate and analyse the data from the REALITY project were not the most 
adequate. We had to obtain the data in the original form and reanalyse them. This 
was a time consuming process as data sets were incomplete and collected for 
other purposes than those of the present research and therefore not all the data 
collected were relevant.  
 
However, the issues of collection, processing, analysis and use of telemonitoring 
data in research trials are not new (Ure and Hanley, 2011). Ure and Hanley 
(2011) argued four stages of the lifecycle of data that involve multiple 
transformations of data in which quality and validity need to be guaranteed: (1) 
data collection/generation by patients at home, (2) transmission and 
transformation (secure server), (3) de-encryption and decision support (call 
centre) and (4) interpretation and validation (health centre). Anomalies found at 
stages 1 and 2 of lifecycle and collection of questionnaires from the clinical sites 
raised questions about the validity of data, but due to the fact that system design 
 157 
and data collection was not under control of the research team, imposing data 
quality were an important limitation. Even though we addressed some of these 
issues by detecting and correcting corrupt or inaccurate records from the original 
record sets, data processing was a relative limitation. 
 
Second, the combination of the three systematic reviews (Bensink et al., 2006a; 
Barlow et al., 2007; Pare et al., 2007) did not take into account any new evidence 
coming from research after 2007 and made the results not exhaustive. However, 
“the evidence base for the value of telemedicine in managing chronic diseases is  
[still] on the whole weak and contradictory” (Wootton, 2012). Most importantly, 
due to the combination and nature of these systematic reviews we cannot neglect 
the heterogeneity of individual studies presented in chapter 3. Such heterogeneity 
explains some of the inconsistency in the results of the studies reviewed. In 
addition, lack of clinical data standards for interventions in the cases of asthma, 
COPD and hypertension made it impossible to evaluate the clinical effectiveness 
of these interventions.  
 
7. 5 Recommendations 
As cited by McLean et al. (2011), the essential steps of a telehealth intervention 
are as follows:  
 Step 1. The patient provides some clinical data that give information about 
his/her health status (e.g. electrocardiography, oxygen saturation or 
glucose measurement). 
 Step 2. Subsequently, the information is transferred electronically to a 
healthcare professional who can view it from his/her current location. 
 Step 3. A clinical decision is made by the healthcare professional who can 
later provide treatment tailored according to the patient’s actual health 
status. 
 
However, although in principle the procedure looks very simple, in fact 
implementation of the intervention can become complicated. For example, in step 
1, clinical data provided by the patient may not be accurate enough since a 
number of mistakes can be made when taking clinical measurements; in step 2, 
some anomalies in the transmission of data can be present; in step 3, scheduling 
communications between the healthcare provider and the patient can be difficult.  
For all these reasons, a standardisation or quality criterion is needed in order to 
create a robust, accurate and reliable telehealth intervention framework. However, 
 158 
it is unlikely that a unique framework will satisfy individual patient’s needs since 
patient profiles vary not only from one medical condition to another but also within 
the same medical condition.  
 
A series of recommendations that can be used by different stakeholders so they 
can take action in order to improve health care, quality of care and health 
information by means of telehealth have been made. 
 
7.5.1 Patients’ individual requirements 
As we discussed in chapter 4, primary disease conditions, demographics 
including socio-economic status, comorbidities, and any other impairment should 
be considered in the design of a telehealth intervention. Taking into account these 
considerations can encourage health care providers to be more flexible and help 
to acknowledge that patients are persons with unique personal histories and 
individual needs (Zandbelt et al., 2007). When health care providers focus on 
patients, their lives and health problems, they promote a patient centred 
approach. Adopting this approach recognises that patients vary in their 
knowledge, skills, psychological adaption and disease trajectory (Gambling and 
Long, 2010) and also recognises that a problem can be defined in terms of its 
physical, psychological and social components (Rolfe and Sanson-Fisher, 2002). 
The advantage of adopting a patient centred approach is that it motivates patients 
to assume an active and independent role in monitoring and treating their disease 
which leads to improved outcomes (Aschner et al., 2007).  
 
7.5.2 Technology 
Technology chosen for telehealth interventions should be safe, easy to use and 
be able to integrate patient data into the electronic patient record (EPR) so an 
accurate clinical decision can be made and treatment tailored according to 
patients’ needs.  
 
Safe intervention. It is desirable that the operating conditions of any intervention 
remain under safe limits and free of hazards to support continuity of care. 
However, such conditions are not always satisfied, and when that happens, errors 
and clinical incidents may occur in healthcare settings. For example, during the 
REALITY project, one of the engineers (JP) raised the concern that there were 
some “points to potential problems in the web server logic; it was even possible, 
that the wrong data were shown to doctors…” The root of this problem was more 
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likely to be attributed to human and technical factors. Safe decision making 
requires access to high quality data and meaningful information that support data 
collection, aggregation, exchange, and retrieval from the point of care setting.  
 
In the UK medical devices require regulatory approval. This approval is 
coordinated by the Medicines and Health Regulatory Authority (MHRA) which 
implements the European medical-device directives into UK law (Heneghan et al., 
2011). Currently there are four medical devices regulations that place obligations 
on manufacturers to ensure that their devices are safe and fit for their intended 
purpose before they can obtain a CE marking (MHRA, 2011). The Statutory 
Instruments that are in place in the UK are: 2002 No. 618, 2003 No. 1697, 2007 
No. 400 and 2008 No 2936 (MHRA, 2011). Although such instruments are in 
place, medical devices may still cause serious adverse effects in patients and 
contribute to additional  healthcare costs (Heneghan et al., 2011). Therefore, 
safety must always be taken into account. 
 
The  risk in telehealth systems depends on a combination of type of users, 
circumstances of use, type of use, and nature of the system (Rigby et al., 2001). 
There is not a specific clinical risk guideline for telehealth, but Connecting for 
Health (CfH, 2009) has published guidance (DSCN 18/2009) related to the 
deployment and use of health software that can be used for identifying clinical 
hazards  and controlling the risks of new systems. The process includes (CfH, 
2009): 
 “identification of current situation, requirements, scope, extent of change 
to the current situation, impact and expected benefits; 
 creation of a clinical risk management plan; 
 setting the requirements for and defining the competencies of personnel; 
 clinical hazard identification; 
 clinical risk analysis; 
 clinical risk evaluation; 
 clinical risk control; 
 residual clinical risk acceptance; 
 creation of clinical safety case report(s); 
 post deployment monitoring and feedback to manufacturers; and 
 review and maintenance of clinical risk management process” 
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The clinical risk management process listed above should be carried out by a 
multi-disciplinary group including clinicians, manufacturers and systems 
integrators. In addition to this process, a functional safety management system 
(Adriano et al., 2011) should be included to overcome any gaps unattended by 
DSCN 18/2009. 
 
Ease of use. In terms of usability, patients from the case study consistently 
claimed that the handheld unit was difficult to use, travelling with the unit was 
inconvenient due to its large size, and the battery only lasted a few hours. 
Patients recommended that the buttons needed to be larger and displays made 
easy to read. Some even suggested that the third party devices (such as the 
blood pressure device) should be integrated within the handheld unit. The system 
should contemplate that some of the users may have a combination of 
impairments such as reduce vision, restricted mobility and poor memory. In order 
to overcome any type of usability problems, a full classification of usability 
requirements for home telehealth systems has been published by Jaspaljeet et al. 
(2010). This classification should help to prevent any individual or system 
limitations, so  we recommend to follow their guidelines (Jaspaljeet et al., 2010): 
 Functionality; (1) the system design should enable patients to interact with 
the system naturally; (2) language should not be a barrier for patients and 
the system should include multilanguage support; (3) scheduling should 
be implemented by useful reminders for monitoring sessions, medications 
and doctor appointments; (4) using interfaces that consist of just one 
screen and a few buttons should reduce computer anxiety; (5) the system 
should be customised according to the users’ level of ability.  
 Understandability; (6) patients need to understand how the system works 
as well as understand what is expected from them when using the system; 
(7) guided instructions in how to use the system should be provided. 
 Interface design; (8) the system should be made readable (avoiding small 
font size and distracting context) and designed to accommodate users 
with visual problems; (9) more pictures than words should be used for 
presenting information; (10) the choice of colours should be appropriate to 
avoid distractions; (11) clear transition between screens should avoid 
confusion about where the users are in the system; 
 Operational support services; (12)  conduct tailored training programmes 
for reducing user’s anxiety and improve self efficacy; (13)  provide 
appropriate technical support and maintenance at home; 
 161 
 Reduce complexity; (14) the system design should incorporate easy data 
entry to collect health information from the patient; (15) tasks should be 
simplified; 
 Feedback; (16) the system should show the health status of the patient at 
an appropriate level of detail and terminology (17) graphical representation 
of health status should be used to visualise progress; 
 Non-functional requirements; (18) the system should be stable, 
interoperate without interruption and provide reliable monitored values and 
(19) the system should support security and data confidentiality. 
 
Data integration into electronic patient records. Ideally, all the data collected 
from the home telehealth intervention should be transmitted directly into the 
electronic patient record (EPR) available at the specific healthcare centre in order 
to provide an efficient patient centred care. Researchers have already 
demonstrated this feasibility of data capture from home monitoring devices into an 
electronic medical record (Shea et al., 2006). Integration between systems is 
important since the ability to exchange data with electronic medical records has 
been related to improvements in process outcomes for patients with chronic 
diseases (Dorr et al., 2007) and associated with success factors to control health 
care costs in the Veteran's Affairs home based primary care programme (Leftwich 
Beales and Edes, 2009). However, proper integration of telehealth data into 
electronic patient records is yet limited by the lack of standards in telehealth 
devices. Continua Health Alliance, a non profit organisation, has focused on 
interoperability aspects, designing guidelines to address the technical barriers of 
interoperability amongst multivendor systems (Wartena et al., 2009), but there are 
still technical and non technical challenges that need to be addressed (Wartena et 
al., 2010). 
 
Continua has focused on the solution of three main barriers (Wartena et al., 
2010): 
 “Technical: design  guidelines to support  interoperable  sensors,  
platforms and  services  and  a  logo  and  certification  program  to  signify  
the  promise  of interoperability to the customer.   
 Regulatory: work  with  regulatory agencies  to  safely  and  effectively  
manage diverse vendor solutions. 
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 Financial: work with leaders in the healthcare  industries to  develop  new 
ways of  addressing  the  costs  of  providing  personal  telehealth  
systems,  such  as  new  reimbursement  models  and  co-pay solutions”. 
 
Continua has focused their efforts of interoperability in the personal area 
networking (PAN) and local area networking (LAN) devices, an application hosting 
device (AHD), a wide area networking (WAN) device, and a health record (HR) 
device (Smart Personal Health, 2010). The interfaces are defined as the PAN, 
LAN, WAN, and x (electronic or personal) health record network (xHRN). At the 
PAN level, The Alliance has incorporated the IEEE 11073 communication 
standard and restricted its use to USB and Bluetooth to Continua Health Alliance 
Version 1 certificate (Wartena et al., 2010). 
 
Continua Health Alliance came into existence to open up and provide guidelines 
for the ecosystem of connected medical devices that was starting to appear a few 
years ago, but its real job has been to ensure the integrity of data as it flows from 
the measuring device to the EPR (Hunn, 2010). Because a variety of EPRs exist 
in the healthcare domain, this makes difficult the exchange of information among 
different systems. Therefore, standard methods for systems to communicate such 
as Health Level 7 (HL7) (an international standard for the transmission of medical 
data) should also be considered as part of the system integration. There are other 
available standards that can be useful to improve the ability to access and 
exchange patient information, but that depends on the kind of EPR to be 
integrated or extended. That can be the case of the International Statistical 
Classification of Diseases and Related Health Problems, 10th Revision (ICD10) or 
the Systematised Nomenclature of Medicine Clinical Terms SNOMED CT among 
others. 
 
7.5.3 Training 
Patients should receive basic training and be evaluated on regular basis in order 
to become more competent in using the telehealth technology. Retraining should 
be expected since the evidence pointed out that training is often an important 
issue. In chapter 5, fig. 5.11 and 5.15 can be observed that almost half of the 
participants of our case study needed additional training (92/193) in how to use 
the handheld unit and use messages from clinicians. The need for additional 
training is not rare. For example, in order to identify work issues and difficulties, 
Sanderson and Atack (2004) conducted a qualitative study on 3 home telehealth 
 163 
programmes. They found that “…patient training in the technology became a 
necessary but repetitive and sometimes unpleasant task for the nurses” 
(Sanderson and Atack, 2004). Similarly, Sandberg et al. (2009) noted that there is 
a “…call for additional, or perhaps ongoing, training and technology support for 
older adult patients involved in telehealth”.  In home blood pressure monitoring, 
clinicians have made their own observation stating that in order to achieve a more 
appropriate use of automated measuring devices, better patient training is needed 
(Parati et al., 2006).  
 
Guidelines about evaluation for further training in teleheatlh were not found. This 
makes sense as each technology may have its own complexity. In chapter 4, the 
need for additional training by the minimum task a patient would need to perform 
was evaluated by:   
 Measurement using the handheld/accessories,  
 Measurement using third party devices,  
 Transfer of data using telephone line,  
 Completion of EQ5D questionnaire,  
 Use of messages from clinician and 
 Use of telephone helpline. 
 
Lai et al. (2006) also identified a number of skills needed to use their telehealth 
system that included 5 tasks:  
 Logging into the telehealth website;  
 Reviewing monitoring data;  
 Entering pedometer data;   
 Sending messages to a provider;   
 Reviewing messages from a provider. 
 
From the above examples we recommend at least to evaluate 4 tasks: 
 Measuring biomedical data  
 Transferring  data from the third party device (if any) to the telehealth unit 
 Sending data from the telehealth unit to the healthcare facility 
 Receiving data from health care providers 
 
7.5.4 Clinical intervention 
Clinical protocols should be developed for specific diseases and action limits 
should be defined. Also the purpose of the monitoring intervention should be 
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defined. Detection of slight changes in vital signs can alert health care providers 
to take actions before the health of the patient deteriorates. However, basic 
questions need to be answered such as how often the patient would send data or 
be monitored? Who takes responsibility for monitoring patients and making a 
phone call or home visit? When would the patient’s doctor be contacted? What 
parameters would be monitored? What sort of decision support systems is 
needed to support care providers in automated tasks?  
 
As any other new clinical intervention, telehealth interventions should be 
evaluated before being integrated in ordinary health care (Loane and Wootton, 
2002). However, clinical effectiveness still needs to be demonstrated. It was 
argued before that patients’ needs vary not only from one medical condition to 
another but also within the same medical condition. Variation of need can be 
observed in the Kaiser Permanente risk pyramid (fig. 7.3). In level 3, patients are 
with multiple and complex conditions (limited mobility). In level 2 patients are at 
high risk but can be managed at home. In level 1, patients are more stable and 
can be manage by self-care. Patients should be managed according to their 
chronic disease risk and the support provided should be according to that risk 
associated (Ham, 2010).  
 
 
Figure 7.3. The Kaiser Permanente risk pyramid. Taken from (Ham, 2010). 
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Kaiser Permanente has shown that providing patients with on call home telehealth 
nurse by remote video technology was well accepted by patients, capable of 
maintaining quality of care, effective and save costs (Johnston et al., 2000).  
 
Another conceptual model for disease management that has been proposed 
includes the following main features (Krumholz et al., 2006):  
 Patient population   
 Intervention recipient  
 Intervention content  
 Delivery personnel  
 Method of communication  
 Environment   
 Clinical outcomes 
 
The classification of disease management above should help to compare 
structures, process and outcome and promote uniformity in the design and 
conduct studies that look for validation of disease management strategies 
(Krumholz et al., 2006). 
 
7.5.5 Health care providers 
A group of different disciplines within the healthcare setting should be defined for 
specific telehealth interventions. As it was described in chapter 3, nurses, in 
preference, should be the intermediary healthcare providers between the patients 
and the consultant. They have begun to play unconventional roles in home 
telehealth, including installation of telehealth technology and training of patients 
(Starren et al., 2005). 
 
7.5.6 Clinical Effectiveness 
All the recommendations mentioned above have to be met before any attempt to 
demonstrate clinical effectiveness is made. At present, the most robust study 
design for evaluating effectiveness of a single intervention is randomised control 
trials (Chumbler et al., 2011).  
 
Considering that there may be some participant withdrawals from future studies, 
as it happened in the REALITY project, and in order not to lose statistical power; 
an ample sample size should be sought. In addition to this, if the conditions allow 
it, the intervention should last more than 6 months (preferably 1 year or more).  
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Furthermore, in order to produce a meta-analysis, when reporting the results of 
these studies it is recommended to report as much data as possible, mainly mean 
values and standard deviations (if it is continuous data). It is also recommended 
that the use of common outcome measures within clinical studies be 
standardised.  
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Chapter 8. Conclusions 
 
 
8.1 Overview 
In this chapter we summarise the research contributions, review the aim and 
objectives, and discuss the future research necessary to help overcome the 
current limitations of this research. 
 
As has been shown in the profiles of the patients participating in the REALITY 
project (chapter 4), chronic diseases are very complex conditions in which two or 
more disease processes may coexist. For example, patients with diabetes can 
develop retinopathy, nephropathy, foot ulceration or a combination of them, and 
these complications can restrict patients’ ability to do basic daily living activities. 
Therefore, managing patients with these conditions represents a major challenge 
to public health, since 80% of total GP consultations are related to these groups, 
and 5% of them represent roughly 42% of the total acute bed day occupancy (DH, 
2004; DH, 2005b) as  has been discussed in chapter 2. 
 
Nowadays, the tendency is to bring patients from high levels of care to primary 
care and home settings. In this scenario, telehealth is one of the methods that can 
be used to improve and provide access to home remote patient monitoring  
important in patients with chronic diseases as it can help to recognise any signs of 
deterioration, provide health education and support management of their 
condition. 
 
Potentially, telehealth can reduce deaths, emergency visits, A&E visits, elective 
admissions and bed stays, and cost (Steventon et al., 2012). This can be done by 
designing and implementing proper telehealth interventions that reduce 
unnecessary visits to specialised healthcare services and monitor patients 
remotely at home.  However, as shown in chapter 3, there is not a unique 
backbone for designing telehealth interventions. Designing and implementing 
telehealth interventions are not straightforward. According to Mair et al. (2012) the 
factors that promote or inhibit the implementation processes by which new health 
technologies and other complex interventions are routinely operational in 
everyday work are coherence (sense making work), cognitive participation 
(relationship work), collective action (enacting work) and reflexive monitoring 
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(appraisal work). In order to design a robust, accurate and reliable intervention a 
number of important factors that have been ignored in previous papers have to be 
taken into account. In addition to patient training, these factors include patients’ 
individual requirements, technology to ensure safe interventions, ease of use, and 
data integration to electronic patient records, and clinical interventions such as 
development of procedures and allocation of staff appropriate to the 
corresponding health intervention. Without all these requirements in place a 
telehealth intervention is unlikely to show clinical effectiveness. 
 
8.2 Summary of contributions 
The contributions of this research can be summarised as follows: 
 Standardisation of common outcome measures to facilitate comparison 
among studies has been recommended. 
 It has been demonstrated that meta-analysis can be used to determine 
from a quantitative approach the best case study in telehealth, for 
example, in the case of diabetes considered here. 
 This research has provided an overall picture that telehealth interventions 
should be designed according to the patients’ individual profiles and 
needs.  
 Evidence that demographics and socio-economic variables can affect the 
patients’ performance during a telehealth intervention has been provided. 
The strongest statistical examples include existing care provision and 
access to local medical and social care, age, education, general location 
of patient’s home, and literacy in local language. 
 A recommendation framework has been developed that includes the 
following components: patients’ individual requirements, technology, 
training, clinical intervention, health care provider, and clinical 
effectiveness. 
 
8.3 Review of the aim and objectives 
The aim of this research was to develop a framework applicable to a broad 
spectrum of telehealth interventions for patients with long term conditions. This 
has been achieved by meeting the following objectives:  
 
1. To provide a comprehensive review of literature on telehealth. This has been 
reviewed and achieved in chapters 2 and 3. In chapter 2 some general topics 
such as definitions, life expectancy, health demand, benefits of telehealth, factors 
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of success and evaluation have been covered. In chapter 3, key research 
publications that addressed home monitoring in the management of diabetes, 
asthma, chronic obstructive pulmonary disease (COPD) and hypertension were 
identified. 
 
2. To identify the most effective telehealth interventions in the cases of diabetes, 
asthma, chronic obstructive pulmonary disease and hypertension. 67 papers were 
identified and systematically reviewed in the cases of diabetes, hypertension, 
COPD and asthma and the main results were summarised using the PICO model 
for each paper. Additionally, we carried out a meta-analysis in the case of 
diabetes.  
 
3. To investigate any relationship between demographics, socio-economic status 
and patient’s performance on telehealth. Chapter 4 covered all the patient 
demographics from the case study (REALITY project) that was used for achieving 
this objective. In Chapter 5, the relationships between patients’ demographics and 
performance were investigated. A set of indicators were selected from the case 
study data and test for associations were performed.   
 
4. To evaluate the clinical effectiveness of a telehealth intervention. This has been 
achieved in two parts: chapter 3 and 6. In chapter 3, clinical effectiveness was 
evaluated by performing meta-analysis for the case of diabetes telehealth 
interventions, and in chapter 6, an evaluation of the case study was performed 
before and after by using a number of t-tests for different clinical sites. 
   
5. To summarise findings and make recommendations. Summary of the findings 
and recommendations can be found in chapter 7. This chapter includes a number 
of recommendations made in order to achieve the aim of the study.  
 
 
8.4 Future research 
A number of recommendations have been made in order to carry out future work 
in this area of research: 
 
1. The framework should be evaluated using real case scenarios and identify any 
flaws present within the recommendations.  
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2. The framework should be expanded by adding patients’ privacy and 
confidentiality and legal aspects. These aspects are important concerns in any 
telehealth initiative since it has been reported as one of the sources of anxiety 
(Kidd et al., 2010). 
 
3. Integration of home data collection with EPR systems is still an issue for a 
patient centred approach. More research is needed in this matter in order to 
satisfy the framework.  
 
4. Further research needs to be done to fully understand the association between 
demographics and patient’s performance. 
 
5. A major limitation of the present research is the fact that the case study did not 
contain information on either staff characteristics or their behaviour regarding 
telehealth interventions. Further research should overcome this limitation and 
integrate that knowledge into the framework. 
 
6. Due to the variations among the different telehealth interventions and the lack 
of reliable and sufficient data available in the literature, further research need to 
be done in order to guarantee that our framework recommendations can be 
generalised. 
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